Covert Observation of Hand Hygiene

Article Type
Changed
Mon, 01/02/2017 - 19:34
Display Headline
Do physicians clean their hands? Insights from a covert observational study

Hand hygiene (HH) is believed to be one of the single most important interventions to prevent healthcare‐associated infection, yet physicians are notorious for their poor compliance.[1, 2, 3] At our 800‐bed acute care academic hospital, we implemented a multifaceted HH program[4] in 2007, which was associated with improved HH compliance rates from 43% to 87%. Despite this improvement, HH compliance among physicians remained suboptimal, with rates below 60% in some patient areas. A targeted campaign focused on recruitment of physician champions, resulted in some improvement, but physician compliance has consistently remained below performance of nurses (70%75% for physicians vs 85%90% for nurses).

Our experience parallels the results seen in multinational surveys demonstrating consistently lower physician HH compliance.[5] Given the multiple improvement efforts directed at physicians and the apparent ceiling observed in HH performance, we wanted to confirm whether physicians are truly recalcitrant to cleaning their hands, or whether lower compliance among physicians reflected a differential in the Hawthorne effect inherent to direct observation methods. Specifically, we wondered if nurses tend to recognize auditors more readily than physicians and therefore show higher apparent HH compliance when auditors are present. We also wanted to verify whether the behavior of attending physicians influenced compliance of their physician trainees. To test these hypotheses, we trained 2 clinical observers to covertly measure HH compliance of nurses and physicians on 3 different clinical services.

METHODS

Between May 27, 2015 and July 31, 2015, 2 student observers joined clinical rotations on physician and nursing teams, respectively. Healthcare teams were unaware that the student observers were measuring HH compliance during their clinical rotation. Students rotated in the emergency department, general medical and surgical wards for no more than 1 week at a time to increase exposure to different providers and minimize risk of exposing the covert observation.

Prior to the study period, the students underwent training and validation with a hospital HH auditor at another clinical setting offsite to avoid any recognition of these students by healthcare providers as observers of HH at the main hospital. Training with the auditors occurred until interobserver agreement between all HH opportunities reached 100% agreement for 2 consecutive observation days.

During their rotations, students covertly recorded HH compliance based on moments of hand hygiene[4] and also noted location, presence, and compliance of the attending physician, team size during patient encounter, and isolation requirements. Both students measured HH compliance of nurses and physicians around them. Although students spent the majority of their time with their assigned physician or nurse teams, they did not limit their observations to these individuals only, but recorded compliance of any nurse or physician on the ward as long as they were within sight during an HH opportunity. To limit clustering of observations of the same healthcare worker, up to a maximum of 2 observations per healthcare worker per day was recorded.

We compared covertly measured HH compliance with data from overt observation by hospital auditors during the same time period. Differences in proportion of HH compliance were compared with hospital audits during the same period with a 2 test. Difference between differences in overtly and covertly measured HH compliance for nurses and physicians was compared using Breslow day test.

The study was approved by the hospital's research ethics board. Although deception was used in this study,[2, 6] all data were collected for quality improvement purposes, and the aggregate results were disclosed to hospital staff following the study.

RESULTS

Covertly observed HH compliance was 50.0% (799/1597) compared with 83.7% (2769/3309) recorded by hospital auditors during the same time period (P < 0.0002) (Table 1). There was no significant difference in the compliance measured by each student (50.1%, 473/928 vs 48.7%, 326/669) (P = 0.3), and their results were combined for the rest of the analysis. Compliance before contact with the patient or patient environment was 43.1% (344/798), 74.3% (26/35) before clean/aseptic procedures, 34.8% (8/23) after potential body fluid exposure, and 56.8% (483/851) after contact with the patient or patient environment. Healthcare providers examining patients with isolation precautions were found to have a HH compliance of 74.8% (101/135) compared to 47.0% (385/820) when isolation precautions were not required (P < 0.0002).

Hand Hygiene Compliance Across Clinical Services and Professional Groupings as Measured by Covert Observers and Hospital Auditors During the Study Period
Covert Observers, Compliance (95% CI) Hospital Auditors, Compliance (95% CI) Difference
  • NOTE: Abbreviations: CI, confidence interval. *When attending physicians cleaned their hands. When attending physicians did not clean their hands.

Overall hand hygiene compliance 50.0% (47.6‐52.5) 83.7% (82.4‐84.9) 33.7%
Service
Medicine 58.9% (55.3‐62.5) 85.0% (82.7‐87.3) 26.1%
Surgery 45.7% (41.6‐49.8) 91.0% (87.5‐93.7) 45.3%
Emergency 43.9% (38.9‐49.9) 73.8% (68.9‐78.2) 29.9%
Nurses 45.1% (41.5‐48.7) 85.8% (83.3‐87.9) 40.7%
Physicians
Overall compliance 54.2% (50.9‐57.1) 73.2% (67.3‐78.4) 19.0%
Trainee compliance* 79.5% (73.6‐84.3)
Trainee compliance 18.9% (13.3‐26.1)

Hospital auditor data showed that surgery and medicine had similarly high rates of compliance (91.0% and 85.0%, respectively), whereas the emergency department had a notably lower rate of 73.8%. Covert observation confirmed a lower rate in the emergency department (43.9%), but showed a higher compliance on general medicine than on surgery (58.9% vs 45.7%; P = 0.02). The difference in physician compliance between hospital auditors and covert observers was 19.0% (73.2%, 175/239 vs. 54.2%, 469/865); for nurses this difference was much higher at 40.7% (85.8%, 754/879 vs. 45.1%, 330/732) (P < 0.0001) (Table 1).

In terms of physician compliance, primary teams tended to have lower HH compliance of 50.4% (323/641) compared with consulting services at 57.0% (158/277) (P = 0.06). Team rounds of 3 members were associated with higher compliance compared with encounters involving <3 members (62.1%, 282/454 vs. 42.0%, 128/308) (P < 0.0002). Presence of attending physician did not affect trainee HH compliance (55.5%, 201/362 when attending present vs. 56.8%, 133/234 when attending absent; P = 0.79). However, trainee HH compliance improved markedly when attending staff cleaned their hands and decreased markedly when they did not (79.5%, 174/219 vs. 18.9%, 27/143; P < 0.0002).

DISCUSSION

We introduced covert HH observers at our hospital to determine whether differences in Hawthorne effect accounted for measured disparity between physician HH compliance, and to gain further insights into the barriers and enablers of physician HH compliance. We discovered that performance differences between physicians and nurses decreased when neither group was aware that HH was being measured, suggesting that healthcare professions are differentially affected by the Hawthorne effect. This difference may be explained by the continuity of nurses on the ward that makes them more aware of visitors like HH auditors,[7] compared with physicians who rotate periodically on the ward.

Although hospital auditors play a central role in HH education through in‐the‐moment feedback, use of these data to benchmark performance can lead to inappropriate inferences about HH compliance. Prior studies using automated HH surveillance have suggested that the magnitude of the Hawthorne effect varies based on baseline HH rates,[8] whereas our study suggests a differential Hawthorne effect between professions and clinical services. If we relied only on auditor data, we would have continued to believe that only physicians in our organization had poor HH compliance, and we would not be aware of the global nature of the HH problem.

Our results are similar to that of Pan et al., who used covert medical students to measure HH and found compliance of 44.1% compared with 94.1% by unit auditors.[2] Because their study involved an active feedback intervention, the differential in Hawthorne effect between professions could not be reliably assessed. However, they observed a progressive increase in nurse HH compliance using covert observation methods, suggesting improvement in HH performance independent of observer bias.[7]

Covert observation in our study also provided important insights regarding barriers and enablers of HH compliance. Self‐preservation behaviors were common among both nurses and physicians, as HH compliance was consistently higher after patient contact compared to before or when seeing patients who required additional precautions. This finding confirms that the perceived risk of transmission seems to be a powerful motivating factor for HH.[9] Larger groups of trainees were more likely to clean their hands, likely due to peer effects.[10] The strong impact of role modeling on HH was also noted as previously suggested in the literature,[3, 6] but our study captures the magnitude of this effect. Whether or not the attending physician cleaned their hands during rounds either positively or negatively influenced HH compliance of the rest of the physician team (80% when compliant vs 20% when noncompliant).

Our study has several important limitations. The differential Hawthorne effect seen at our center may not reflect other institutions that have numerous HH auditors or high staff turnover resulting in lower ability to recognize auditors. We cannot exclude the possibility of Hawthorne effect using covert methods that could have affected nurse and physician performance differently, but frequent rotation of the students helped maintain covertness of observations. Finally, due to the nature of the covert student observers, a longer observation time frame could not be sustained.

Our experience using covert HH auditors suggests that traditional HH audits not only overstate HH performance overall, but can lead to inaccurate inferences regarding HH performance due to relative differences in Hawthorne effect. The answer to the question regarding whether physicians clean their hands appears to be that they do just as often as nurses, but that all healthcare workers have tremendous room for improvement. We suggest that future improvement efforts will rely on more accurate HH monitoring systems and strong attending physician leadership to set an example for trainees.

Disclosures

This study was jointly funded by the Centre for Quality Improvement and Patient Safety of the University of Toronto in collaboration with Sunnybrook Health Sciences Centre. All authors report no conflicts of interest relevant to this article.

Files
References
  1. World Health Organization. WHO guidelines on hand hygiene in health care. Available at: http://whqlibdoc.who.int/publications/2009/9789241597906_eng.pdf. Accessed April 4th, 2015.
  2. Pan SC, Tien KL, Hung IC, et al. Compliance of health care workers with hand hygiene practices: independent advantages of overt and covert observers. PLoS One. 2013;8:e53746.
  3. Squires JE, Linklater S, Grimshaw JM, et al. Understanding practice: factors that influence physician hand hygiene compliance. Infect Control Hosp Epidemiol. 2014;35:15111520.
  4. (JCYH) Just Clean Your Hands. Ontario Agency for Health Promotion and Protection. Available at: http://www.publichealthontario.ca/en/BrowseByTopic/InfectiousDiseases/JustCleanYourHands/Pages/Just‐Clean‐Your‐Hands.aspx. Accessed August 4, 2015.
  5. Allegranzi B, Gayet‐Ageron A, Damani N, et al. Global implementation of WHO's multimodal strategy for improvement of hand hygiene: a quasi‐experimental study. Lancet Infect Dis. 2013;13:843851.
  6. Schneider J, Moromisato D, Zemetra B, et al. Hand hygiene adherence is influenced by the behavior of role models. Pediatr Crit Care Med. 2009;10:360363.
  7. Srigley JA, Furness CD, Baker GR, Gardam M. Quantification of the Hawthorne effect in hand hygiene compliance monitoring using an electronic monitoring system: a retrospective cohort study. BMJ Qual Saf. 2014;23:974980.
  8. Kohli E, Ptak J, Smith R, et al. Variability in the Hawthorne effect with regard to hand hygiene performance in high‐ and low‐performing inpatient care units. Infect Control Hosp Epidemiol. 2009;30:222225.
  9. Borg MA, Benbachir M, Cookson BD, et al. Self‐protection as a driver for hand hygiene among healthcare workers. Infect Control. 2009;30:578580.
  10. Monsalve MN, Pemmaraju SV, Thomas GW et al. Do peer effects improve hand hygiene adherence among healthcare workers? Infect Control Hosp Epidemiol. 2014;35:12771285.
Article PDF
Issue
Journal of Hospital Medicine - 11(12)
Page Number
862-864
Sections
Files
Files
Article PDF
Article PDF

Hand hygiene (HH) is believed to be one of the single most important interventions to prevent healthcare‐associated infection, yet physicians are notorious for their poor compliance.[1, 2, 3] At our 800‐bed acute care academic hospital, we implemented a multifaceted HH program[4] in 2007, which was associated with improved HH compliance rates from 43% to 87%. Despite this improvement, HH compliance among physicians remained suboptimal, with rates below 60% in some patient areas. A targeted campaign focused on recruitment of physician champions, resulted in some improvement, but physician compliance has consistently remained below performance of nurses (70%75% for physicians vs 85%90% for nurses).

Our experience parallels the results seen in multinational surveys demonstrating consistently lower physician HH compliance.[5] Given the multiple improvement efforts directed at physicians and the apparent ceiling observed in HH performance, we wanted to confirm whether physicians are truly recalcitrant to cleaning their hands, or whether lower compliance among physicians reflected a differential in the Hawthorne effect inherent to direct observation methods. Specifically, we wondered if nurses tend to recognize auditors more readily than physicians and therefore show higher apparent HH compliance when auditors are present. We also wanted to verify whether the behavior of attending physicians influenced compliance of their physician trainees. To test these hypotheses, we trained 2 clinical observers to covertly measure HH compliance of nurses and physicians on 3 different clinical services.

METHODS

Between May 27, 2015 and July 31, 2015, 2 student observers joined clinical rotations on physician and nursing teams, respectively. Healthcare teams were unaware that the student observers were measuring HH compliance during their clinical rotation. Students rotated in the emergency department, general medical and surgical wards for no more than 1 week at a time to increase exposure to different providers and minimize risk of exposing the covert observation.

Prior to the study period, the students underwent training and validation with a hospital HH auditor at another clinical setting offsite to avoid any recognition of these students by healthcare providers as observers of HH at the main hospital. Training with the auditors occurred until interobserver agreement between all HH opportunities reached 100% agreement for 2 consecutive observation days.

During their rotations, students covertly recorded HH compliance based on moments of hand hygiene[4] and also noted location, presence, and compliance of the attending physician, team size during patient encounter, and isolation requirements. Both students measured HH compliance of nurses and physicians around them. Although students spent the majority of their time with their assigned physician or nurse teams, they did not limit their observations to these individuals only, but recorded compliance of any nurse or physician on the ward as long as they were within sight during an HH opportunity. To limit clustering of observations of the same healthcare worker, up to a maximum of 2 observations per healthcare worker per day was recorded.

We compared covertly measured HH compliance with data from overt observation by hospital auditors during the same time period. Differences in proportion of HH compliance were compared with hospital audits during the same period with a 2 test. Difference between differences in overtly and covertly measured HH compliance for nurses and physicians was compared using Breslow day test.

The study was approved by the hospital's research ethics board. Although deception was used in this study,[2, 6] all data were collected for quality improvement purposes, and the aggregate results were disclosed to hospital staff following the study.

RESULTS

Covertly observed HH compliance was 50.0% (799/1597) compared with 83.7% (2769/3309) recorded by hospital auditors during the same time period (P < 0.0002) (Table 1). There was no significant difference in the compliance measured by each student (50.1%, 473/928 vs 48.7%, 326/669) (P = 0.3), and their results were combined for the rest of the analysis. Compliance before contact with the patient or patient environment was 43.1% (344/798), 74.3% (26/35) before clean/aseptic procedures, 34.8% (8/23) after potential body fluid exposure, and 56.8% (483/851) after contact with the patient or patient environment. Healthcare providers examining patients with isolation precautions were found to have a HH compliance of 74.8% (101/135) compared to 47.0% (385/820) when isolation precautions were not required (P < 0.0002).

Hand Hygiene Compliance Across Clinical Services and Professional Groupings as Measured by Covert Observers and Hospital Auditors During the Study Period
Covert Observers, Compliance (95% CI) Hospital Auditors, Compliance (95% CI) Difference
  • NOTE: Abbreviations: CI, confidence interval. *When attending physicians cleaned their hands. When attending physicians did not clean their hands.

Overall hand hygiene compliance 50.0% (47.6‐52.5) 83.7% (82.4‐84.9) 33.7%
Service
Medicine 58.9% (55.3‐62.5) 85.0% (82.7‐87.3) 26.1%
Surgery 45.7% (41.6‐49.8) 91.0% (87.5‐93.7) 45.3%
Emergency 43.9% (38.9‐49.9) 73.8% (68.9‐78.2) 29.9%
Nurses 45.1% (41.5‐48.7) 85.8% (83.3‐87.9) 40.7%
Physicians
Overall compliance 54.2% (50.9‐57.1) 73.2% (67.3‐78.4) 19.0%
Trainee compliance* 79.5% (73.6‐84.3)
Trainee compliance 18.9% (13.3‐26.1)

Hospital auditor data showed that surgery and medicine had similarly high rates of compliance (91.0% and 85.0%, respectively), whereas the emergency department had a notably lower rate of 73.8%. Covert observation confirmed a lower rate in the emergency department (43.9%), but showed a higher compliance on general medicine than on surgery (58.9% vs 45.7%; P = 0.02). The difference in physician compliance between hospital auditors and covert observers was 19.0% (73.2%, 175/239 vs. 54.2%, 469/865); for nurses this difference was much higher at 40.7% (85.8%, 754/879 vs. 45.1%, 330/732) (P < 0.0001) (Table 1).

In terms of physician compliance, primary teams tended to have lower HH compliance of 50.4% (323/641) compared with consulting services at 57.0% (158/277) (P = 0.06). Team rounds of 3 members were associated with higher compliance compared with encounters involving <3 members (62.1%, 282/454 vs. 42.0%, 128/308) (P < 0.0002). Presence of attending physician did not affect trainee HH compliance (55.5%, 201/362 when attending present vs. 56.8%, 133/234 when attending absent; P = 0.79). However, trainee HH compliance improved markedly when attending staff cleaned their hands and decreased markedly when they did not (79.5%, 174/219 vs. 18.9%, 27/143; P < 0.0002).

DISCUSSION

We introduced covert HH observers at our hospital to determine whether differences in Hawthorne effect accounted for measured disparity between physician HH compliance, and to gain further insights into the barriers and enablers of physician HH compliance. We discovered that performance differences between physicians and nurses decreased when neither group was aware that HH was being measured, suggesting that healthcare professions are differentially affected by the Hawthorne effect. This difference may be explained by the continuity of nurses on the ward that makes them more aware of visitors like HH auditors,[7] compared with physicians who rotate periodically on the ward.

Although hospital auditors play a central role in HH education through in‐the‐moment feedback, use of these data to benchmark performance can lead to inappropriate inferences about HH compliance. Prior studies using automated HH surveillance have suggested that the magnitude of the Hawthorne effect varies based on baseline HH rates,[8] whereas our study suggests a differential Hawthorne effect between professions and clinical services. If we relied only on auditor data, we would have continued to believe that only physicians in our organization had poor HH compliance, and we would not be aware of the global nature of the HH problem.

Our results are similar to that of Pan et al., who used covert medical students to measure HH and found compliance of 44.1% compared with 94.1% by unit auditors.[2] Because their study involved an active feedback intervention, the differential in Hawthorne effect between professions could not be reliably assessed. However, they observed a progressive increase in nurse HH compliance using covert observation methods, suggesting improvement in HH performance independent of observer bias.[7]

Covert observation in our study also provided important insights regarding barriers and enablers of HH compliance. Self‐preservation behaviors were common among both nurses and physicians, as HH compliance was consistently higher after patient contact compared to before or when seeing patients who required additional precautions. This finding confirms that the perceived risk of transmission seems to be a powerful motivating factor for HH.[9] Larger groups of trainees were more likely to clean their hands, likely due to peer effects.[10] The strong impact of role modeling on HH was also noted as previously suggested in the literature,[3, 6] but our study captures the magnitude of this effect. Whether or not the attending physician cleaned their hands during rounds either positively or negatively influenced HH compliance of the rest of the physician team (80% when compliant vs 20% when noncompliant).

Our study has several important limitations. The differential Hawthorne effect seen at our center may not reflect other institutions that have numerous HH auditors or high staff turnover resulting in lower ability to recognize auditors. We cannot exclude the possibility of Hawthorne effect using covert methods that could have affected nurse and physician performance differently, but frequent rotation of the students helped maintain covertness of observations. Finally, due to the nature of the covert student observers, a longer observation time frame could not be sustained.

Our experience using covert HH auditors suggests that traditional HH audits not only overstate HH performance overall, but can lead to inaccurate inferences regarding HH performance due to relative differences in Hawthorne effect. The answer to the question regarding whether physicians clean their hands appears to be that they do just as often as nurses, but that all healthcare workers have tremendous room for improvement. We suggest that future improvement efforts will rely on more accurate HH monitoring systems and strong attending physician leadership to set an example for trainees.

Disclosures

This study was jointly funded by the Centre for Quality Improvement and Patient Safety of the University of Toronto in collaboration with Sunnybrook Health Sciences Centre. All authors report no conflicts of interest relevant to this article.

Hand hygiene (HH) is believed to be one of the single most important interventions to prevent healthcare‐associated infection, yet physicians are notorious for their poor compliance.[1, 2, 3] At our 800‐bed acute care academic hospital, we implemented a multifaceted HH program[4] in 2007, which was associated with improved HH compliance rates from 43% to 87%. Despite this improvement, HH compliance among physicians remained suboptimal, with rates below 60% in some patient areas. A targeted campaign focused on recruitment of physician champions, resulted in some improvement, but physician compliance has consistently remained below performance of nurses (70%75% for physicians vs 85%90% for nurses).

Our experience parallels the results seen in multinational surveys demonstrating consistently lower physician HH compliance.[5] Given the multiple improvement efforts directed at physicians and the apparent ceiling observed in HH performance, we wanted to confirm whether physicians are truly recalcitrant to cleaning their hands, or whether lower compliance among physicians reflected a differential in the Hawthorne effect inherent to direct observation methods. Specifically, we wondered if nurses tend to recognize auditors more readily than physicians and therefore show higher apparent HH compliance when auditors are present. We also wanted to verify whether the behavior of attending physicians influenced compliance of their physician trainees. To test these hypotheses, we trained 2 clinical observers to covertly measure HH compliance of nurses and physicians on 3 different clinical services.

METHODS

Between May 27, 2015 and July 31, 2015, 2 student observers joined clinical rotations on physician and nursing teams, respectively. Healthcare teams were unaware that the student observers were measuring HH compliance during their clinical rotation. Students rotated in the emergency department, general medical and surgical wards for no more than 1 week at a time to increase exposure to different providers and minimize risk of exposing the covert observation.

Prior to the study period, the students underwent training and validation with a hospital HH auditor at another clinical setting offsite to avoid any recognition of these students by healthcare providers as observers of HH at the main hospital. Training with the auditors occurred until interobserver agreement between all HH opportunities reached 100% agreement for 2 consecutive observation days.

During their rotations, students covertly recorded HH compliance based on moments of hand hygiene[4] and also noted location, presence, and compliance of the attending physician, team size during patient encounter, and isolation requirements. Both students measured HH compliance of nurses and physicians around them. Although students spent the majority of their time with their assigned physician or nurse teams, they did not limit their observations to these individuals only, but recorded compliance of any nurse or physician on the ward as long as they were within sight during an HH opportunity. To limit clustering of observations of the same healthcare worker, up to a maximum of 2 observations per healthcare worker per day was recorded.

We compared covertly measured HH compliance with data from overt observation by hospital auditors during the same time period. Differences in proportion of HH compliance were compared with hospital audits during the same period with a 2 test. Difference between differences in overtly and covertly measured HH compliance for nurses and physicians was compared using Breslow day test.

The study was approved by the hospital's research ethics board. Although deception was used in this study,[2, 6] all data were collected for quality improvement purposes, and the aggregate results were disclosed to hospital staff following the study.

RESULTS

Covertly observed HH compliance was 50.0% (799/1597) compared with 83.7% (2769/3309) recorded by hospital auditors during the same time period (P < 0.0002) (Table 1). There was no significant difference in the compliance measured by each student (50.1%, 473/928 vs 48.7%, 326/669) (P = 0.3), and their results were combined for the rest of the analysis. Compliance before contact with the patient or patient environment was 43.1% (344/798), 74.3% (26/35) before clean/aseptic procedures, 34.8% (8/23) after potential body fluid exposure, and 56.8% (483/851) after contact with the patient or patient environment. Healthcare providers examining patients with isolation precautions were found to have a HH compliance of 74.8% (101/135) compared to 47.0% (385/820) when isolation precautions were not required (P < 0.0002).

Hand Hygiene Compliance Across Clinical Services and Professional Groupings as Measured by Covert Observers and Hospital Auditors During the Study Period
Covert Observers, Compliance (95% CI) Hospital Auditors, Compliance (95% CI) Difference
  • NOTE: Abbreviations: CI, confidence interval. *When attending physicians cleaned their hands. When attending physicians did not clean their hands.

Overall hand hygiene compliance 50.0% (47.6‐52.5) 83.7% (82.4‐84.9) 33.7%
Service
Medicine 58.9% (55.3‐62.5) 85.0% (82.7‐87.3) 26.1%
Surgery 45.7% (41.6‐49.8) 91.0% (87.5‐93.7) 45.3%
Emergency 43.9% (38.9‐49.9) 73.8% (68.9‐78.2) 29.9%
Nurses 45.1% (41.5‐48.7) 85.8% (83.3‐87.9) 40.7%
Physicians
Overall compliance 54.2% (50.9‐57.1) 73.2% (67.3‐78.4) 19.0%
Trainee compliance* 79.5% (73.6‐84.3)
Trainee compliance 18.9% (13.3‐26.1)

Hospital auditor data showed that surgery and medicine had similarly high rates of compliance (91.0% and 85.0%, respectively), whereas the emergency department had a notably lower rate of 73.8%. Covert observation confirmed a lower rate in the emergency department (43.9%), but showed a higher compliance on general medicine than on surgery (58.9% vs 45.7%; P = 0.02). The difference in physician compliance between hospital auditors and covert observers was 19.0% (73.2%, 175/239 vs. 54.2%, 469/865); for nurses this difference was much higher at 40.7% (85.8%, 754/879 vs. 45.1%, 330/732) (P < 0.0001) (Table 1).

In terms of physician compliance, primary teams tended to have lower HH compliance of 50.4% (323/641) compared with consulting services at 57.0% (158/277) (P = 0.06). Team rounds of 3 members were associated with higher compliance compared with encounters involving <3 members (62.1%, 282/454 vs. 42.0%, 128/308) (P < 0.0002). Presence of attending physician did not affect trainee HH compliance (55.5%, 201/362 when attending present vs. 56.8%, 133/234 when attending absent; P = 0.79). However, trainee HH compliance improved markedly when attending staff cleaned their hands and decreased markedly when they did not (79.5%, 174/219 vs. 18.9%, 27/143; P < 0.0002).

DISCUSSION

We introduced covert HH observers at our hospital to determine whether differences in Hawthorne effect accounted for measured disparity between physician HH compliance, and to gain further insights into the barriers and enablers of physician HH compliance. We discovered that performance differences between physicians and nurses decreased when neither group was aware that HH was being measured, suggesting that healthcare professions are differentially affected by the Hawthorne effect. This difference may be explained by the continuity of nurses on the ward that makes them more aware of visitors like HH auditors,[7] compared with physicians who rotate periodically on the ward.

Although hospital auditors play a central role in HH education through in‐the‐moment feedback, use of these data to benchmark performance can lead to inappropriate inferences about HH compliance. Prior studies using automated HH surveillance have suggested that the magnitude of the Hawthorne effect varies based on baseline HH rates,[8] whereas our study suggests a differential Hawthorne effect between professions and clinical services. If we relied only on auditor data, we would have continued to believe that only physicians in our organization had poor HH compliance, and we would not be aware of the global nature of the HH problem.

Our results are similar to that of Pan et al., who used covert medical students to measure HH and found compliance of 44.1% compared with 94.1% by unit auditors.[2] Because their study involved an active feedback intervention, the differential in Hawthorne effect between professions could not be reliably assessed. However, they observed a progressive increase in nurse HH compliance using covert observation methods, suggesting improvement in HH performance independent of observer bias.[7]

Covert observation in our study also provided important insights regarding barriers and enablers of HH compliance. Self‐preservation behaviors were common among both nurses and physicians, as HH compliance was consistently higher after patient contact compared to before or when seeing patients who required additional precautions. This finding confirms that the perceived risk of transmission seems to be a powerful motivating factor for HH.[9] Larger groups of trainees were more likely to clean their hands, likely due to peer effects.[10] The strong impact of role modeling on HH was also noted as previously suggested in the literature,[3, 6] but our study captures the magnitude of this effect. Whether or not the attending physician cleaned their hands during rounds either positively or negatively influenced HH compliance of the rest of the physician team (80% when compliant vs 20% when noncompliant).

Our study has several important limitations. The differential Hawthorne effect seen at our center may not reflect other institutions that have numerous HH auditors or high staff turnover resulting in lower ability to recognize auditors. We cannot exclude the possibility of Hawthorne effect using covert methods that could have affected nurse and physician performance differently, but frequent rotation of the students helped maintain covertness of observations. Finally, due to the nature of the covert student observers, a longer observation time frame could not be sustained.

Our experience using covert HH auditors suggests that traditional HH audits not only overstate HH performance overall, but can lead to inaccurate inferences regarding HH performance due to relative differences in Hawthorne effect. The answer to the question regarding whether physicians clean their hands appears to be that they do just as often as nurses, but that all healthcare workers have tremendous room for improvement. We suggest that future improvement efforts will rely on more accurate HH monitoring systems and strong attending physician leadership to set an example for trainees.

Disclosures

This study was jointly funded by the Centre for Quality Improvement and Patient Safety of the University of Toronto in collaboration with Sunnybrook Health Sciences Centre. All authors report no conflicts of interest relevant to this article.

References
  1. World Health Organization. WHO guidelines on hand hygiene in health care. Available at: http://whqlibdoc.who.int/publications/2009/9789241597906_eng.pdf. Accessed April 4th, 2015.
  2. Pan SC, Tien KL, Hung IC, et al. Compliance of health care workers with hand hygiene practices: independent advantages of overt and covert observers. PLoS One. 2013;8:e53746.
  3. Squires JE, Linklater S, Grimshaw JM, et al. Understanding practice: factors that influence physician hand hygiene compliance. Infect Control Hosp Epidemiol. 2014;35:15111520.
  4. (JCYH) Just Clean Your Hands. Ontario Agency for Health Promotion and Protection. Available at: http://www.publichealthontario.ca/en/BrowseByTopic/InfectiousDiseases/JustCleanYourHands/Pages/Just‐Clean‐Your‐Hands.aspx. Accessed August 4, 2015.
  5. Allegranzi B, Gayet‐Ageron A, Damani N, et al. Global implementation of WHO's multimodal strategy for improvement of hand hygiene: a quasi‐experimental study. Lancet Infect Dis. 2013;13:843851.
  6. Schneider J, Moromisato D, Zemetra B, et al. Hand hygiene adherence is influenced by the behavior of role models. Pediatr Crit Care Med. 2009;10:360363.
  7. Srigley JA, Furness CD, Baker GR, Gardam M. Quantification of the Hawthorne effect in hand hygiene compliance monitoring using an electronic monitoring system: a retrospective cohort study. BMJ Qual Saf. 2014;23:974980.
  8. Kohli E, Ptak J, Smith R, et al. Variability in the Hawthorne effect with regard to hand hygiene performance in high‐ and low‐performing inpatient care units. Infect Control Hosp Epidemiol. 2009;30:222225.
  9. Borg MA, Benbachir M, Cookson BD, et al. Self‐protection as a driver for hand hygiene among healthcare workers. Infect Control. 2009;30:578580.
  10. Monsalve MN, Pemmaraju SV, Thomas GW et al. Do peer effects improve hand hygiene adherence among healthcare workers? Infect Control Hosp Epidemiol. 2014;35:12771285.
References
  1. World Health Organization. WHO guidelines on hand hygiene in health care. Available at: http://whqlibdoc.who.int/publications/2009/9789241597906_eng.pdf. Accessed April 4th, 2015.
  2. Pan SC, Tien KL, Hung IC, et al. Compliance of health care workers with hand hygiene practices: independent advantages of overt and covert observers. PLoS One. 2013;8:e53746.
  3. Squires JE, Linklater S, Grimshaw JM, et al. Understanding practice: factors that influence physician hand hygiene compliance. Infect Control Hosp Epidemiol. 2014;35:15111520.
  4. (JCYH) Just Clean Your Hands. Ontario Agency for Health Promotion and Protection. Available at: http://www.publichealthontario.ca/en/BrowseByTopic/InfectiousDiseases/JustCleanYourHands/Pages/Just‐Clean‐Your‐Hands.aspx. Accessed August 4, 2015.
  5. Allegranzi B, Gayet‐Ageron A, Damani N, et al. Global implementation of WHO's multimodal strategy for improvement of hand hygiene: a quasi‐experimental study. Lancet Infect Dis. 2013;13:843851.
  6. Schneider J, Moromisato D, Zemetra B, et al. Hand hygiene adherence is influenced by the behavior of role models. Pediatr Crit Care Med. 2009;10:360363.
  7. Srigley JA, Furness CD, Baker GR, Gardam M. Quantification of the Hawthorne effect in hand hygiene compliance monitoring using an electronic monitoring system: a retrospective cohort study. BMJ Qual Saf. 2014;23:974980.
  8. Kohli E, Ptak J, Smith R, et al. Variability in the Hawthorne effect with regard to hand hygiene performance in high‐ and low‐performing inpatient care units. Infect Control Hosp Epidemiol. 2009;30:222225.
  9. Borg MA, Benbachir M, Cookson BD, et al. Self‐protection as a driver for hand hygiene among healthcare workers. Infect Control. 2009;30:578580.
  10. Monsalve MN, Pemmaraju SV, Thomas GW et al. Do peer effects improve hand hygiene adherence among healthcare workers? Infect Control Hosp Epidemiol. 2014;35:12771285.
Issue
Journal of Hospital Medicine - 11(12)
Issue
Journal of Hospital Medicine - 11(12)
Page Number
862-864
Page Number
862-864
Article Type
Display Headline
Do physicians clean their hands? Insights from a covert observational study
Display Headline
Do physicians clean their hands? Insights from a covert observational study
Sections
Article Source
© 2016 Society of Hospital Medicine
Disallow All Ads
Correspondence Location
Address for correspondence and reprint requests: Jerome A. Leis, MD, Sunnybrook Health Sciences Centre, H463, 2075 Bayview Avenue, Toronto, Ontario, M4N 3M5 Canada; Telephone: 416‐480‐6100 x89352; Fax: 416‐480‐6769; E‐mail: [email protected]
Content Gating
Gated (full article locked unless allowed per User)
Gating Strategy
First Peek Free
Article PDF Media
Media Files

LOS in Children With Medical Complexity

Article Type
Changed
Mon, 01/02/2017 - 19:34
Display Headline
Long length of hospital stay in children with medical complexity

Children with medical complexity (CMC) have complex and chronic health conditions that often involve multiple organ systems and severely affect cognitive and physical functioning. Although the prevalence of CMC is low (1% of all children), they account for nearly one‐fifth of all pediatric admissions and one‐half of all hospital days and charges in the United States.[1] Over the last decade, CMC have had a particularly large and increasing impact in tertiary‐care children's hospitals.[1, 2] The Institute of Medicine has identified CMC as a priority population for a revised healthcare system.[3]

Medical homes, hospitals, health plans, states, federal agencies, and others are striving to reduce excessive hospital use in CMC because of its high cost.[4, 5, 6] Containing length of stay (LOS)an increasingly used indicator of the time sensitiveness and efficiency of hospital careis a common aim across these initiatives. CMC have longer hospitalizations than children without medical complexity. Speculated reasons for this are that CMC tend to have (1) higher severity of acute illnesses (eg, pneumonia, cellulitis), (2) prolonged recovery time in the hospital, and (3) higher risk of adverse events in the hospital. Moreover, hospital clinicians caring for CMC often find it difficult to determine discharge readiness, given that many CMC do not return to a completely healthy baseline.[7]

Little is known about long LOS in CMC, including which CMC have the highest risk of experiencing such stays and which stays might have the greatest opportunity to be shortened. Patient characteristics associated with prolonged length of stay have been studied extensively for many pediatric conditions (eg, asthma).[8, 9, 10, 11, 12, 13, 14] However, most of these studies excluded CMC. Therefore, the objectives of this study were to examine (1) the prevalence of long LOS in CMC, (2) patient characteristics associated with long LOS, and (3) hospital‐to‐hospital variation in prevalence of long LOS hospitalizations.

METHODS

Study Design and Data Source

This study is a multicenter, retrospective cohort analysis of the Pediatric Health Information System (PHIS). PHIS is an administrative database of 44 not for profit, tertiary care pediatric hospitals affiliated with the Children's Hospital Association (CHA) (Overland Park, KS). PHIS contains data regarding patient demographics, diagnoses, and procedures (with International Classification of Diseases, 9th Revision, Clinical Modification [ICD‐9‐CM] codes), All‐Patient Refined Diagnostic Related Groups version 30 (APR‐DRGs) (3M Health Information Systems, Salt Lake City, UT), and service lines that aggregate the APR‐DRGs into 38 distinct groups. Data quality and reliability are assured through CHA and participating hospitals. In accordance with the policies of the Cincinnati Children's Hospital Medical Center Institutional Review Board, this study of deidentified data was not considered human subjects research.

Study Population

Inclusion Criteria

Children discharged following an observation or inpatient admission from a hospital participating in the PHIS database between January 1, 2013 and December 31, 2014 were eligible for inclusion if they were considered medically complex. Medical complexity was defined using Clinical Risk Groups (CRGs) version 1.8, developed by 3M Health Information Systems and the National Association of Children's Hospitals and Related Institutions. CRGs were used to assign each hospitalized patient to 1 of 9 mutually exclusive chronicity groups according to the presence, type, and severity of chronic conditions.[15, 16, 17, 18] Each patient's CRG designation was based on 2 years of previous hospital encounters.

As defined in prior studies and definitional frameworks of CMC,[1] patients belonging to CRG group 6 (significant chronic disease in 2 organ systems), CRG group 7 (dominant chronic disease in 3 organ systems), and CRG group 9 (catastrophic condition) were considered medically complex.[17, 19] Patients with malignancies (CRG group 8) were not included for analysis because they are a unique population with anticipated, long hospital stays. Patients with CRG group 5, representing those with chronic conditions affecting a single body system, were also not included because most do not have attributes consistent with medical complexity.

Exclusion Criteria

We used the APR‐DRG system, which leverages ICD‐9‐CM codes to identify the health problem most responsible for the hospitalization, to refine the study cohort. We excluded hospitalizations that were classified by the APR‐DRG system as neonatal, as we did not wish to focus on LOS in the neonatal intensive care unit (ICU) or for birth admissions. Similarly, hospitalizations for chemotherapy (APR‐DRG 693) or malignancy (identified with previously used ICD‐9‐CM codes)[20] were also excluded because long LOS is anticipated. We also excluded hospitalizations for medical rehabilitation (APR‐DRG 860).

Outcome Measures

The primary outcome measure was long LOS, defined as LOS 10 days. The cut point of LOS 10 days represents the 90th percentile of LOS for all children, with and without medical complexity, hospitalized during 2013 to 2014. LOS 10 days has previously been used as a threshold of long LOS.[21] For hospitalizations involving transfer at admission from another acute care facility, LOS was measured from the date of transfer. We also assessed hospitals' cost attributable to long LOS admissions.

Patient Demographics and Clinical Characteristics

We measured demographic characteristics including age, gender, race/ethnicity, insurance type, and distance traveled (the linear distance between the centroid of the patient's home ZIP code and the centroid of the hospital's ZIP code). Clinical characteristics included CRG classification, complex chronic condition (CCC), and dependence on medical technology. CCCs are defined as any medical condition that can be reasonably expected to last at least 12 months (unless death intervenes) and to involve either several different organ systems or 1 system severely enough to require specialty pediatric care and probably some period of hospitalization in a tertiary care center.[20] Medical technology included devices used to optimize the health and functioning of the child (eg, gastrostomy, tracheostomy, cerebrospinal fluid shunt).[22]

Hospitalization Characteristics

Characteristics of the hospitalization included transfer from an outside facility, ICU admission, surgical procedure (using surgical APR‐DRGs), and discharge disposition (home, skilled nursing facility, home health services, death, other). Cost of the hospitalization was estimated in the PHIS from charges using hospital and year‐specific ratios of cost to charge.

Statistical Analysis

Continuous data (eg, distance from hospital to home residence) were described with median and interquartile ranges (IQR) because they were not normally distributed. Categorical data (eg, type of chronic condition) were described with counts and frequencies. In bivariate analyses, demographic, clinical, and hospitalization characteristics were stratified by LOS (long LOS vs LOS <10 days), and compared using 2 statistics or Wilcoxon rank sum tests as appropriate.

We modeled the likelihood of experiencing a long LOS using generalized linear mixed effects models with a random hospital intercept and discharge‐level fixed effects for age, gender, payor, CCC type, ICU utilization, transfer status, a medical/surgical admission indicator derived from the APR‐DRG, and CRG assigned to each hospitalization. To examine hospital‐to‐hospital variability, we generated hospital risk‐adjusted rates of long LOS from these models. Similar models and hospital risk‐adjusted rates were built for a post hoc correlational analysis of 30‐day all cause readmission, where hospitals' rates and percent of long LOS were compared with a Pearson correlation coefficient. Also, for our multivariable models, we performed a sensitivity analysis using an alternative definition of long LOS as 4 days (the 75th percentile of LOS for all children, with and without medical complexity, hospitalized during 20132014). All analyses were performed using SAS version 9.4 (SAS Institute, Cary, NC), and P values <0.05 were considered statistically significant.

RESULTS

Study Population

There were 954,018 hospitalizations of 217,163 CMC at 44 children's hospitals included for analysis. Forty‐seven percent of hospitalizations were for females, 49.4% for non‐Hispanic whites, and 61.1% for children with government insurance. Fifteen percent (n = 142,082) had a long LOS of 10 days. The median (IQR) LOS of hospitalizations <10 days versus 10 days were 2 (IQR, 14) and 16 days (IQR, 1226), respectively. Long LOS hospitalizations accounted for 61.1% (3.7 million) hospital days and 61.8% ($13.7 billion) of total hospitalization costs for all CMC in the cohort (Table 1).

Demographic, Clinical, and Hospitalization Characteristics of Hospitalized Children With Medical Complexity by Length of Stay*
Characteristic Overall (n = 954,018) Length of Stay
<10 Days (n = 811,936) 10 Days (n = 142,082)
  • NOTE: Abbreviations: IQR, interquartile range. *All comparisons were significant at the P < 0.001 level.

Age at admission, y, %
<1 14.6 12.7 25.7
14 27.1 27.9 22.4
59 20.1 21.0 14.9
1018 33.6 34.0 31.7
18+ 4.6 4.4 5.4
Gender, %
Female 47.0 46.9 47.5
Race/ethnicity, %
Non‐Hispanic white 49.4 49.4 49.4
Non‐Hispanic black 23.1 23.8 19.3
Hispanic 18.2 17.8 20.4
Asian 2.0 1.9 2.3
Other 7.4 7.1 8.6
Complex chronic condition, %
Any 79.5 77.3 91.8
Technology assistance 37.1 34.1 54.2
Gastrointestinal 30.0 27.2 45.9
Neuromuscular 28.2 27.7 30.9
Cardiovascular 16.8 14.5 29.9
Respiratory 14.1 11.5 29.4
Congenital/genetic defect 17.2 16.7 20.2
Metabolic 9.9 8.9 15.4
Renal 10.1 9.5 13.8
Hematology/emmmunodeficiency 11.7 12.0 10.0
Neonatal 3.8 3.1 7.7
Transplantation 4.5 4.2 6.7
Clinical risk group, %
Chronic condition in 2 systems 68.4 71.2 53.9
Catastrophic chronic condition 31.4 28.8 46.1
Distance from hospital to home residence in miles, median [IQR] 16.2 [7.440.4] 15.8 [7.338.7] 19.1 [8.552.6]
Transferred from outside hospital (%) 6.5 5.3 13.6
Admitted for surgery, % 23.4 20.7 38.7
Use of intensive care, % 19.6 14.9 46.5
Discharge disposition, %
Home 91.2 92.9 81.4
Home healthcare 4.5 3.5 9.9
Other 2.9 2.6 4.5
Postacute care facility 1.1 0.8 3.1
Died 0.4 0.3 1.1
Payor, %
Government 61.1 60.6 63.5
Private 33.2 33.6 30.9
Other 5.7 5.7 5.7
Hospital resource use
Median length of stay [IQR] 3 [16] 2 [14] 16 [1226]
Median hospital cost [IQR] $8,144 [$4,122$18,447] $6,689 [$3,685$12,395] $49,207 [$29,444$95,738]
Total hospital cost, $, billions $22.2 $8.5 $13.7

Demographics and Clinical Characteristics of Children With and Without Long LOS

Compared with hospitalized CMC with LOS <10 days, a higher percentage of hospitalizations with LOS 10 days were CMC age <1 year (25.7% vs 12.7%, P < 0.001) and Hispanic (20.4% vs 17.8%, P < 0.001). CMC hospitalizations with a long LOS had a higher percentage of any CCC (91.8% vs 77.3%, P < 0.001); the most common CCCs were gastrointestinal (45.9%), neuromuscular (30.9%), and cardiovascular (29.9%). Hospitalizations of CMC with a long LOS had a higher percentage of a catastrophic chronic condition (46.1% vs 28.8%, P < 0.001) and technology dependence (46.1% vs 28.8%, P < 0.001) (Table 1).

Hospitalization Characteristics of Children With and Without Long LOS

Compared with hospitalizations of CMC with LOS <10 days, hospitalizations of CMC with a long LOS more often involved transfer in from another hospital at admission (13.6% vs 5.3%, P < 0.001). CMC hospital stays with a long LOS more often involved surgery (38.7% vs 20.7%, P < 0.001) and use of intensive care (46.5% vs 14.9%; P < 0.001). A higher percentage of CMC with long LOS were discharged with home health services (9.9% vs 3.5%; P < 0.001) (Table 1).

The most common admitting diagnoses and CCCs for hospitalizations of CMC with long LOS are presented in Table 2. The two most prevalent APR‐DRGs in CMC hospitalizations lasting 10 days or longer were cystic fibrosis (10.7%) and respiratory system disease with ventilator support (5.5%). The two most common chronic condition characteristics represented among long CMC hospitalizations were gastrointestinal devices (eg, gastrostomy tube) (39.7%) and heart and great vessel malformations (eg, tetralogy of Fallot) (12.8%). The 5 most common CCC subcategories, as listed in Table 2, account for nearly 100% of the patients with long LOS hospitalizations.

Most Common Reasons for Admission and Specific Complex Chronic Conditions for Hospitalized Children With Medical Complexity Who Had Length of Stay 10 Days
  • NOTE: *Reason for admission identified using All‐Patient Refined Diagnosis‐Related Groups. Complex chronic conditions identified using Feudtner and colleagues set of International Classification of Diseases, 9th Revision, Clinical Modification codes. Gastrointestinal devices include gastrostomy, gastrojejunostomy, colostomy. Respiratory devices include tracheostomy, noninvasive positive pressure, ventilator.

Most common reason for admission*
Cystic fibrosis 10.7%
Respiratory system diagnosis with ventilator support 96+ hours 5.5%
Malfunction, reaction, and complication of cardiac or vascular device or procedure 2.8%
Craniotomy except for trauma 2.6%
Major small and large bowel procedures 2.3%
Most common complex chronic condition
Gastrointestinal devices 39.7%
Heart and great vessel malformations 12.8%
Cystic fibrosis 12.5%
Dysrhythmias 11.0%
Respiratory devices 10.7%

Multivariable Analysis of Characteristics Associated With Long LOS

In multivariable analysis, the highest likelihood of long LOS was experienced by children who received care in the ICU (odds ratio [OR]: 3.5, 95% confidence interval [CI]: 3.43.5), who had a respiratory CCC (OR: 2.7, 95% CI: 2.62.7), and who were transferred from another acute care hospital at admission (OR: 2.1, 95% CI: 2.0, 2.1). The likelihood of long LOS was also higher in children <1 year of age (OR: 1.2, 95% CI: 1.21.3), and Hispanic children (OR: 1.1, 95% CI 1.0‐1.10) (Table 3). Similar multivariable findings were observed in sensitivity analysis using the 75th percentile of LOS (4 days) as the model outcome.

Multivariable Analysis of the Likelihood of Long Length of Stay 10 Days
Characteristic Odds Ratio (95% CI) of LOS 10 Days P Value
  • NOTE: Abbreviations: CI, confidence interval; LOS, length of stay.

Use of intensive care 3.5 (3.4‐3.5) <0.001
Transfer from another acute‐care hospital 2.1 (2.0‐2.1) <0.001
Procedure/surgery 1.8 (1.8‐1.9) <0.001
Complex chronic condition
Respiratory 2.7 (2.6‐2.7) <0.001
Gastrointestinal 1.8 (1.8‐1.8) <0.001
Metabolic 1.7 (1.7‐1.7) <0.001
Cardiovascular 1.6 (1.5‐1.6) <0.001
Neonatal 1.5 (1.5‐1.5) <0.001
Renal 1.4 (1.4‐1.4) <0.001
Transplant 1.4 (1.4‐1.4) <0.001
Hematology and immunodeficiency 1.3 (1.3‐1.3) <0.001
Technology assistance 1.1 (1.1, 1.1) <0.001
Neuromuscular 0.9 (0.9‐0.9) <0.001
Congenital or genetic defect 0.8 (0.8‐0.8) <0.001
Age at admission, y
<1 1.2 (1.2‐1.3) <0.001
14 0.5 (0.5‐0.5) <0.001
59 0.6 (0.6‐0.6) <0.001
1018 0.9 (0.9‐0.9) <0.001
18+ Reference
Male 0.9 (0.9‐0.9) <0.001
Race/ethnicity
Non‐Hispanic black 0.9 (0.9‐0.9) <0.001
Hispanic 1.1 (1.0‐1.1) <0.001
Asian 1.0 (1.0‐1.1) 0.3
Other 1.1 (1.1‐1.1) <0.001
Non‐Hispanic white Reference
Payor
Private 0.9 (0.8 0.9) <0.001
Other 1.0 (1.0‐1.0) 0.4
Government Reference
Season
Spring 1.0 (1.0 1.0) <0.001
Summer 0.9 (0.9‐0.9) <0.001
Fall 1.0 (0.9‐1.0) <0.001
Winter Reference

Variation in the Prevalence of Long LOS Across Children's Hospitals

After controlling for demographic, clinical, and hospital characteristics associated with long LOS, there was significant (P < 0.001) variation in the prevalence of long LOS for CMC across children's hospitals in the cohort (range, 10.3%21.8%) (Figure 1). Twelve (27%) hospitals had a significantly (P < 0.001) higher prevalence of long LOS for their hospitalized CMC, compared to the mean. Eighteen (41%) had a significantly (P < 0.001) lower prevalence of long LOS for their hospitalized CMC. There was also significant variation across hospitals with respect to cost, with 49.7% to 73.7% of all hospital costs of CMC attributed to long LOS hospitalizations. Finally, there was indirect correlation with the prevalence of LOS across hospitals and the hospitals' 30‐day readmission rate ( = 0.3; P = 0.04). As the prevalence of long LOS increased, the readmission rate decreased.

Figure 1
Variation in the Prevalence and Cost of Long Length of Stay ≥10 days for Children with Medical Complexity Across Children's Hospitals. Presented from the left y‐axis are the adjusted percentages (with 95% confidence interval)—shown as circles and whiskers—of total admissions for complex chronic condition (CMC) with length of stay (LOS) ≥10 days across 44 freestanding children's hospitals. The percentages are adjusted for demographic, clinical, and hospitalization characteristics associated with the likelihood of CMC experiencing LOS ≥10 days. The dashed line indicates the mean percentage (15%) across all hospitals. Also presented on the right y‐axis are the percentages—shown as gray bars—of all hospital charges attributable to hospitalizations ≥10 days among CMC across children's hospitals.

DISCUSSION

The main findings from this study suggest that a small percentage of CMC experiencing long LOS account for the majority of hospital bed days and cost of all hospitalized CMC in children's hospitals. The likelihood of long LOS varies significantly by CMC's age, race/ethnicity, and payor as well as by type and number of chronic conditions. Among CMC with long LOS, the use of gastrointestinal devices such as gastrostomy tubes, as well as congenital heart disease, were highly prevalent. In multivariable analysis, the characteristics most strongly associated with LOS 10 days were use of the ICU, respiratory complex chronic condition, and transfer from another medical facility at admission. After adjusting for these factors, there was significant variation in the prevalence of LOS 10 days for CMC across children's hospitals.

Although it is well known that CMC as a whole have a major impact on resource use in children's hospitals, this study reveals that 15% of hospitalizations of CMC account for 62% of all hospital costs of CMC. That is, a small fraction of hospitalizations of CMC is largely responsible for the significant financial impact of hospital resource use. To date, most clinical efforts and policies striving to reduce hospital use in CMC have focused on avoiding readmissions or index hospital admissions entirely, rather than improving the efficiency of hospital care after admission occurs.[23, 24, 25, 26] In the adult population, the impact of long LOS on hospital costs has been recognized, and several Medicare incentive programs have focused on in‐hospital timeliness and efficiency. As a result, LOS in Medicare beneficiaries has decreased dramatically over the past 2 decades.[27, 28, 29, 30] Optimizing the efficiency of hospital care for CMC may be an important goal to pursue, especially with precedent set in the adult literature.

Perhaps the substantial variation across hospitals in the prevalence of long LOS in CMC indicates opportunity to improve the efficiency of their inpatient care. This variation was not due to differences across hospitals' case mix of CMC. Further investigation is needed to determine how much of it is due to differences in quality of care. Clinical practice guidelines for hospital treatment of common illnesses usually exclude CMC. In our clinical experience across 9 children's hospitals, we have experienced varying approaches to setting discharge goals (ie, parameters on how healthy the child needs to be to ensure a successful hospital discharge) for CMC.[31] When the goals are absent or not clearly articulated, they can contribute to a prolonged hospitalization. Some families of CMC report significant issues when working with pediatric hospital staff to assess their child's discharge readiness.[7, 32, 33] In addition, there is significant variation across states and regions in access to and quality of post‐discharge health services (eg, home nursing, postacute care, durable medical equipment).[34, 35] In some areas, many CMC are not actively involved with their primary care physician.[5] These issues might also influence the ability of some children's hospitals to efficiently discharge CMC to a safe and supportive post‐discharge environment. Further examination of hospital outliersthose with the lowest and highest percentage of CMC hospitalizations with long LOSmay reveal opportunities to identify and spread best practices.

The demographic and clinical factors associated with long LOS in the present study, including age, ICU use, and transfer from another hospital, might help hospitals target which CMC have the greatest risk for experiencing long LOS. We found that infants age <1 year had longer LOS when compared with older children. Similar to our findings, younger‐aged children hospitalized with bronchiolitis have longer LOS.[36] Certainly, infants with medical complexity, in general, are a high‐acuity population with the potential for rapid clinical deterioration during an acute illness. Prolonged hospitalization for treatment and stabilization may be expected for many of them. Additional investigation is warranted to examine ICU use in CMC, and whether ICU admission or duration can be safely prevented or abbreviated. Opportunities to assess the quality of transfers into children's hospitals of CMC admitted to outside hospitals may be necessary. A study of pediatric burn patients reported that patients initially stabilized at a facility that was not a burn center and subsequently transferred to a burn center had a longer LOS than patients solely treated at a designated burn center.[37] Furthermore, events during transport itself may adversely impact the stability of an already fragile patient. Interventions to optimize the quality of care provided by transport teams have resulted in decreased LOS at the receiving hospital.[38]

This study's findings should be considered in the context of several limitations. Absent a gold‐standard definition of long LOS, we used the distribution of LOS across patients to inform our methods; LOS at the 90th percentile was selected as long. Although our sensitivity analysis using LOS at the 75th percentile produced similar findings, other cut points in LOS might be associated with different results. The study is not positioned to determine how much of the reported LOS was excessive, unnecessary, or preventable. The study findings may not generalize to types of hospitals not contained in PHIS (eg, nonchildren's hospitals and community hospitals). We did not focus on the impact of a new diagnosis (eg, new chronic illness) or acute in‐hospital event (eg, nosocomial infection) on prolonged LOS; future studies should investigate these clinical events with LOS.

PHIS does not contain information regarding characteristics that could influence LOS, including the children's social and familial attributes, transportation availability, home equipment needs, and local availability of postacute care facilities. Moreover, PHIS does not contain information about the hospital discharge procedures, process, or personnel across hospitals, which could influence LOS. Future studies on prolonged LOS should consider assessing this information. Because of the large sample size of hospitalizations included, the statistical power for the analyses was strong, rendering it possible that some findings that were statistically significant might have modest clinical significance (eg, relationship of Hispanic ethnicity with prolonged LOS). We could not determine why a positive correlation was not observed between hospitals' long LOS prevalence and their percentage of cost associated with long LOS; future studies should investigate the reasons for this finding.

Despite these limitations, the findings of the present study highlight the significance of long LOS in hospitalized CMC. These long hospitalizations account for a significant proportion of all hospital costs for this important population of children. The prevalence of long LOS for CMC varies considerably across children's hospitals, even after accounting for the case mix. Efforts to curtail hospital resource use and costs for CMC may benefit from focus on long LOS.

Files
References
  1. Berry JG, Hall M, Hall DE, et al. Inpatient growth and resource use in 28 children's hospitals: a longitudinal, multi‐institutional study. JAMA Pediatr. 2013;167(2):170177.
  2. Simon TD, Berry J, Feudtner C, et al. Children with complex chronic conditions in inpatient hospital settings in the united states. Pediatrics. 2010;126(4):647655.
  3. Clancy CM, Andresen EM. Meeting the health care needs of persons with disabilities. Milbank Q. 2002;80(2):381391.
  4. Mosquera RA, Avritscher EBC, Samuels CL, et al. Effect of an enhanced medical home on serious illness and cost of care among high‐risk children with chronic illness: a randomized clinical trial. JAMA. 2014;312(24):26402648.
  5. Berry JG, Hall M, Neff J, et al. Children with medical complexity and Medicaid: spending and cost savings. Health Aff Proj Hope. 2014;33(12):21992206.
  6. Children's Hospital Association. CARE Award. Available at: https://www.childrenshospitals.org/Programs‐and‐Services/Quality‐Improvement‐and‐Measurement/CARE‐Award. Accessed December 18, 2015.
  7. Berry JG, Ziniel SI, Freeman L, et al. Hospital readmission and parent perceptions of their child's hospital discharge. Int J Qual Health Care. 2013;25(5):573581.
  8. Fendler W, Baranowska‐Jazwiecka A, Hogendorf A, et al. Weekend matters: Friday and Saturday admissions are associated with prolonged hospitalization of children. Clin Pediatr (Phila). 2013;52(9):875878.
  9. Goudie A, Dynan L, Brady PW, Rettiganti M. Attributable cost and length of stay for central line‐associated bloodstream infections. Pediatrics. 2014;133(6):e1525e1532.
  10. Graves N, Weinhold D, Tong E, et al. Effect of healthcare‐acquired infection on length of hospital stay and cost. Infect Control Hosp Epidemiol. 2007;28(3):280292.
  11. Hassan F, Lewis TC, Davis MM, Gebremariam A, Dombkowski K. Hospital utilization and costs among children with influenza, 2003. Am J Prev Med. 2009;36(4):292296.
  12. Kronman MP, Hall M, Slonim AD, Shah SS. Charges and lengths of stay attributable to adverse patient‐care events using pediatric‐specific quality indicators: a multicenter study of freestanding children's hospitals. Pediatrics. 2008;121(6):e1653e1659.
  13. Leyenaar JK, Lagu T, Shieh M‐S, Pekow PS, Lindenauer PK. Variation in resource utilization for the management of uncomplicated community‐acquired pneumonia across community and children's hospitals. J Pediatr. 2014;165(3):585591.
  14. Leyenaar JK, Shieh M‐S, Lagu T, Pekow PS, Lindenauer PK. Variation and outcomes associated with direct hospital admission among children with pneumonia in the United States. JAMA Pediatr. 2014;168(9):829836.
  15. Hughes JS, Averill RF, Eisenhandler J, et al. Clinical Risk Groups (CRGs): a classification system for risk‐adjusted capitation‐based payment and health care management. Med Care. 2004;42(1):8190.
  16. Neff JM, Clifton H, Park KJ, et al. Identifying children with lifelong chronic conditions for care coordination by using hospital discharge data. Acad Pediatr. 2010;10(6):417423.
  17. Neff JM, Sharp VL, Muldoon J, Graham J, Myers K. Profile of medical charges for children by health status group and severity level in a Washington State Health Plan. Health Serv Res. 2004;39(1):7389.
  18. Neff JM, Sharp VL, Popalisky J, Fitzgibbon T. Using medical billing data to evaluate chronically ill children over time. J Ambulatory Care Manage. 2006;29(4):283290.
  19. O'Mahony L, O'Mahony DS, Simon TD, Neff J, Klein EJ, Quan L. Medical complexity and pediatric emergency department and inpatient utilization. Pediatrics. 2013;131(2):e559e565.
  20. Feudtner C, Feinstein JA, Zhong W, Hall M, Dai D. Pediatric complex chronic conditions classification system version 2: updated for ICD‐10 and complex medical technology dependence and transplantation. BMC Pediatr. 2014;14:199.
  21. Weissman C. Analyzing intensive care unit length of stay data: problems and possible solutions. Crit Care Med. 1997;25(9):15941600.
  22. Berry JG, Hall DE, Kuo DZ, et al. Hospital utilization and characteristics of patients experiencing recurrent readmissions within children's hospitals. JAMA. 2011;305(7):682690.
  23. Hudson SM. Hospital readmissions and repeat emergency department visits among children with medical complexity: an integrative review. J Pediatr Nurs. 2013;28(4):316339.
  24. Jurgens V, Spaeder MC, Pavuluri P, Waldman Z. Hospital readmission in children with complex chronic conditions discharged from subacute care. Hosp Pediatr. 2014;4(3):153158.
  25. Coller RJ, Nelson BB, Sklansky DJ, et al. Preventing hospitalizations in children with medical complexity: a systematic review. Pediatrics. 2014;134(6):e1628e1647.
  26. Kun SS, Edwards JD, Ward SLD, Keens TG. Hospital readmissions for newly discharged pediatric home mechanical ventilation patients. Pediatr Pulmonol. 2012;47(4):409414.
  27. Cram P, Lu X, Kaboli PJ, et al. Clinical characteristics and outcomes of Medicare patients undergoing total hip arthroplasty, 1991–2008. JAMA. 2011;305(15):15601567.
  28. Bueno H, Ross JS, Wang Y, et al. Trends in length of stay and short‐term outcomes among Medicare patients hospitalized for heart failure, 1993–2006. JAMA. 2010;303(21):21412147.
  29. U.S. Department of Health and Human Services. CMS Statistics 2013. Available at: https://www.cms.gov/Research‐Statistics‐Data‐and‐Systems/Statistics‐Trends‐and‐Reports/CMS‐Statistics‐Reference‐Booklet/Downloads/CMS_Stats_2013_final.pdf. Published August 2013. Accessed October 6, 2015.
  30. Centers for Medicare and Medicaid Services. Evaluation of the premier hospital quality incentive demonstration. Available at: https://www.cms.gov/Research‐Statistics‐Data‐and‐Systems/Statistics‐Trends‐and‐Reports/Reports/downloads/Premier_ExecSum_2010.pdf. Published March 3, 2009. Accessed September 18, 2015.
  31. Berry JG, Blaine K, Rogers J, et al. A framework of pediatric hospital discharge care informed by legislation, research, and practice. JAMA Pediatr. 2014;168(10):955962; quiz 965–966.
  32. Brittan M, Albright K, Cifuentes M, Jimenez‐Zambrano A, Kempe A. Parent and provider perspectives on pediatric readmissions: what can we learn about readiness for discharge? Hosp Pediatr. 2015;5(11):559565.
  33. Berry JG, Gay JC. Preventing readmissions in children: how do we do that? Hosp Pediatr. 2015;5(11):602604.
  34. O'Brien JE, Berry J, Dumas H. Pediatric post‐acute hospital care: striving for identity and value. Hosp Pediatr. 2015;5(10):548551.
  35. Berry JG, Hall M, Dumas H, et al. Pediatric hospital discharges to home health and postacute facility care: a national study. JAMA Pediatr. 2016;170(4):326333.
  36. Corneli HM, Zorc JJ, Holubkov R, et al. Bronchiolitis: clinical characteristics associated with hospitalization and length of stay. Pediatr Emerg Care. 2012;28(2):99103.
  37. Myers J, Smith M, Woods C, Espinosa C, Lehna C. The effect of transfers between health care facilities on costs and length of stay for pediatric burn patients. J Burn Care Res. 2015;36(1):178183.
  38. Stroud MH, Sanders RC, Moss MM, et al. Goal‐directed resuscitative interventions during pediatric interfacility transport. Crit Care Med. 2015;43(8):16921698.
Article PDF
Issue
Journal of Hospital Medicine - 11(11)
Page Number
750-756
Sections
Files
Files
Article PDF
Article PDF

Children with medical complexity (CMC) have complex and chronic health conditions that often involve multiple organ systems and severely affect cognitive and physical functioning. Although the prevalence of CMC is low (1% of all children), they account for nearly one‐fifth of all pediatric admissions and one‐half of all hospital days and charges in the United States.[1] Over the last decade, CMC have had a particularly large and increasing impact in tertiary‐care children's hospitals.[1, 2] The Institute of Medicine has identified CMC as a priority population for a revised healthcare system.[3]

Medical homes, hospitals, health plans, states, federal agencies, and others are striving to reduce excessive hospital use in CMC because of its high cost.[4, 5, 6] Containing length of stay (LOS)an increasingly used indicator of the time sensitiveness and efficiency of hospital careis a common aim across these initiatives. CMC have longer hospitalizations than children without medical complexity. Speculated reasons for this are that CMC tend to have (1) higher severity of acute illnesses (eg, pneumonia, cellulitis), (2) prolonged recovery time in the hospital, and (3) higher risk of adverse events in the hospital. Moreover, hospital clinicians caring for CMC often find it difficult to determine discharge readiness, given that many CMC do not return to a completely healthy baseline.[7]

Little is known about long LOS in CMC, including which CMC have the highest risk of experiencing such stays and which stays might have the greatest opportunity to be shortened. Patient characteristics associated with prolonged length of stay have been studied extensively for many pediatric conditions (eg, asthma).[8, 9, 10, 11, 12, 13, 14] However, most of these studies excluded CMC. Therefore, the objectives of this study were to examine (1) the prevalence of long LOS in CMC, (2) patient characteristics associated with long LOS, and (3) hospital‐to‐hospital variation in prevalence of long LOS hospitalizations.

METHODS

Study Design and Data Source

This study is a multicenter, retrospective cohort analysis of the Pediatric Health Information System (PHIS). PHIS is an administrative database of 44 not for profit, tertiary care pediatric hospitals affiliated with the Children's Hospital Association (CHA) (Overland Park, KS). PHIS contains data regarding patient demographics, diagnoses, and procedures (with International Classification of Diseases, 9th Revision, Clinical Modification [ICD‐9‐CM] codes), All‐Patient Refined Diagnostic Related Groups version 30 (APR‐DRGs) (3M Health Information Systems, Salt Lake City, UT), and service lines that aggregate the APR‐DRGs into 38 distinct groups. Data quality and reliability are assured through CHA and participating hospitals. In accordance with the policies of the Cincinnati Children's Hospital Medical Center Institutional Review Board, this study of deidentified data was not considered human subjects research.

Study Population

Inclusion Criteria

Children discharged following an observation or inpatient admission from a hospital participating in the PHIS database between January 1, 2013 and December 31, 2014 were eligible for inclusion if they were considered medically complex. Medical complexity was defined using Clinical Risk Groups (CRGs) version 1.8, developed by 3M Health Information Systems and the National Association of Children's Hospitals and Related Institutions. CRGs were used to assign each hospitalized patient to 1 of 9 mutually exclusive chronicity groups according to the presence, type, and severity of chronic conditions.[15, 16, 17, 18] Each patient's CRG designation was based on 2 years of previous hospital encounters.

As defined in prior studies and definitional frameworks of CMC,[1] patients belonging to CRG group 6 (significant chronic disease in 2 organ systems), CRG group 7 (dominant chronic disease in 3 organ systems), and CRG group 9 (catastrophic condition) were considered medically complex.[17, 19] Patients with malignancies (CRG group 8) were not included for analysis because they are a unique population with anticipated, long hospital stays. Patients with CRG group 5, representing those with chronic conditions affecting a single body system, were also not included because most do not have attributes consistent with medical complexity.

Exclusion Criteria

We used the APR‐DRG system, which leverages ICD‐9‐CM codes to identify the health problem most responsible for the hospitalization, to refine the study cohort. We excluded hospitalizations that were classified by the APR‐DRG system as neonatal, as we did not wish to focus on LOS in the neonatal intensive care unit (ICU) or for birth admissions. Similarly, hospitalizations for chemotherapy (APR‐DRG 693) or malignancy (identified with previously used ICD‐9‐CM codes)[20] were also excluded because long LOS is anticipated. We also excluded hospitalizations for medical rehabilitation (APR‐DRG 860).

Outcome Measures

The primary outcome measure was long LOS, defined as LOS 10 days. The cut point of LOS 10 days represents the 90th percentile of LOS for all children, with and without medical complexity, hospitalized during 2013 to 2014. LOS 10 days has previously been used as a threshold of long LOS.[21] For hospitalizations involving transfer at admission from another acute care facility, LOS was measured from the date of transfer. We also assessed hospitals' cost attributable to long LOS admissions.

Patient Demographics and Clinical Characteristics

We measured demographic characteristics including age, gender, race/ethnicity, insurance type, and distance traveled (the linear distance between the centroid of the patient's home ZIP code and the centroid of the hospital's ZIP code). Clinical characteristics included CRG classification, complex chronic condition (CCC), and dependence on medical technology. CCCs are defined as any medical condition that can be reasonably expected to last at least 12 months (unless death intervenes) and to involve either several different organ systems or 1 system severely enough to require specialty pediatric care and probably some period of hospitalization in a tertiary care center.[20] Medical technology included devices used to optimize the health and functioning of the child (eg, gastrostomy, tracheostomy, cerebrospinal fluid shunt).[22]

Hospitalization Characteristics

Characteristics of the hospitalization included transfer from an outside facility, ICU admission, surgical procedure (using surgical APR‐DRGs), and discharge disposition (home, skilled nursing facility, home health services, death, other). Cost of the hospitalization was estimated in the PHIS from charges using hospital and year‐specific ratios of cost to charge.

Statistical Analysis

Continuous data (eg, distance from hospital to home residence) were described with median and interquartile ranges (IQR) because they were not normally distributed. Categorical data (eg, type of chronic condition) were described with counts and frequencies. In bivariate analyses, demographic, clinical, and hospitalization characteristics were stratified by LOS (long LOS vs LOS <10 days), and compared using 2 statistics or Wilcoxon rank sum tests as appropriate.

We modeled the likelihood of experiencing a long LOS using generalized linear mixed effects models with a random hospital intercept and discharge‐level fixed effects for age, gender, payor, CCC type, ICU utilization, transfer status, a medical/surgical admission indicator derived from the APR‐DRG, and CRG assigned to each hospitalization. To examine hospital‐to‐hospital variability, we generated hospital risk‐adjusted rates of long LOS from these models. Similar models and hospital risk‐adjusted rates were built for a post hoc correlational analysis of 30‐day all cause readmission, where hospitals' rates and percent of long LOS were compared with a Pearson correlation coefficient. Also, for our multivariable models, we performed a sensitivity analysis using an alternative definition of long LOS as 4 days (the 75th percentile of LOS for all children, with and without medical complexity, hospitalized during 20132014). All analyses were performed using SAS version 9.4 (SAS Institute, Cary, NC), and P values <0.05 were considered statistically significant.

RESULTS

Study Population

There were 954,018 hospitalizations of 217,163 CMC at 44 children's hospitals included for analysis. Forty‐seven percent of hospitalizations were for females, 49.4% for non‐Hispanic whites, and 61.1% for children with government insurance. Fifteen percent (n = 142,082) had a long LOS of 10 days. The median (IQR) LOS of hospitalizations <10 days versus 10 days were 2 (IQR, 14) and 16 days (IQR, 1226), respectively. Long LOS hospitalizations accounted for 61.1% (3.7 million) hospital days and 61.8% ($13.7 billion) of total hospitalization costs for all CMC in the cohort (Table 1).

Demographic, Clinical, and Hospitalization Characteristics of Hospitalized Children With Medical Complexity by Length of Stay*
Characteristic Overall (n = 954,018) Length of Stay
<10 Days (n = 811,936) 10 Days (n = 142,082)
  • NOTE: Abbreviations: IQR, interquartile range. *All comparisons were significant at the P < 0.001 level.

Age at admission, y, %
<1 14.6 12.7 25.7
14 27.1 27.9 22.4
59 20.1 21.0 14.9
1018 33.6 34.0 31.7
18+ 4.6 4.4 5.4
Gender, %
Female 47.0 46.9 47.5
Race/ethnicity, %
Non‐Hispanic white 49.4 49.4 49.4
Non‐Hispanic black 23.1 23.8 19.3
Hispanic 18.2 17.8 20.4
Asian 2.0 1.9 2.3
Other 7.4 7.1 8.6
Complex chronic condition, %
Any 79.5 77.3 91.8
Technology assistance 37.1 34.1 54.2
Gastrointestinal 30.0 27.2 45.9
Neuromuscular 28.2 27.7 30.9
Cardiovascular 16.8 14.5 29.9
Respiratory 14.1 11.5 29.4
Congenital/genetic defect 17.2 16.7 20.2
Metabolic 9.9 8.9 15.4
Renal 10.1 9.5 13.8
Hematology/emmmunodeficiency 11.7 12.0 10.0
Neonatal 3.8 3.1 7.7
Transplantation 4.5 4.2 6.7
Clinical risk group, %
Chronic condition in 2 systems 68.4 71.2 53.9
Catastrophic chronic condition 31.4 28.8 46.1
Distance from hospital to home residence in miles, median [IQR] 16.2 [7.440.4] 15.8 [7.338.7] 19.1 [8.552.6]
Transferred from outside hospital (%) 6.5 5.3 13.6
Admitted for surgery, % 23.4 20.7 38.7
Use of intensive care, % 19.6 14.9 46.5
Discharge disposition, %
Home 91.2 92.9 81.4
Home healthcare 4.5 3.5 9.9
Other 2.9 2.6 4.5
Postacute care facility 1.1 0.8 3.1
Died 0.4 0.3 1.1
Payor, %
Government 61.1 60.6 63.5
Private 33.2 33.6 30.9
Other 5.7 5.7 5.7
Hospital resource use
Median length of stay [IQR] 3 [16] 2 [14] 16 [1226]
Median hospital cost [IQR] $8,144 [$4,122$18,447] $6,689 [$3,685$12,395] $49,207 [$29,444$95,738]
Total hospital cost, $, billions $22.2 $8.5 $13.7

Demographics and Clinical Characteristics of Children With and Without Long LOS

Compared with hospitalized CMC with LOS <10 days, a higher percentage of hospitalizations with LOS 10 days were CMC age <1 year (25.7% vs 12.7%, P < 0.001) and Hispanic (20.4% vs 17.8%, P < 0.001). CMC hospitalizations with a long LOS had a higher percentage of any CCC (91.8% vs 77.3%, P < 0.001); the most common CCCs were gastrointestinal (45.9%), neuromuscular (30.9%), and cardiovascular (29.9%). Hospitalizations of CMC with a long LOS had a higher percentage of a catastrophic chronic condition (46.1% vs 28.8%, P < 0.001) and technology dependence (46.1% vs 28.8%, P < 0.001) (Table 1).

Hospitalization Characteristics of Children With and Without Long LOS

Compared with hospitalizations of CMC with LOS <10 days, hospitalizations of CMC with a long LOS more often involved transfer in from another hospital at admission (13.6% vs 5.3%, P < 0.001). CMC hospital stays with a long LOS more often involved surgery (38.7% vs 20.7%, P < 0.001) and use of intensive care (46.5% vs 14.9%; P < 0.001). A higher percentage of CMC with long LOS were discharged with home health services (9.9% vs 3.5%; P < 0.001) (Table 1).

The most common admitting diagnoses and CCCs for hospitalizations of CMC with long LOS are presented in Table 2. The two most prevalent APR‐DRGs in CMC hospitalizations lasting 10 days or longer were cystic fibrosis (10.7%) and respiratory system disease with ventilator support (5.5%). The two most common chronic condition characteristics represented among long CMC hospitalizations were gastrointestinal devices (eg, gastrostomy tube) (39.7%) and heart and great vessel malformations (eg, tetralogy of Fallot) (12.8%). The 5 most common CCC subcategories, as listed in Table 2, account for nearly 100% of the patients with long LOS hospitalizations.

Most Common Reasons for Admission and Specific Complex Chronic Conditions for Hospitalized Children With Medical Complexity Who Had Length of Stay 10 Days
  • NOTE: *Reason for admission identified using All‐Patient Refined Diagnosis‐Related Groups. Complex chronic conditions identified using Feudtner and colleagues set of International Classification of Diseases, 9th Revision, Clinical Modification codes. Gastrointestinal devices include gastrostomy, gastrojejunostomy, colostomy. Respiratory devices include tracheostomy, noninvasive positive pressure, ventilator.

Most common reason for admission*
Cystic fibrosis 10.7%
Respiratory system diagnosis with ventilator support 96+ hours 5.5%
Malfunction, reaction, and complication of cardiac or vascular device or procedure 2.8%
Craniotomy except for trauma 2.6%
Major small and large bowel procedures 2.3%
Most common complex chronic condition
Gastrointestinal devices 39.7%
Heart and great vessel malformations 12.8%
Cystic fibrosis 12.5%
Dysrhythmias 11.0%
Respiratory devices 10.7%

Multivariable Analysis of Characteristics Associated With Long LOS

In multivariable analysis, the highest likelihood of long LOS was experienced by children who received care in the ICU (odds ratio [OR]: 3.5, 95% confidence interval [CI]: 3.43.5), who had a respiratory CCC (OR: 2.7, 95% CI: 2.62.7), and who were transferred from another acute care hospital at admission (OR: 2.1, 95% CI: 2.0, 2.1). The likelihood of long LOS was also higher in children <1 year of age (OR: 1.2, 95% CI: 1.21.3), and Hispanic children (OR: 1.1, 95% CI 1.0‐1.10) (Table 3). Similar multivariable findings were observed in sensitivity analysis using the 75th percentile of LOS (4 days) as the model outcome.

Multivariable Analysis of the Likelihood of Long Length of Stay 10 Days
Characteristic Odds Ratio (95% CI) of LOS 10 Days P Value
  • NOTE: Abbreviations: CI, confidence interval; LOS, length of stay.

Use of intensive care 3.5 (3.4‐3.5) <0.001
Transfer from another acute‐care hospital 2.1 (2.0‐2.1) <0.001
Procedure/surgery 1.8 (1.8‐1.9) <0.001
Complex chronic condition
Respiratory 2.7 (2.6‐2.7) <0.001
Gastrointestinal 1.8 (1.8‐1.8) <0.001
Metabolic 1.7 (1.7‐1.7) <0.001
Cardiovascular 1.6 (1.5‐1.6) <0.001
Neonatal 1.5 (1.5‐1.5) <0.001
Renal 1.4 (1.4‐1.4) <0.001
Transplant 1.4 (1.4‐1.4) <0.001
Hematology and immunodeficiency 1.3 (1.3‐1.3) <0.001
Technology assistance 1.1 (1.1, 1.1) <0.001
Neuromuscular 0.9 (0.9‐0.9) <0.001
Congenital or genetic defect 0.8 (0.8‐0.8) <0.001
Age at admission, y
<1 1.2 (1.2‐1.3) <0.001
14 0.5 (0.5‐0.5) <0.001
59 0.6 (0.6‐0.6) <0.001
1018 0.9 (0.9‐0.9) <0.001
18+ Reference
Male 0.9 (0.9‐0.9) <0.001
Race/ethnicity
Non‐Hispanic black 0.9 (0.9‐0.9) <0.001
Hispanic 1.1 (1.0‐1.1) <0.001
Asian 1.0 (1.0‐1.1) 0.3
Other 1.1 (1.1‐1.1) <0.001
Non‐Hispanic white Reference
Payor
Private 0.9 (0.8 0.9) <0.001
Other 1.0 (1.0‐1.0) 0.4
Government Reference
Season
Spring 1.0 (1.0 1.0) <0.001
Summer 0.9 (0.9‐0.9) <0.001
Fall 1.0 (0.9‐1.0) <0.001
Winter Reference

Variation in the Prevalence of Long LOS Across Children's Hospitals

After controlling for demographic, clinical, and hospital characteristics associated with long LOS, there was significant (P < 0.001) variation in the prevalence of long LOS for CMC across children's hospitals in the cohort (range, 10.3%21.8%) (Figure 1). Twelve (27%) hospitals had a significantly (P < 0.001) higher prevalence of long LOS for their hospitalized CMC, compared to the mean. Eighteen (41%) had a significantly (P < 0.001) lower prevalence of long LOS for their hospitalized CMC. There was also significant variation across hospitals with respect to cost, with 49.7% to 73.7% of all hospital costs of CMC attributed to long LOS hospitalizations. Finally, there was indirect correlation with the prevalence of LOS across hospitals and the hospitals' 30‐day readmission rate ( = 0.3; P = 0.04). As the prevalence of long LOS increased, the readmission rate decreased.

Figure 1
Variation in the Prevalence and Cost of Long Length of Stay ≥10 days for Children with Medical Complexity Across Children's Hospitals. Presented from the left y‐axis are the adjusted percentages (with 95% confidence interval)—shown as circles and whiskers—of total admissions for complex chronic condition (CMC) with length of stay (LOS) ≥10 days across 44 freestanding children's hospitals. The percentages are adjusted for demographic, clinical, and hospitalization characteristics associated with the likelihood of CMC experiencing LOS ≥10 days. The dashed line indicates the mean percentage (15%) across all hospitals. Also presented on the right y‐axis are the percentages—shown as gray bars—of all hospital charges attributable to hospitalizations ≥10 days among CMC across children's hospitals.

DISCUSSION

The main findings from this study suggest that a small percentage of CMC experiencing long LOS account for the majority of hospital bed days and cost of all hospitalized CMC in children's hospitals. The likelihood of long LOS varies significantly by CMC's age, race/ethnicity, and payor as well as by type and number of chronic conditions. Among CMC with long LOS, the use of gastrointestinal devices such as gastrostomy tubes, as well as congenital heart disease, were highly prevalent. In multivariable analysis, the characteristics most strongly associated with LOS 10 days were use of the ICU, respiratory complex chronic condition, and transfer from another medical facility at admission. After adjusting for these factors, there was significant variation in the prevalence of LOS 10 days for CMC across children's hospitals.

Although it is well known that CMC as a whole have a major impact on resource use in children's hospitals, this study reveals that 15% of hospitalizations of CMC account for 62% of all hospital costs of CMC. That is, a small fraction of hospitalizations of CMC is largely responsible for the significant financial impact of hospital resource use. To date, most clinical efforts and policies striving to reduce hospital use in CMC have focused on avoiding readmissions or index hospital admissions entirely, rather than improving the efficiency of hospital care after admission occurs.[23, 24, 25, 26] In the adult population, the impact of long LOS on hospital costs has been recognized, and several Medicare incentive programs have focused on in‐hospital timeliness and efficiency. As a result, LOS in Medicare beneficiaries has decreased dramatically over the past 2 decades.[27, 28, 29, 30] Optimizing the efficiency of hospital care for CMC may be an important goal to pursue, especially with precedent set in the adult literature.

Perhaps the substantial variation across hospitals in the prevalence of long LOS in CMC indicates opportunity to improve the efficiency of their inpatient care. This variation was not due to differences across hospitals' case mix of CMC. Further investigation is needed to determine how much of it is due to differences in quality of care. Clinical practice guidelines for hospital treatment of common illnesses usually exclude CMC. In our clinical experience across 9 children's hospitals, we have experienced varying approaches to setting discharge goals (ie, parameters on how healthy the child needs to be to ensure a successful hospital discharge) for CMC.[31] When the goals are absent or not clearly articulated, they can contribute to a prolonged hospitalization. Some families of CMC report significant issues when working with pediatric hospital staff to assess their child's discharge readiness.[7, 32, 33] In addition, there is significant variation across states and regions in access to and quality of post‐discharge health services (eg, home nursing, postacute care, durable medical equipment).[34, 35] In some areas, many CMC are not actively involved with their primary care physician.[5] These issues might also influence the ability of some children's hospitals to efficiently discharge CMC to a safe and supportive post‐discharge environment. Further examination of hospital outliersthose with the lowest and highest percentage of CMC hospitalizations with long LOSmay reveal opportunities to identify and spread best practices.

The demographic and clinical factors associated with long LOS in the present study, including age, ICU use, and transfer from another hospital, might help hospitals target which CMC have the greatest risk for experiencing long LOS. We found that infants age <1 year had longer LOS when compared with older children. Similar to our findings, younger‐aged children hospitalized with bronchiolitis have longer LOS.[36] Certainly, infants with medical complexity, in general, are a high‐acuity population with the potential for rapid clinical deterioration during an acute illness. Prolonged hospitalization for treatment and stabilization may be expected for many of them. Additional investigation is warranted to examine ICU use in CMC, and whether ICU admission or duration can be safely prevented or abbreviated. Opportunities to assess the quality of transfers into children's hospitals of CMC admitted to outside hospitals may be necessary. A study of pediatric burn patients reported that patients initially stabilized at a facility that was not a burn center and subsequently transferred to a burn center had a longer LOS than patients solely treated at a designated burn center.[37] Furthermore, events during transport itself may adversely impact the stability of an already fragile patient. Interventions to optimize the quality of care provided by transport teams have resulted in decreased LOS at the receiving hospital.[38]

This study's findings should be considered in the context of several limitations. Absent a gold‐standard definition of long LOS, we used the distribution of LOS across patients to inform our methods; LOS at the 90th percentile was selected as long. Although our sensitivity analysis using LOS at the 75th percentile produced similar findings, other cut points in LOS might be associated with different results. The study is not positioned to determine how much of the reported LOS was excessive, unnecessary, or preventable. The study findings may not generalize to types of hospitals not contained in PHIS (eg, nonchildren's hospitals and community hospitals). We did not focus on the impact of a new diagnosis (eg, new chronic illness) or acute in‐hospital event (eg, nosocomial infection) on prolonged LOS; future studies should investigate these clinical events with LOS.

PHIS does not contain information regarding characteristics that could influence LOS, including the children's social and familial attributes, transportation availability, home equipment needs, and local availability of postacute care facilities. Moreover, PHIS does not contain information about the hospital discharge procedures, process, or personnel across hospitals, which could influence LOS. Future studies on prolonged LOS should consider assessing this information. Because of the large sample size of hospitalizations included, the statistical power for the analyses was strong, rendering it possible that some findings that were statistically significant might have modest clinical significance (eg, relationship of Hispanic ethnicity with prolonged LOS). We could not determine why a positive correlation was not observed between hospitals' long LOS prevalence and their percentage of cost associated with long LOS; future studies should investigate the reasons for this finding.

Despite these limitations, the findings of the present study highlight the significance of long LOS in hospitalized CMC. These long hospitalizations account for a significant proportion of all hospital costs for this important population of children. The prevalence of long LOS for CMC varies considerably across children's hospitals, even after accounting for the case mix. Efforts to curtail hospital resource use and costs for CMC may benefit from focus on long LOS.

Children with medical complexity (CMC) have complex and chronic health conditions that often involve multiple organ systems and severely affect cognitive and physical functioning. Although the prevalence of CMC is low (1% of all children), they account for nearly one‐fifth of all pediatric admissions and one‐half of all hospital days and charges in the United States.[1] Over the last decade, CMC have had a particularly large and increasing impact in tertiary‐care children's hospitals.[1, 2] The Institute of Medicine has identified CMC as a priority population for a revised healthcare system.[3]

Medical homes, hospitals, health plans, states, federal agencies, and others are striving to reduce excessive hospital use in CMC because of its high cost.[4, 5, 6] Containing length of stay (LOS)an increasingly used indicator of the time sensitiveness and efficiency of hospital careis a common aim across these initiatives. CMC have longer hospitalizations than children without medical complexity. Speculated reasons for this are that CMC tend to have (1) higher severity of acute illnesses (eg, pneumonia, cellulitis), (2) prolonged recovery time in the hospital, and (3) higher risk of adverse events in the hospital. Moreover, hospital clinicians caring for CMC often find it difficult to determine discharge readiness, given that many CMC do not return to a completely healthy baseline.[7]

Little is known about long LOS in CMC, including which CMC have the highest risk of experiencing such stays and which stays might have the greatest opportunity to be shortened. Patient characteristics associated with prolonged length of stay have been studied extensively for many pediatric conditions (eg, asthma).[8, 9, 10, 11, 12, 13, 14] However, most of these studies excluded CMC. Therefore, the objectives of this study were to examine (1) the prevalence of long LOS in CMC, (2) patient characteristics associated with long LOS, and (3) hospital‐to‐hospital variation in prevalence of long LOS hospitalizations.

METHODS

Study Design and Data Source

This study is a multicenter, retrospective cohort analysis of the Pediatric Health Information System (PHIS). PHIS is an administrative database of 44 not for profit, tertiary care pediatric hospitals affiliated with the Children's Hospital Association (CHA) (Overland Park, KS). PHIS contains data regarding patient demographics, diagnoses, and procedures (with International Classification of Diseases, 9th Revision, Clinical Modification [ICD‐9‐CM] codes), All‐Patient Refined Diagnostic Related Groups version 30 (APR‐DRGs) (3M Health Information Systems, Salt Lake City, UT), and service lines that aggregate the APR‐DRGs into 38 distinct groups. Data quality and reliability are assured through CHA and participating hospitals. In accordance with the policies of the Cincinnati Children's Hospital Medical Center Institutional Review Board, this study of deidentified data was not considered human subjects research.

Study Population

Inclusion Criteria

Children discharged following an observation or inpatient admission from a hospital participating in the PHIS database between January 1, 2013 and December 31, 2014 were eligible for inclusion if they were considered medically complex. Medical complexity was defined using Clinical Risk Groups (CRGs) version 1.8, developed by 3M Health Information Systems and the National Association of Children's Hospitals and Related Institutions. CRGs were used to assign each hospitalized patient to 1 of 9 mutually exclusive chronicity groups according to the presence, type, and severity of chronic conditions.[15, 16, 17, 18] Each patient's CRG designation was based on 2 years of previous hospital encounters.

As defined in prior studies and definitional frameworks of CMC,[1] patients belonging to CRG group 6 (significant chronic disease in 2 organ systems), CRG group 7 (dominant chronic disease in 3 organ systems), and CRG group 9 (catastrophic condition) were considered medically complex.[17, 19] Patients with malignancies (CRG group 8) were not included for analysis because they are a unique population with anticipated, long hospital stays. Patients with CRG group 5, representing those with chronic conditions affecting a single body system, were also not included because most do not have attributes consistent with medical complexity.

Exclusion Criteria

We used the APR‐DRG system, which leverages ICD‐9‐CM codes to identify the health problem most responsible for the hospitalization, to refine the study cohort. We excluded hospitalizations that were classified by the APR‐DRG system as neonatal, as we did not wish to focus on LOS in the neonatal intensive care unit (ICU) or for birth admissions. Similarly, hospitalizations for chemotherapy (APR‐DRG 693) or malignancy (identified with previously used ICD‐9‐CM codes)[20] were also excluded because long LOS is anticipated. We also excluded hospitalizations for medical rehabilitation (APR‐DRG 860).

Outcome Measures

The primary outcome measure was long LOS, defined as LOS 10 days. The cut point of LOS 10 days represents the 90th percentile of LOS for all children, with and without medical complexity, hospitalized during 2013 to 2014. LOS 10 days has previously been used as a threshold of long LOS.[21] For hospitalizations involving transfer at admission from another acute care facility, LOS was measured from the date of transfer. We also assessed hospitals' cost attributable to long LOS admissions.

Patient Demographics and Clinical Characteristics

We measured demographic characteristics including age, gender, race/ethnicity, insurance type, and distance traveled (the linear distance between the centroid of the patient's home ZIP code and the centroid of the hospital's ZIP code). Clinical characteristics included CRG classification, complex chronic condition (CCC), and dependence on medical technology. CCCs are defined as any medical condition that can be reasonably expected to last at least 12 months (unless death intervenes) and to involve either several different organ systems or 1 system severely enough to require specialty pediatric care and probably some period of hospitalization in a tertiary care center.[20] Medical technology included devices used to optimize the health and functioning of the child (eg, gastrostomy, tracheostomy, cerebrospinal fluid shunt).[22]

Hospitalization Characteristics

Characteristics of the hospitalization included transfer from an outside facility, ICU admission, surgical procedure (using surgical APR‐DRGs), and discharge disposition (home, skilled nursing facility, home health services, death, other). Cost of the hospitalization was estimated in the PHIS from charges using hospital and year‐specific ratios of cost to charge.

Statistical Analysis

Continuous data (eg, distance from hospital to home residence) were described with median and interquartile ranges (IQR) because they were not normally distributed. Categorical data (eg, type of chronic condition) were described with counts and frequencies. In bivariate analyses, demographic, clinical, and hospitalization characteristics were stratified by LOS (long LOS vs LOS <10 days), and compared using 2 statistics or Wilcoxon rank sum tests as appropriate.

We modeled the likelihood of experiencing a long LOS using generalized linear mixed effects models with a random hospital intercept and discharge‐level fixed effects for age, gender, payor, CCC type, ICU utilization, transfer status, a medical/surgical admission indicator derived from the APR‐DRG, and CRG assigned to each hospitalization. To examine hospital‐to‐hospital variability, we generated hospital risk‐adjusted rates of long LOS from these models. Similar models and hospital risk‐adjusted rates were built for a post hoc correlational analysis of 30‐day all cause readmission, where hospitals' rates and percent of long LOS were compared with a Pearson correlation coefficient. Also, for our multivariable models, we performed a sensitivity analysis using an alternative definition of long LOS as 4 days (the 75th percentile of LOS for all children, with and without medical complexity, hospitalized during 20132014). All analyses were performed using SAS version 9.4 (SAS Institute, Cary, NC), and P values <0.05 were considered statistically significant.

RESULTS

Study Population

There were 954,018 hospitalizations of 217,163 CMC at 44 children's hospitals included for analysis. Forty‐seven percent of hospitalizations were for females, 49.4% for non‐Hispanic whites, and 61.1% for children with government insurance. Fifteen percent (n = 142,082) had a long LOS of 10 days. The median (IQR) LOS of hospitalizations <10 days versus 10 days were 2 (IQR, 14) and 16 days (IQR, 1226), respectively. Long LOS hospitalizations accounted for 61.1% (3.7 million) hospital days and 61.8% ($13.7 billion) of total hospitalization costs for all CMC in the cohort (Table 1).

Demographic, Clinical, and Hospitalization Characteristics of Hospitalized Children With Medical Complexity by Length of Stay*
Characteristic Overall (n = 954,018) Length of Stay
<10 Days (n = 811,936) 10 Days (n = 142,082)
  • NOTE: Abbreviations: IQR, interquartile range. *All comparisons were significant at the P < 0.001 level.

Age at admission, y, %
<1 14.6 12.7 25.7
14 27.1 27.9 22.4
59 20.1 21.0 14.9
1018 33.6 34.0 31.7
18+ 4.6 4.4 5.4
Gender, %
Female 47.0 46.9 47.5
Race/ethnicity, %
Non‐Hispanic white 49.4 49.4 49.4
Non‐Hispanic black 23.1 23.8 19.3
Hispanic 18.2 17.8 20.4
Asian 2.0 1.9 2.3
Other 7.4 7.1 8.6
Complex chronic condition, %
Any 79.5 77.3 91.8
Technology assistance 37.1 34.1 54.2
Gastrointestinal 30.0 27.2 45.9
Neuromuscular 28.2 27.7 30.9
Cardiovascular 16.8 14.5 29.9
Respiratory 14.1 11.5 29.4
Congenital/genetic defect 17.2 16.7 20.2
Metabolic 9.9 8.9 15.4
Renal 10.1 9.5 13.8
Hematology/emmmunodeficiency 11.7 12.0 10.0
Neonatal 3.8 3.1 7.7
Transplantation 4.5 4.2 6.7
Clinical risk group, %
Chronic condition in 2 systems 68.4 71.2 53.9
Catastrophic chronic condition 31.4 28.8 46.1
Distance from hospital to home residence in miles, median [IQR] 16.2 [7.440.4] 15.8 [7.338.7] 19.1 [8.552.6]
Transferred from outside hospital (%) 6.5 5.3 13.6
Admitted for surgery, % 23.4 20.7 38.7
Use of intensive care, % 19.6 14.9 46.5
Discharge disposition, %
Home 91.2 92.9 81.4
Home healthcare 4.5 3.5 9.9
Other 2.9 2.6 4.5
Postacute care facility 1.1 0.8 3.1
Died 0.4 0.3 1.1
Payor, %
Government 61.1 60.6 63.5
Private 33.2 33.6 30.9
Other 5.7 5.7 5.7
Hospital resource use
Median length of stay [IQR] 3 [16] 2 [14] 16 [1226]
Median hospital cost [IQR] $8,144 [$4,122$18,447] $6,689 [$3,685$12,395] $49,207 [$29,444$95,738]
Total hospital cost, $, billions $22.2 $8.5 $13.7

Demographics and Clinical Characteristics of Children With and Without Long LOS

Compared with hospitalized CMC with LOS <10 days, a higher percentage of hospitalizations with LOS 10 days were CMC age <1 year (25.7% vs 12.7%, P < 0.001) and Hispanic (20.4% vs 17.8%, P < 0.001). CMC hospitalizations with a long LOS had a higher percentage of any CCC (91.8% vs 77.3%, P < 0.001); the most common CCCs were gastrointestinal (45.9%), neuromuscular (30.9%), and cardiovascular (29.9%). Hospitalizations of CMC with a long LOS had a higher percentage of a catastrophic chronic condition (46.1% vs 28.8%, P < 0.001) and technology dependence (46.1% vs 28.8%, P < 0.001) (Table 1).

Hospitalization Characteristics of Children With and Without Long LOS

Compared with hospitalizations of CMC with LOS <10 days, hospitalizations of CMC with a long LOS more often involved transfer in from another hospital at admission (13.6% vs 5.3%, P < 0.001). CMC hospital stays with a long LOS more often involved surgery (38.7% vs 20.7%, P < 0.001) and use of intensive care (46.5% vs 14.9%; P < 0.001). A higher percentage of CMC with long LOS were discharged with home health services (9.9% vs 3.5%; P < 0.001) (Table 1).

The most common admitting diagnoses and CCCs for hospitalizations of CMC with long LOS are presented in Table 2. The two most prevalent APR‐DRGs in CMC hospitalizations lasting 10 days or longer were cystic fibrosis (10.7%) and respiratory system disease with ventilator support (5.5%). The two most common chronic condition characteristics represented among long CMC hospitalizations were gastrointestinal devices (eg, gastrostomy tube) (39.7%) and heart and great vessel malformations (eg, tetralogy of Fallot) (12.8%). The 5 most common CCC subcategories, as listed in Table 2, account for nearly 100% of the patients with long LOS hospitalizations.

Most Common Reasons for Admission and Specific Complex Chronic Conditions for Hospitalized Children With Medical Complexity Who Had Length of Stay 10 Days
  • NOTE: *Reason for admission identified using All‐Patient Refined Diagnosis‐Related Groups. Complex chronic conditions identified using Feudtner and colleagues set of International Classification of Diseases, 9th Revision, Clinical Modification codes. Gastrointestinal devices include gastrostomy, gastrojejunostomy, colostomy. Respiratory devices include tracheostomy, noninvasive positive pressure, ventilator.

Most common reason for admission*
Cystic fibrosis 10.7%
Respiratory system diagnosis with ventilator support 96+ hours 5.5%
Malfunction, reaction, and complication of cardiac or vascular device or procedure 2.8%
Craniotomy except for trauma 2.6%
Major small and large bowel procedures 2.3%
Most common complex chronic condition
Gastrointestinal devices 39.7%
Heart and great vessel malformations 12.8%
Cystic fibrosis 12.5%
Dysrhythmias 11.0%
Respiratory devices 10.7%

Multivariable Analysis of Characteristics Associated With Long LOS

In multivariable analysis, the highest likelihood of long LOS was experienced by children who received care in the ICU (odds ratio [OR]: 3.5, 95% confidence interval [CI]: 3.43.5), who had a respiratory CCC (OR: 2.7, 95% CI: 2.62.7), and who were transferred from another acute care hospital at admission (OR: 2.1, 95% CI: 2.0, 2.1). The likelihood of long LOS was also higher in children <1 year of age (OR: 1.2, 95% CI: 1.21.3), and Hispanic children (OR: 1.1, 95% CI 1.0‐1.10) (Table 3). Similar multivariable findings were observed in sensitivity analysis using the 75th percentile of LOS (4 days) as the model outcome.

Multivariable Analysis of the Likelihood of Long Length of Stay 10 Days
Characteristic Odds Ratio (95% CI) of LOS 10 Days P Value
  • NOTE: Abbreviations: CI, confidence interval; LOS, length of stay.

Use of intensive care 3.5 (3.4‐3.5) <0.001
Transfer from another acute‐care hospital 2.1 (2.0‐2.1) <0.001
Procedure/surgery 1.8 (1.8‐1.9) <0.001
Complex chronic condition
Respiratory 2.7 (2.6‐2.7) <0.001
Gastrointestinal 1.8 (1.8‐1.8) <0.001
Metabolic 1.7 (1.7‐1.7) <0.001
Cardiovascular 1.6 (1.5‐1.6) <0.001
Neonatal 1.5 (1.5‐1.5) <0.001
Renal 1.4 (1.4‐1.4) <0.001
Transplant 1.4 (1.4‐1.4) <0.001
Hematology and immunodeficiency 1.3 (1.3‐1.3) <0.001
Technology assistance 1.1 (1.1, 1.1) <0.001
Neuromuscular 0.9 (0.9‐0.9) <0.001
Congenital or genetic defect 0.8 (0.8‐0.8) <0.001
Age at admission, y
<1 1.2 (1.2‐1.3) <0.001
14 0.5 (0.5‐0.5) <0.001
59 0.6 (0.6‐0.6) <0.001
1018 0.9 (0.9‐0.9) <0.001
18+ Reference
Male 0.9 (0.9‐0.9) <0.001
Race/ethnicity
Non‐Hispanic black 0.9 (0.9‐0.9) <0.001
Hispanic 1.1 (1.0‐1.1) <0.001
Asian 1.0 (1.0‐1.1) 0.3
Other 1.1 (1.1‐1.1) <0.001
Non‐Hispanic white Reference
Payor
Private 0.9 (0.8 0.9) <0.001
Other 1.0 (1.0‐1.0) 0.4
Government Reference
Season
Spring 1.0 (1.0 1.0) <0.001
Summer 0.9 (0.9‐0.9) <0.001
Fall 1.0 (0.9‐1.0) <0.001
Winter Reference

Variation in the Prevalence of Long LOS Across Children's Hospitals

After controlling for demographic, clinical, and hospital characteristics associated with long LOS, there was significant (P < 0.001) variation in the prevalence of long LOS for CMC across children's hospitals in the cohort (range, 10.3%21.8%) (Figure 1). Twelve (27%) hospitals had a significantly (P < 0.001) higher prevalence of long LOS for their hospitalized CMC, compared to the mean. Eighteen (41%) had a significantly (P < 0.001) lower prevalence of long LOS for their hospitalized CMC. There was also significant variation across hospitals with respect to cost, with 49.7% to 73.7% of all hospital costs of CMC attributed to long LOS hospitalizations. Finally, there was indirect correlation with the prevalence of LOS across hospitals and the hospitals' 30‐day readmission rate ( = 0.3; P = 0.04). As the prevalence of long LOS increased, the readmission rate decreased.

Figure 1
Variation in the Prevalence and Cost of Long Length of Stay ≥10 days for Children with Medical Complexity Across Children's Hospitals. Presented from the left y‐axis are the adjusted percentages (with 95% confidence interval)—shown as circles and whiskers—of total admissions for complex chronic condition (CMC) with length of stay (LOS) ≥10 days across 44 freestanding children's hospitals. The percentages are adjusted for demographic, clinical, and hospitalization characteristics associated with the likelihood of CMC experiencing LOS ≥10 days. The dashed line indicates the mean percentage (15%) across all hospitals. Also presented on the right y‐axis are the percentages—shown as gray bars—of all hospital charges attributable to hospitalizations ≥10 days among CMC across children's hospitals.

DISCUSSION

The main findings from this study suggest that a small percentage of CMC experiencing long LOS account for the majority of hospital bed days and cost of all hospitalized CMC in children's hospitals. The likelihood of long LOS varies significantly by CMC's age, race/ethnicity, and payor as well as by type and number of chronic conditions. Among CMC with long LOS, the use of gastrointestinal devices such as gastrostomy tubes, as well as congenital heart disease, were highly prevalent. In multivariable analysis, the characteristics most strongly associated with LOS 10 days were use of the ICU, respiratory complex chronic condition, and transfer from another medical facility at admission. After adjusting for these factors, there was significant variation in the prevalence of LOS 10 days for CMC across children's hospitals.

Although it is well known that CMC as a whole have a major impact on resource use in children's hospitals, this study reveals that 15% of hospitalizations of CMC account for 62% of all hospital costs of CMC. That is, a small fraction of hospitalizations of CMC is largely responsible for the significant financial impact of hospital resource use. To date, most clinical efforts and policies striving to reduce hospital use in CMC have focused on avoiding readmissions or index hospital admissions entirely, rather than improving the efficiency of hospital care after admission occurs.[23, 24, 25, 26] In the adult population, the impact of long LOS on hospital costs has been recognized, and several Medicare incentive programs have focused on in‐hospital timeliness and efficiency. As a result, LOS in Medicare beneficiaries has decreased dramatically over the past 2 decades.[27, 28, 29, 30] Optimizing the efficiency of hospital care for CMC may be an important goal to pursue, especially with precedent set in the adult literature.

Perhaps the substantial variation across hospitals in the prevalence of long LOS in CMC indicates opportunity to improve the efficiency of their inpatient care. This variation was not due to differences across hospitals' case mix of CMC. Further investigation is needed to determine how much of it is due to differences in quality of care. Clinical practice guidelines for hospital treatment of common illnesses usually exclude CMC. In our clinical experience across 9 children's hospitals, we have experienced varying approaches to setting discharge goals (ie, parameters on how healthy the child needs to be to ensure a successful hospital discharge) for CMC.[31] When the goals are absent or not clearly articulated, they can contribute to a prolonged hospitalization. Some families of CMC report significant issues when working with pediatric hospital staff to assess their child's discharge readiness.[7, 32, 33] In addition, there is significant variation across states and regions in access to and quality of post‐discharge health services (eg, home nursing, postacute care, durable medical equipment).[34, 35] In some areas, many CMC are not actively involved with their primary care physician.[5] These issues might also influence the ability of some children's hospitals to efficiently discharge CMC to a safe and supportive post‐discharge environment. Further examination of hospital outliersthose with the lowest and highest percentage of CMC hospitalizations with long LOSmay reveal opportunities to identify and spread best practices.

The demographic and clinical factors associated with long LOS in the present study, including age, ICU use, and transfer from another hospital, might help hospitals target which CMC have the greatest risk for experiencing long LOS. We found that infants age <1 year had longer LOS when compared with older children. Similar to our findings, younger‐aged children hospitalized with bronchiolitis have longer LOS.[36] Certainly, infants with medical complexity, in general, are a high‐acuity population with the potential for rapid clinical deterioration during an acute illness. Prolonged hospitalization for treatment and stabilization may be expected for many of them. Additional investigation is warranted to examine ICU use in CMC, and whether ICU admission or duration can be safely prevented or abbreviated. Opportunities to assess the quality of transfers into children's hospitals of CMC admitted to outside hospitals may be necessary. A study of pediatric burn patients reported that patients initially stabilized at a facility that was not a burn center and subsequently transferred to a burn center had a longer LOS than patients solely treated at a designated burn center.[37] Furthermore, events during transport itself may adversely impact the stability of an already fragile patient. Interventions to optimize the quality of care provided by transport teams have resulted in decreased LOS at the receiving hospital.[38]

This study's findings should be considered in the context of several limitations. Absent a gold‐standard definition of long LOS, we used the distribution of LOS across patients to inform our methods; LOS at the 90th percentile was selected as long. Although our sensitivity analysis using LOS at the 75th percentile produced similar findings, other cut points in LOS might be associated with different results. The study is not positioned to determine how much of the reported LOS was excessive, unnecessary, or preventable. The study findings may not generalize to types of hospitals not contained in PHIS (eg, nonchildren's hospitals and community hospitals). We did not focus on the impact of a new diagnosis (eg, new chronic illness) or acute in‐hospital event (eg, nosocomial infection) on prolonged LOS; future studies should investigate these clinical events with LOS.

PHIS does not contain information regarding characteristics that could influence LOS, including the children's social and familial attributes, transportation availability, home equipment needs, and local availability of postacute care facilities. Moreover, PHIS does not contain information about the hospital discharge procedures, process, or personnel across hospitals, which could influence LOS. Future studies on prolonged LOS should consider assessing this information. Because of the large sample size of hospitalizations included, the statistical power for the analyses was strong, rendering it possible that some findings that were statistically significant might have modest clinical significance (eg, relationship of Hispanic ethnicity with prolonged LOS). We could not determine why a positive correlation was not observed between hospitals' long LOS prevalence and their percentage of cost associated with long LOS; future studies should investigate the reasons for this finding.

Despite these limitations, the findings of the present study highlight the significance of long LOS in hospitalized CMC. These long hospitalizations account for a significant proportion of all hospital costs for this important population of children. The prevalence of long LOS for CMC varies considerably across children's hospitals, even after accounting for the case mix. Efforts to curtail hospital resource use and costs for CMC may benefit from focus on long LOS.

References
  1. Berry JG, Hall M, Hall DE, et al. Inpatient growth and resource use in 28 children's hospitals: a longitudinal, multi‐institutional study. JAMA Pediatr. 2013;167(2):170177.
  2. Simon TD, Berry J, Feudtner C, et al. Children with complex chronic conditions in inpatient hospital settings in the united states. Pediatrics. 2010;126(4):647655.
  3. Clancy CM, Andresen EM. Meeting the health care needs of persons with disabilities. Milbank Q. 2002;80(2):381391.
  4. Mosquera RA, Avritscher EBC, Samuels CL, et al. Effect of an enhanced medical home on serious illness and cost of care among high‐risk children with chronic illness: a randomized clinical trial. JAMA. 2014;312(24):26402648.
  5. Berry JG, Hall M, Neff J, et al. Children with medical complexity and Medicaid: spending and cost savings. Health Aff Proj Hope. 2014;33(12):21992206.
  6. Children's Hospital Association. CARE Award. Available at: https://www.childrenshospitals.org/Programs‐and‐Services/Quality‐Improvement‐and‐Measurement/CARE‐Award. Accessed December 18, 2015.
  7. Berry JG, Ziniel SI, Freeman L, et al. Hospital readmission and parent perceptions of their child's hospital discharge. Int J Qual Health Care. 2013;25(5):573581.
  8. Fendler W, Baranowska‐Jazwiecka A, Hogendorf A, et al. Weekend matters: Friday and Saturday admissions are associated with prolonged hospitalization of children. Clin Pediatr (Phila). 2013;52(9):875878.
  9. Goudie A, Dynan L, Brady PW, Rettiganti M. Attributable cost and length of stay for central line‐associated bloodstream infections. Pediatrics. 2014;133(6):e1525e1532.
  10. Graves N, Weinhold D, Tong E, et al. Effect of healthcare‐acquired infection on length of hospital stay and cost. Infect Control Hosp Epidemiol. 2007;28(3):280292.
  11. Hassan F, Lewis TC, Davis MM, Gebremariam A, Dombkowski K. Hospital utilization and costs among children with influenza, 2003. Am J Prev Med. 2009;36(4):292296.
  12. Kronman MP, Hall M, Slonim AD, Shah SS. Charges and lengths of stay attributable to adverse patient‐care events using pediatric‐specific quality indicators: a multicenter study of freestanding children's hospitals. Pediatrics. 2008;121(6):e1653e1659.
  13. Leyenaar JK, Lagu T, Shieh M‐S, Pekow PS, Lindenauer PK. Variation in resource utilization for the management of uncomplicated community‐acquired pneumonia across community and children's hospitals. J Pediatr. 2014;165(3):585591.
  14. Leyenaar JK, Shieh M‐S, Lagu T, Pekow PS, Lindenauer PK. Variation and outcomes associated with direct hospital admission among children with pneumonia in the United States. JAMA Pediatr. 2014;168(9):829836.
  15. Hughes JS, Averill RF, Eisenhandler J, et al. Clinical Risk Groups (CRGs): a classification system for risk‐adjusted capitation‐based payment and health care management. Med Care. 2004;42(1):8190.
  16. Neff JM, Clifton H, Park KJ, et al. Identifying children with lifelong chronic conditions for care coordination by using hospital discharge data. Acad Pediatr. 2010;10(6):417423.
  17. Neff JM, Sharp VL, Muldoon J, Graham J, Myers K. Profile of medical charges for children by health status group and severity level in a Washington State Health Plan. Health Serv Res. 2004;39(1):7389.
  18. Neff JM, Sharp VL, Popalisky J, Fitzgibbon T. Using medical billing data to evaluate chronically ill children over time. J Ambulatory Care Manage. 2006;29(4):283290.
  19. O'Mahony L, O'Mahony DS, Simon TD, Neff J, Klein EJ, Quan L. Medical complexity and pediatric emergency department and inpatient utilization. Pediatrics. 2013;131(2):e559e565.
  20. Feudtner C, Feinstein JA, Zhong W, Hall M, Dai D. Pediatric complex chronic conditions classification system version 2: updated for ICD‐10 and complex medical technology dependence and transplantation. BMC Pediatr. 2014;14:199.
  21. Weissman C. Analyzing intensive care unit length of stay data: problems and possible solutions. Crit Care Med. 1997;25(9):15941600.
  22. Berry JG, Hall DE, Kuo DZ, et al. Hospital utilization and characteristics of patients experiencing recurrent readmissions within children's hospitals. JAMA. 2011;305(7):682690.
  23. Hudson SM. Hospital readmissions and repeat emergency department visits among children with medical complexity: an integrative review. J Pediatr Nurs. 2013;28(4):316339.
  24. Jurgens V, Spaeder MC, Pavuluri P, Waldman Z. Hospital readmission in children with complex chronic conditions discharged from subacute care. Hosp Pediatr. 2014;4(3):153158.
  25. Coller RJ, Nelson BB, Sklansky DJ, et al. Preventing hospitalizations in children with medical complexity: a systematic review. Pediatrics. 2014;134(6):e1628e1647.
  26. Kun SS, Edwards JD, Ward SLD, Keens TG. Hospital readmissions for newly discharged pediatric home mechanical ventilation patients. Pediatr Pulmonol. 2012;47(4):409414.
  27. Cram P, Lu X, Kaboli PJ, et al. Clinical characteristics and outcomes of Medicare patients undergoing total hip arthroplasty, 1991–2008. JAMA. 2011;305(15):15601567.
  28. Bueno H, Ross JS, Wang Y, et al. Trends in length of stay and short‐term outcomes among Medicare patients hospitalized for heart failure, 1993–2006. JAMA. 2010;303(21):21412147.
  29. U.S. Department of Health and Human Services. CMS Statistics 2013. Available at: https://www.cms.gov/Research‐Statistics‐Data‐and‐Systems/Statistics‐Trends‐and‐Reports/CMS‐Statistics‐Reference‐Booklet/Downloads/CMS_Stats_2013_final.pdf. Published August 2013. Accessed October 6, 2015.
  30. Centers for Medicare and Medicaid Services. Evaluation of the premier hospital quality incentive demonstration. Available at: https://www.cms.gov/Research‐Statistics‐Data‐and‐Systems/Statistics‐Trends‐and‐Reports/Reports/downloads/Premier_ExecSum_2010.pdf. Published March 3, 2009. Accessed September 18, 2015.
  31. Berry JG, Blaine K, Rogers J, et al. A framework of pediatric hospital discharge care informed by legislation, research, and practice. JAMA Pediatr. 2014;168(10):955962; quiz 965–966.
  32. Brittan M, Albright K, Cifuentes M, Jimenez‐Zambrano A, Kempe A. Parent and provider perspectives on pediatric readmissions: what can we learn about readiness for discharge? Hosp Pediatr. 2015;5(11):559565.
  33. Berry JG, Gay JC. Preventing readmissions in children: how do we do that? Hosp Pediatr. 2015;5(11):602604.
  34. O'Brien JE, Berry J, Dumas H. Pediatric post‐acute hospital care: striving for identity and value. Hosp Pediatr. 2015;5(10):548551.
  35. Berry JG, Hall M, Dumas H, et al. Pediatric hospital discharges to home health and postacute facility care: a national study. JAMA Pediatr. 2016;170(4):326333.
  36. Corneli HM, Zorc JJ, Holubkov R, et al. Bronchiolitis: clinical characteristics associated with hospitalization and length of stay. Pediatr Emerg Care. 2012;28(2):99103.
  37. Myers J, Smith M, Woods C, Espinosa C, Lehna C. The effect of transfers between health care facilities on costs and length of stay for pediatric burn patients. J Burn Care Res. 2015;36(1):178183.
  38. Stroud MH, Sanders RC, Moss MM, et al. Goal‐directed resuscitative interventions during pediatric interfacility transport. Crit Care Med. 2015;43(8):16921698.
References
  1. Berry JG, Hall M, Hall DE, et al. Inpatient growth and resource use in 28 children's hospitals: a longitudinal, multi‐institutional study. JAMA Pediatr. 2013;167(2):170177.
  2. Simon TD, Berry J, Feudtner C, et al. Children with complex chronic conditions in inpatient hospital settings in the united states. Pediatrics. 2010;126(4):647655.
  3. Clancy CM, Andresen EM. Meeting the health care needs of persons with disabilities. Milbank Q. 2002;80(2):381391.
  4. Mosquera RA, Avritscher EBC, Samuels CL, et al. Effect of an enhanced medical home on serious illness and cost of care among high‐risk children with chronic illness: a randomized clinical trial. JAMA. 2014;312(24):26402648.
  5. Berry JG, Hall M, Neff J, et al. Children with medical complexity and Medicaid: spending and cost savings. Health Aff Proj Hope. 2014;33(12):21992206.
  6. Children's Hospital Association. CARE Award. Available at: https://www.childrenshospitals.org/Programs‐and‐Services/Quality‐Improvement‐and‐Measurement/CARE‐Award. Accessed December 18, 2015.
  7. Berry JG, Ziniel SI, Freeman L, et al. Hospital readmission and parent perceptions of their child's hospital discharge. Int J Qual Health Care. 2013;25(5):573581.
  8. Fendler W, Baranowska‐Jazwiecka A, Hogendorf A, et al. Weekend matters: Friday and Saturday admissions are associated with prolonged hospitalization of children. Clin Pediatr (Phila). 2013;52(9):875878.
  9. Goudie A, Dynan L, Brady PW, Rettiganti M. Attributable cost and length of stay for central line‐associated bloodstream infections. Pediatrics. 2014;133(6):e1525e1532.
  10. Graves N, Weinhold D, Tong E, et al. Effect of healthcare‐acquired infection on length of hospital stay and cost. Infect Control Hosp Epidemiol. 2007;28(3):280292.
  11. Hassan F, Lewis TC, Davis MM, Gebremariam A, Dombkowski K. Hospital utilization and costs among children with influenza, 2003. Am J Prev Med. 2009;36(4):292296.
  12. Kronman MP, Hall M, Slonim AD, Shah SS. Charges and lengths of stay attributable to adverse patient‐care events using pediatric‐specific quality indicators: a multicenter study of freestanding children's hospitals. Pediatrics. 2008;121(6):e1653e1659.
  13. Leyenaar JK, Lagu T, Shieh M‐S, Pekow PS, Lindenauer PK. Variation in resource utilization for the management of uncomplicated community‐acquired pneumonia across community and children's hospitals. J Pediatr. 2014;165(3):585591.
  14. Leyenaar JK, Shieh M‐S, Lagu T, Pekow PS, Lindenauer PK. Variation and outcomes associated with direct hospital admission among children with pneumonia in the United States. JAMA Pediatr. 2014;168(9):829836.
  15. Hughes JS, Averill RF, Eisenhandler J, et al. Clinical Risk Groups (CRGs): a classification system for risk‐adjusted capitation‐based payment and health care management. Med Care. 2004;42(1):8190.
  16. Neff JM, Clifton H, Park KJ, et al. Identifying children with lifelong chronic conditions for care coordination by using hospital discharge data. Acad Pediatr. 2010;10(6):417423.
  17. Neff JM, Sharp VL, Muldoon J, Graham J, Myers K. Profile of medical charges for children by health status group and severity level in a Washington State Health Plan. Health Serv Res. 2004;39(1):7389.
  18. Neff JM, Sharp VL, Popalisky J, Fitzgibbon T. Using medical billing data to evaluate chronically ill children over time. J Ambulatory Care Manage. 2006;29(4):283290.
  19. O'Mahony L, O'Mahony DS, Simon TD, Neff J, Klein EJ, Quan L. Medical complexity and pediatric emergency department and inpatient utilization. Pediatrics. 2013;131(2):e559e565.
  20. Feudtner C, Feinstein JA, Zhong W, Hall M, Dai D. Pediatric complex chronic conditions classification system version 2: updated for ICD‐10 and complex medical technology dependence and transplantation. BMC Pediatr. 2014;14:199.
  21. Weissman C. Analyzing intensive care unit length of stay data: problems and possible solutions. Crit Care Med. 1997;25(9):15941600.
  22. Berry JG, Hall DE, Kuo DZ, et al. Hospital utilization and characteristics of patients experiencing recurrent readmissions within children's hospitals. JAMA. 2011;305(7):682690.
  23. Hudson SM. Hospital readmissions and repeat emergency department visits among children with medical complexity: an integrative review. J Pediatr Nurs. 2013;28(4):316339.
  24. Jurgens V, Spaeder MC, Pavuluri P, Waldman Z. Hospital readmission in children with complex chronic conditions discharged from subacute care. Hosp Pediatr. 2014;4(3):153158.
  25. Coller RJ, Nelson BB, Sklansky DJ, et al. Preventing hospitalizations in children with medical complexity: a systematic review. Pediatrics. 2014;134(6):e1628e1647.
  26. Kun SS, Edwards JD, Ward SLD, Keens TG. Hospital readmissions for newly discharged pediatric home mechanical ventilation patients. Pediatr Pulmonol. 2012;47(4):409414.
  27. Cram P, Lu X, Kaboli PJ, et al. Clinical characteristics and outcomes of Medicare patients undergoing total hip arthroplasty, 1991–2008. JAMA. 2011;305(15):15601567.
  28. Bueno H, Ross JS, Wang Y, et al. Trends in length of stay and short‐term outcomes among Medicare patients hospitalized for heart failure, 1993–2006. JAMA. 2010;303(21):21412147.
  29. U.S. Department of Health and Human Services. CMS Statistics 2013. Available at: https://www.cms.gov/Research‐Statistics‐Data‐and‐Systems/Statistics‐Trends‐and‐Reports/CMS‐Statistics‐Reference‐Booklet/Downloads/CMS_Stats_2013_final.pdf. Published August 2013. Accessed October 6, 2015.
  30. Centers for Medicare and Medicaid Services. Evaluation of the premier hospital quality incentive demonstration. Available at: https://www.cms.gov/Research‐Statistics‐Data‐and‐Systems/Statistics‐Trends‐and‐Reports/Reports/downloads/Premier_ExecSum_2010.pdf. Published March 3, 2009. Accessed September 18, 2015.
  31. Berry JG, Blaine K, Rogers J, et al. A framework of pediatric hospital discharge care informed by legislation, research, and practice. JAMA Pediatr. 2014;168(10):955962; quiz 965–966.
  32. Brittan M, Albright K, Cifuentes M, Jimenez‐Zambrano A, Kempe A. Parent and provider perspectives on pediatric readmissions: what can we learn about readiness for discharge? Hosp Pediatr. 2015;5(11):559565.
  33. Berry JG, Gay JC. Preventing readmissions in children: how do we do that? Hosp Pediatr. 2015;5(11):602604.
  34. O'Brien JE, Berry J, Dumas H. Pediatric post‐acute hospital care: striving for identity and value. Hosp Pediatr. 2015;5(10):548551.
  35. Berry JG, Hall M, Dumas H, et al. Pediatric hospital discharges to home health and postacute facility care: a national study. JAMA Pediatr. 2016;170(4):326333.
  36. Corneli HM, Zorc JJ, Holubkov R, et al. Bronchiolitis: clinical characteristics associated with hospitalization and length of stay. Pediatr Emerg Care. 2012;28(2):99103.
  37. Myers J, Smith M, Woods C, Espinosa C, Lehna C. The effect of transfers between health care facilities on costs and length of stay for pediatric burn patients. J Burn Care Res. 2015;36(1):178183.
  38. Stroud MH, Sanders RC, Moss MM, et al. Goal‐directed resuscitative interventions during pediatric interfacility transport. Crit Care Med. 2015;43(8):16921698.
Issue
Journal of Hospital Medicine - 11(11)
Issue
Journal of Hospital Medicine - 11(11)
Page Number
750-756
Page Number
750-756
Article Type
Display Headline
Long length of hospital stay in children with medical complexity
Display Headline
Long length of hospital stay in children with medical complexity
Sections
Article Source
© 2016 Society of Hospital Medicine
Disallow All Ads
Correspondence Location
Address for correspondence and reprint requests: Jessica Gold, MD, Division of Pediatric Hospital Medicine, Lucile Packard Children's Hospital and Stanford University School of Medicine, 300 Pasteur Drive, MC 5776, Stanford, CA 94305; Telephone: 650‐736‐4423; Fax: (650) 736‐6690 E‐mail: [email protected]
Content Gating
Gated (full article locked unless allowed per User)
Gating Strategy
First Peek Free
Article PDF Media
Media Files

Is It Safe to Discharge a Patient with IDU History, PICC for Outpatient Antimicrobial Therapy?

Article Type
Changed
Fri, 09/14/2018 - 12:03
Display Headline
Is It Safe to Discharge a Patient with IDU History, PICC for Outpatient Antimicrobial Therapy?

Case

A 42-year-old female with a history of intravenous (IV) drug use presents with severe neck pain, gait instability, and bilateral C5 motor weakness. A cervical MRI shows inflammation consistent with infection of her cervical spine at C5 and C6 and significant boney destruction. The patient undergoes kyphoplasty and debridement of her cervical spine. Operative cultures are significant for Pseudomonas aeruginosa. Infectious disease consultants recommend parenteral ceftriaxone for six weeks. The patient has no insurance, and efforts to obtain long-term placement are unsuccessful. The patient states that her last use of IV drugs was three months ago, and she insists that she will abstain from illicit IV drug abuse going forward.

Background

Outpatient parenteral antibiotic treatment (OPAT) has proven to be a cost-effective and relatively safe treatment option for most patients.1 For these reasons, it has been encouraged for use among a wide a variety of clinical situations. Intravenous drug users (IDUs) are often underinsured and have few options other than costly treatment in an inpatient acute-care facility.

A history of illicit injection drug use frequently raises questions about the appropriateness of OPAT. Some of our most vulnerable patients are those who abuse illicit drugs. Due to psychiatric, social, and financial factors, their ability to adequately transition to outpatient care may be limited. They are often underinsured, and appropriate options for inpatient post-acute care may not exist. Hospitalists often feel pressure to discharge these patients despite the lack of optimal follow-up care, and they must weigh the risks and benefits in each case.

The enrollment of IDUs into an OPAT service using a peripherally inserted central catheter (PICC) is controversial and often avoided. No clear-cut guidelines concerning the use of OPAT in IDUs by national medical societies exist.2 Consultants are often reluctant to recommend options that deviate from the typical standard of inpatient or directly observed care. The obvious risk is that a PICC line provides easy and tempting access to veins for continued drug abuse. In addition, there is an increased risk of infection and/or thrombosis if the PICC is abused.3

The safety and efficacy of PICC line use for OPAT in IDUs are unknown, and studies addressing these issues are limited. In one study at the National University Hospital of Singapore, 29 IDU patients received OPAT without complications.4 Patients were closely monitored, including by use of a tamper-proof security seal on the PICC. Infective endocarditis was the primary diagnosis in 42% of the cases studied. There were no deaths or cases of PICC abuse reported. In another abstract presentation, 39 IDU patients at Henry Ford Health System in Detroit were discharged to outpatient therapy with a PICC line and demonstrated a high cure rate (73.3%). Nine patients were lost to follow-up.5

No studies have compared OPAT therapy to inpatient therapy in IDU patients.

Back to the Case

Despite multiple attempts and due to financial considerations, no long-term care facility is able to admit the patient for therapy. The frequency of required antibiotics makes outpatient therapy in an infusion center problematic. The primary service is reluctant to discharge the patient home with a PICC line in place due to the potential of abuse and complications. A “Goals of Care” committee, consisting of several physicians from multiple specialties, legal counsel, and case management, is convened to review the case. The committee concludes that, in this particular case, it would be a reasonable option to discharge the patient to home with a PICC line in place to complete OPAT. A patient agreement document is drafted; it describes the complications of PICC line abuse and stipulates that the patient agrees to drug testing throughout the duration of her treatment. A similar agreement is required by the home infusion company. Both documents are signed by the patient, and she is subsequently discharged home.

 

 

Bottom Line

Our strategy is to deal with each of these cases as unique situations because no policies, procedures, protocols, or guidelines currently exist. One of the guiding principles should be, despite financial pressures, that the primary focus is on appropriate care of this vulnerable population. A type of “Goals of Care” committee (or organizational equivalent) can be utilized to offer assistance in decision making. Unfortunately, the safety and efficacy of OPAT in IDU patients are uncertain, and there is a lack of studies to support definitive protocols. In select cases, OPAT in IDU patients may be considered, but signed consent of the risks and the patient’s responsibilities concerning OPAT should be clearly documented in the medical record by the discharging team. TH

Dr. Conrad is a hospitalist with Ochsner Health System in New Orleans.

References

  1. Tice AD, Hoaglund PA, Nolet B, McKinnon PS, Mozaffari E. Cost perspectives for outpatient intravenous antimicrobial therapy. Pharmacotherapy. 2002;22(2, pt 2):63S-70S.
  2. Tice AD, Rehm SJ, Dalovisio JR, et al. Practice guidelines for outpatient parenteral antimicrobial therapy. IDSA guidelines. Clin Infect Dis. 2004;38(12):1651-1672.
  3. Chemaly R, de Parres JB, Rehm SJ, et al. Venous thrombosis associated with peripherally inserted central catheters: a retrospective analysis of the Cleveland Clinic experience. Clin Infect Dis. 2002;34(9):1179-1183.
  4. Ho J, Archuleta S, Sulaiman Z, Fisher D. Safe and successful treatment of intravenous drug users with a peripherally inserted central catheter in an outpatient parenteral antibiotic treatment service. J Antimicrobial Chemotherapy. 2010;65(12):2641-2644.
  5. Papalekas E, Patel N, Neph A, Moreno D, Zervos M, Reyes K. Outpatient parenteral antimicrobial therapy (OPAT) in intravenous drug users (IVDUs): epidemiology and outcomes. Oral abstract presented at: IDWeek; October 2014; Philadelphia.
Issue
The Hospitalist - 2016(07)
Publications
Sections

Case

A 42-year-old female with a history of intravenous (IV) drug use presents with severe neck pain, gait instability, and bilateral C5 motor weakness. A cervical MRI shows inflammation consistent with infection of her cervical spine at C5 and C6 and significant boney destruction. The patient undergoes kyphoplasty and debridement of her cervical spine. Operative cultures are significant for Pseudomonas aeruginosa. Infectious disease consultants recommend parenteral ceftriaxone for six weeks. The patient has no insurance, and efforts to obtain long-term placement are unsuccessful. The patient states that her last use of IV drugs was three months ago, and she insists that she will abstain from illicit IV drug abuse going forward.

Background

Outpatient parenteral antibiotic treatment (OPAT) has proven to be a cost-effective and relatively safe treatment option for most patients.1 For these reasons, it has been encouraged for use among a wide a variety of clinical situations. Intravenous drug users (IDUs) are often underinsured and have few options other than costly treatment in an inpatient acute-care facility.

A history of illicit injection drug use frequently raises questions about the appropriateness of OPAT. Some of our most vulnerable patients are those who abuse illicit drugs. Due to psychiatric, social, and financial factors, their ability to adequately transition to outpatient care may be limited. They are often underinsured, and appropriate options for inpatient post-acute care may not exist. Hospitalists often feel pressure to discharge these patients despite the lack of optimal follow-up care, and they must weigh the risks and benefits in each case.

The enrollment of IDUs into an OPAT service using a peripherally inserted central catheter (PICC) is controversial and often avoided. No clear-cut guidelines concerning the use of OPAT in IDUs by national medical societies exist.2 Consultants are often reluctant to recommend options that deviate from the typical standard of inpatient or directly observed care. The obvious risk is that a PICC line provides easy and tempting access to veins for continued drug abuse. In addition, there is an increased risk of infection and/or thrombosis if the PICC is abused.3

The safety and efficacy of PICC line use for OPAT in IDUs are unknown, and studies addressing these issues are limited. In one study at the National University Hospital of Singapore, 29 IDU patients received OPAT without complications.4 Patients were closely monitored, including by use of a tamper-proof security seal on the PICC. Infective endocarditis was the primary diagnosis in 42% of the cases studied. There were no deaths or cases of PICC abuse reported. In another abstract presentation, 39 IDU patients at Henry Ford Health System in Detroit were discharged to outpatient therapy with a PICC line and demonstrated a high cure rate (73.3%). Nine patients were lost to follow-up.5

No studies have compared OPAT therapy to inpatient therapy in IDU patients.

Back to the Case

Despite multiple attempts and due to financial considerations, no long-term care facility is able to admit the patient for therapy. The frequency of required antibiotics makes outpatient therapy in an infusion center problematic. The primary service is reluctant to discharge the patient home with a PICC line in place due to the potential of abuse and complications. A “Goals of Care” committee, consisting of several physicians from multiple specialties, legal counsel, and case management, is convened to review the case. The committee concludes that, in this particular case, it would be a reasonable option to discharge the patient to home with a PICC line in place to complete OPAT. A patient agreement document is drafted; it describes the complications of PICC line abuse and stipulates that the patient agrees to drug testing throughout the duration of her treatment. A similar agreement is required by the home infusion company. Both documents are signed by the patient, and she is subsequently discharged home.

 

 

Bottom Line

Our strategy is to deal with each of these cases as unique situations because no policies, procedures, protocols, or guidelines currently exist. One of the guiding principles should be, despite financial pressures, that the primary focus is on appropriate care of this vulnerable population. A type of “Goals of Care” committee (or organizational equivalent) can be utilized to offer assistance in decision making. Unfortunately, the safety and efficacy of OPAT in IDU patients are uncertain, and there is a lack of studies to support definitive protocols. In select cases, OPAT in IDU patients may be considered, but signed consent of the risks and the patient’s responsibilities concerning OPAT should be clearly documented in the medical record by the discharging team. TH

Dr. Conrad is a hospitalist with Ochsner Health System in New Orleans.

References

  1. Tice AD, Hoaglund PA, Nolet B, McKinnon PS, Mozaffari E. Cost perspectives for outpatient intravenous antimicrobial therapy. Pharmacotherapy. 2002;22(2, pt 2):63S-70S.
  2. Tice AD, Rehm SJ, Dalovisio JR, et al. Practice guidelines for outpatient parenteral antimicrobial therapy. IDSA guidelines. Clin Infect Dis. 2004;38(12):1651-1672.
  3. Chemaly R, de Parres JB, Rehm SJ, et al. Venous thrombosis associated with peripherally inserted central catheters: a retrospective analysis of the Cleveland Clinic experience. Clin Infect Dis. 2002;34(9):1179-1183.
  4. Ho J, Archuleta S, Sulaiman Z, Fisher D. Safe and successful treatment of intravenous drug users with a peripherally inserted central catheter in an outpatient parenteral antibiotic treatment service. J Antimicrobial Chemotherapy. 2010;65(12):2641-2644.
  5. Papalekas E, Patel N, Neph A, Moreno D, Zervos M, Reyes K. Outpatient parenteral antimicrobial therapy (OPAT) in intravenous drug users (IVDUs): epidemiology and outcomes. Oral abstract presented at: IDWeek; October 2014; Philadelphia.

Case

A 42-year-old female with a history of intravenous (IV) drug use presents with severe neck pain, gait instability, and bilateral C5 motor weakness. A cervical MRI shows inflammation consistent with infection of her cervical spine at C5 and C6 and significant boney destruction. The patient undergoes kyphoplasty and debridement of her cervical spine. Operative cultures are significant for Pseudomonas aeruginosa. Infectious disease consultants recommend parenteral ceftriaxone for six weeks. The patient has no insurance, and efforts to obtain long-term placement are unsuccessful. The patient states that her last use of IV drugs was three months ago, and she insists that she will abstain from illicit IV drug abuse going forward.

Background

Outpatient parenteral antibiotic treatment (OPAT) has proven to be a cost-effective and relatively safe treatment option for most patients.1 For these reasons, it has been encouraged for use among a wide a variety of clinical situations. Intravenous drug users (IDUs) are often underinsured and have few options other than costly treatment in an inpatient acute-care facility.

A history of illicit injection drug use frequently raises questions about the appropriateness of OPAT. Some of our most vulnerable patients are those who abuse illicit drugs. Due to psychiatric, social, and financial factors, their ability to adequately transition to outpatient care may be limited. They are often underinsured, and appropriate options for inpatient post-acute care may not exist. Hospitalists often feel pressure to discharge these patients despite the lack of optimal follow-up care, and they must weigh the risks and benefits in each case.

The enrollment of IDUs into an OPAT service using a peripherally inserted central catheter (PICC) is controversial and often avoided. No clear-cut guidelines concerning the use of OPAT in IDUs by national medical societies exist.2 Consultants are often reluctant to recommend options that deviate from the typical standard of inpatient or directly observed care. The obvious risk is that a PICC line provides easy and tempting access to veins for continued drug abuse. In addition, there is an increased risk of infection and/or thrombosis if the PICC is abused.3

The safety and efficacy of PICC line use for OPAT in IDUs are unknown, and studies addressing these issues are limited. In one study at the National University Hospital of Singapore, 29 IDU patients received OPAT without complications.4 Patients were closely monitored, including by use of a tamper-proof security seal on the PICC. Infective endocarditis was the primary diagnosis in 42% of the cases studied. There were no deaths or cases of PICC abuse reported. In another abstract presentation, 39 IDU patients at Henry Ford Health System in Detroit were discharged to outpatient therapy with a PICC line and demonstrated a high cure rate (73.3%). Nine patients were lost to follow-up.5

No studies have compared OPAT therapy to inpatient therapy in IDU patients.

Back to the Case

Despite multiple attempts and due to financial considerations, no long-term care facility is able to admit the patient for therapy. The frequency of required antibiotics makes outpatient therapy in an infusion center problematic. The primary service is reluctant to discharge the patient home with a PICC line in place due to the potential of abuse and complications. A “Goals of Care” committee, consisting of several physicians from multiple specialties, legal counsel, and case management, is convened to review the case. The committee concludes that, in this particular case, it would be a reasonable option to discharge the patient to home with a PICC line in place to complete OPAT. A patient agreement document is drafted; it describes the complications of PICC line abuse and stipulates that the patient agrees to drug testing throughout the duration of her treatment. A similar agreement is required by the home infusion company. Both documents are signed by the patient, and she is subsequently discharged home.

 

 

Bottom Line

Our strategy is to deal with each of these cases as unique situations because no policies, procedures, protocols, or guidelines currently exist. One of the guiding principles should be, despite financial pressures, that the primary focus is on appropriate care of this vulnerable population. A type of “Goals of Care” committee (or organizational equivalent) can be utilized to offer assistance in decision making. Unfortunately, the safety and efficacy of OPAT in IDU patients are uncertain, and there is a lack of studies to support definitive protocols. In select cases, OPAT in IDU patients may be considered, but signed consent of the risks and the patient’s responsibilities concerning OPAT should be clearly documented in the medical record by the discharging team. TH

Dr. Conrad is a hospitalist with Ochsner Health System in New Orleans.

References

  1. Tice AD, Hoaglund PA, Nolet B, McKinnon PS, Mozaffari E. Cost perspectives for outpatient intravenous antimicrobial therapy. Pharmacotherapy. 2002;22(2, pt 2):63S-70S.
  2. Tice AD, Rehm SJ, Dalovisio JR, et al. Practice guidelines for outpatient parenteral antimicrobial therapy. IDSA guidelines. Clin Infect Dis. 2004;38(12):1651-1672.
  3. Chemaly R, de Parres JB, Rehm SJ, et al. Venous thrombosis associated with peripherally inserted central catheters: a retrospective analysis of the Cleveland Clinic experience. Clin Infect Dis. 2002;34(9):1179-1183.
  4. Ho J, Archuleta S, Sulaiman Z, Fisher D. Safe and successful treatment of intravenous drug users with a peripherally inserted central catheter in an outpatient parenteral antibiotic treatment service. J Antimicrobial Chemotherapy. 2010;65(12):2641-2644.
  5. Papalekas E, Patel N, Neph A, Moreno D, Zervos M, Reyes K. Outpatient parenteral antimicrobial therapy (OPAT) in intravenous drug users (IVDUs): epidemiology and outcomes. Oral abstract presented at: IDWeek; October 2014; Philadelphia.
Issue
The Hospitalist - 2016(07)
Issue
The Hospitalist - 2016(07)
Publications
Publications
Article Type
Display Headline
Is It Safe to Discharge a Patient with IDU History, PICC for Outpatient Antimicrobial Therapy?
Display Headline
Is It Safe to Discharge a Patient with IDU History, PICC for Outpatient Antimicrobial Therapy?
Sections
Disallow All Ads
Content Gating
No Gating (article Unlocked/Free)

Study reveals SNPs that may increase risk of MM

Article Type
Changed
Mon, 07/04/2016 - 05:00
Display Headline
Study reveals SNPs that may increase risk of MM

Micrograph showing MM

A large study has revealed several genetic variations that may increase a person’s risk of developing multiple myeloma (MM).

The findings, published in Nature Communications, build on existing research that suggests MM can run in families.

“Our study expands our understanding of how inherited risk factors can influence the risk of myeloma,” said Richard Houlston, MD, PhD, of The Institute of Cancer Research in London, UK.

“We know that the inherited risk of myeloma does not come from just one or two major risk genes, as can be the case with breast cancer, but from multiple different genetic variants, each with only a small individual effect on risk. Identifying more of these variants gives us new insights into the potential causes of the disease and open up new strategies for prevention.”

For this study, Dr Houlston and his colleagues compared DNA from 9866 MM patients and 239,188 healthy adults.

This confirmed the association between MM and 9 previously reported single nucleotide polymorphisms (SNPs):

  • rs6746082 at 2p23.3
  • rs1052501 at 3p22.1
  • rs4487645 at 7p15.3
  • rs10936599 at 3q26.2
  • rs2285803 at 6p21.3
  • rs4273077 at 17p11.2
  • rs877529 at 22q13.1
  • rs56219066 at 5q15
  • rs138740 at 22q13.

It also revealed 8 new SNPs that may increase the risk of MM:

  • rs34229995 at 6p22.3 (P=1.31 × 10−8)
  • rs9372120 at 6q21 (P=9.09 × 10−15)
  • rs7781265 at 7q36.1 (P=9.71 × 10−9)
  • rs1948915 at 8q24.21 (P=4.20 × 10−11)
  • rs2811710 at 9p21.3 (P=1.72 × 10−13)
  • rs2790457 at 10p12.1 (P=1.77 × 10−8)
  • rs7193541 at 16q23.1 (P=5.00 × 10−12)
  • rs6066835 at 20q13.13 (P=1.36 × 10−13).

These SNPs are located in regions of the genome involved in regulating genes linked to cell processes known to go wrong in MM development—namely, JARID2, ATG5, SMARCD3, CCAT1, CDKN2A, WAC, RFWD3, and PREX1.

This suggests that subtle effects on the activity of key genes could mean the proper development of plasma cells breaks down, increasing the likelihood of developing MM. However, as the researchers noted, further study is needed to confirm and better understand this phenomenon.

Publications
Topics

Micrograph showing MM

A large study has revealed several genetic variations that may increase a person’s risk of developing multiple myeloma (MM).

The findings, published in Nature Communications, build on existing research that suggests MM can run in families.

“Our study expands our understanding of how inherited risk factors can influence the risk of myeloma,” said Richard Houlston, MD, PhD, of The Institute of Cancer Research in London, UK.

“We know that the inherited risk of myeloma does not come from just one or two major risk genes, as can be the case with breast cancer, but from multiple different genetic variants, each with only a small individual effect on risk. Identifying more of these variants gives us new insights into the potential causes of the disease and open up new strategies for prevention.”

For this study, Dr Houlston and his colleagues compared DNA from 9866 MM patients and 239,188 healthy adults.

This confirmed the association between MM and 9 previously reported single nucleotide polymorphisms (SNPs):

  • rs6746082 at 2p23.3
  • rs1052501 at 3p22.1
  • rs4487645 at 7p15.3
  • rs10936599 at 3q26.2
  • rs2285803 at 6p21.3
  • rs4273077 at 17p11.2
  • rs877529 at 22q13.1
  • rs56219066 at 5q15
  • rs138740 at 22q13.

It also revealed 8 new SNPs that may increase the risk of MM:

  • rs34229995 at 6p22.3 (P=1.31 × 10−8)
  • rs9372120 at 6q21 (P=9.09 × 10−15)
  • rs7781265 at 7q36.1 (P=9.71 × 10−9)
  • rs1948915 at 8q24.21 (P=4.20 × 10−11)
  • rs2811710 at 9p21.3 (P=1.72 × 10−13)
  • rs2790457 at 10p12.1 (P=1.77 × 10−8)
  • rs7193541 at 16q23.1 (P=5.00 × 10−12)
  • rs6066835 at 20q13.13 (P=1.36 × 10−13).

These SNPs are located in regions of the genome involved in regulating genes linked to cell processes known to go wrong in MM development—namely, JARID2, ATG5, SMARCD3, CCAT1, CDKN2A, WAC, RFWD3, and PREX1.

This suggests that subtle effects on the activity of key genes could mean the proper development of plasma cells breaks down, increasing the likelihood of developing MM. However, as the researchers noted, further study is needed to confirm and better understand this phenomenon.

Micrograph showing MM

A large study has revealed several genetic variations that may increase a person’s risk of developing multiple myeloma (MM).

The findings, published in Nature Communications, build on existing research that suggests MM can run in families.

“Our study expands our understanding of how inherited risk factors can influence the risk of myeloma,” said Richard Houlston, MD, PhD, of The Institute of Cancer Research in London, UK.

“We know that the inherited risk of myeloma does not come from just one or two major risk genes, as can be the case with breast cancer, but from multiple different genetic variants, each with only a small individual effect on risk. Identifying more of these variants gives us new insights into the potential causes of the disease and open up new strategies for prevention.”

For this study, Dr Houlston and his colleagues compared DNA from 9866 MM patients and 239,188 healthy adults.

This confirmed the association between MM and 9 previously reported single nucleotide polymorphisms (SNPs):

  • rs6746082 at 2p23.3
  • rs1052501 at 3p22.1
  • rs4487645 at 7p15.3
  • rs10936599 at 3q26.2
  • rs2285803 at 6p21.3
  • rs4273077 at 17p11.2
  • rs877529 at 22q13.1
  • rs56219066 at 5q15
  • rs138740 at 22q13.

It also revealed 8 new SNPs that may increase the risk of MM:

  • rs34229995 at 6p22.3 (P=1.31 × 10−8)
  • rs9372120 at 6q21 (P=9.09 × 10−15)
  • rs7781265 at 7q36.1 (P=9.71 × 10−9)
  • rs1948915 at 8q24.21 (P=4.20 × 10−11)
  • rs2811710 at 9p21.3 (P=1.72 × 10−13)
  • rs2790457 at 10p12.1 (P=1.77 × 10−8)
  • rs7193541 at 16q23.1 (P=5.00 × 10−12)
  • rs6066835 at 20q13.13 (P=1.36 × 10−13).

These SNPs are located in regions of the genome involved in regulating genes linked to cell processes known to go wrong in MM development—namely, JARID2, ATG5, SMARCD3, CCAT1, CDKN2A, WAC, RFWD3, and PREX1.

This suggests that subtle effects on the activity of key genes could mean the proper development of plasma cells breaks down, increasing the likelihood of developing MM. However, as the researchers noted, further study is needed to confirm and better understand this phenomenon.

Publications
Publications
Topics
Article Type
Display Headline
Study reveals SNPs that may increase risk of MM
Display Headline
Study reveals SNPs that may increase risk of MM
Disallow All Ads
Content Gating
No Gating (article Unlocked/Free)
Alternative CME
Disqus Comments
Default
Use ProPublica

Prolonged IV Instead of Oral Antibiotics

Article Type
Changed
Sun, 03/03/2019 - 07:15
Display Headline
Prolonged intravenous instead of oral antibiotics for acute hematogenous osteomyelitis in children

The Things We Do for No Reason (TWDFNR) series reviews practices which have become common parts of hospital care but which may provide little value to our patients. Practices reviewed in the TWDFNR series do not represent black and white conclusions or clinical practice standards, but are meant as a starting place for research and active discussions among hospitalists and patients. We invite you to be part of that discussion. https://www.choosingwisely.org/

A previously healthy 6‐year‐old boy presented to the emergency room with 3 days of right lower leg pain and fevers up to 102F. The leg pain had progressed until he refused to walk. The patient and family did not recall any trauma to the leg. In the emergency department, he had a blood culture drawn. Because he had elevated inflammatory markers and a negative x‐ray of his right leg, a magnetic resonance imaging scan of the right leg was obtained that revealed right tibial osteomyelitis. He was taken to the operating room for debridement. After obtaining blood and bone cultures, he was started on intravenous (IV) vancomycin. His blood and surgical cultures grew methicillin‐resistant Staphylococcus aureus, sensitive to clindamycin. Subsequent blood cultures were negative, and his inflammatory markers trended down shortly after starting therapy. As he clinically improved, a peripherally inserted central catheter (PICC) was placed, and he was discharged home to complete a 6‐week course of IV vancomycin.

BACKGROUND

Osteoarticular infections (osteomyelitis and septic arthritis) are common problems in the pediatric population, affecting 1/2000 children annually and accounting for approximately 1% of all pediatric hospitalizations.[1, 2] Osteomyelitis can occur in children of all ages and usually requires hospitalization for diagnosis and initial management. The most common mechanism of infection in children is hematogenous inoculation of the bone during an episode of bacteremia (acute hematogenous osteomyelitis), particularly in young children, due to the highly vascular nature of the developing bone. Long bones, such as the femur, tibia, and humerus, are most commonly involved. Treatment of acute osteomyelitis requires prolonged administration of antimicrobial agents. Inadequately treated osteomyelitis can result in progression to chronic infection and loss of function of the affected bone.[3]

WHY YOU MIGHT THINK PARENTERAL ANTIBIOTICS AT DISCHARGE IS SUPERIOR TO ENTERAL THERAPY

In the United States, a large proportion of children with hematogenous osteomyelitis are discharged from the hospital with long‐term parenteral intravenous antibiotics through a PICC line.[3] The medical community historically favored parenteral therapy for young children with serious bacterial infections given concerns regarding impaired enteral absorption. As a result, children with osteomyelitis were initially stabilized in the hospital and discharged with parenteral therapy through a PICC line to continue or complete care, even when the organism was susceptible to a viable oral alternative such as clindamycin or cephalexin. Recommendations regarding the safety and timing to transition to oral antibiotics have been lacking. There is also extreme variation in practice in route of administration (oral vs prolonged IV therapy) in patients being discharged from the hospital with osteomyelitis.[3, 4] The most recent Infectious Diseases Society of America (IDSA) guidelines do not clearly state when transition to oral antibiotics may be safe. Specifically, they state that if patients are stable and without ongoing bacteremia, they can transition to oral therapy to complete a 4‐ to 6‐week course.[5]

WHY LONG‐TERM PARENTERAL ANTIBIOTICS MAY NOT BE SUPERIOR

The use of PICC lines has increased substantially in recent years. This has led to an increasing awareness of complications associated with PICC lines. As a result, guidelines for the appropriate use of PICC lines have been established in adults by collaborators at the University of Michigan.[6] Mounting evidence has called into question whether longer parenteral therapy is truly a more conservative or safer approach for the treatment of osteomyelitis.[3, 4, 7, 8, 9] Providing antibiotics via a PICC line in both the inpatient and outpatient settings may not be as benign as once accepted and may not improve outcomes in osteomyelitis as expected.

Costs and Potential Harms Associated With PICC Lines

PICC lines are known to have complications in the hospital including infection and thrombotic events,[10] but these events are not isolated to the hospital setting. Multiple studies have shown outpatient PICC line complication rates ranging from 29% to 41% depending on the type of catheter, the population, and the indication for use.[8, 10, 11, 12, 13] In a recently published study by Keren et al. looking specifically at children with osteomyelitis, emergency department visits and readmissions for PICC line complications occurred in 15% of patients discharged with a PICC line.[4] Given the potential complications and complexity that are inherent in outpatient parenteral therapy, the ISDA has even published guidelines regarding its use.[9] In addition, the cost of IV antibiotics, including administration costs, need for sedation in some children for line placement, and cost of the antibiotic itself, is significantly higher compared to oral therapy. In studies looking at early conversion to oral antibiotics versus prolonged intravenous antibiotics for complicated skin and soft tissue infections, as well as perforated appendicitis, oral antibiotics were more cost effective with an average savings of 30% to 50% and >$4000 respectively.[14, 15]

Patient Outcomes Are Similar When Comparing Parenteral and Enteral Therapy

In addition to increased costs and medication‐related complications, treatment of osteomyelitis with parenteral antibiotics through a PICC line does not improve clinical outcomes. As early as 1997, evidence emerged that an early transition to enteral therapy for osteomyelitis in children may be safe.[16] In 2010, the same group published a larger randomized study with the intent of determining overall treatment duration for osteomyelitis. This study involved 131 culture‐positive cases of osteomyelitis randomized to either a short‐term (20 days) or long‐term (30 days) oral antibiotics following 2 to 4 days of parenteral therapy. In this study, outcomes were favorable and similar despite such a short course of parenteral antibiotics and regardless of the overall treatment duration.[17] Although the aim of this study was not to compare oral and parenteral antibiotics, all patients in this large cohort were treated successfully with early transition to oral therapy.

In 2009, Zaoutis et al. published a large, multicenter, retrospective study of 1969 children with culture‐positive osteomyelitis treated with either prolonged IV therapy (defined as a central line placed before discharge) or oral therapy (no central line placed). They found a 4% incidence of treatment failure in the oral therapy group compared to a 5% incidence in the prolonged IV therapy group. They concluded that early transition to oral therapy was not associated with an increased risk of treatment failure.[3]

More recently, Keren et al. published a comparative effectiveness study using propensity scorebased matching to adjust for confounding variables. This retrospective study included 2060 children without comorbid conditions, ages 2 months to 18 years, with both culture‐positive and culture‐negative acute hematogenous osteomyelitis. Propensity‐based matching used logistic regression to compare patient‐level characteristics including age, race, insurance, length of stay, location of infection, surgical procedures, and isolation of causative pathogens. The rates of treatment failure were nearly identical in the oral therapy (5.0%) and PICC line (6.0%) groups. Similarly, in across‐hospital (risk difference, 0.3% [95% confidence interval {CI}: 0.1% to 2.5%]) and within‐hospital (risk difference, 0.6% [95% CI: 0.2% to 3.0%]) matched analyses, children in the oral therapy group did not have more treatment failures than those in the PICC line group. In the same comparisons, both adverse drug reactions and all treatment‐related events were significantly more likely to occur in children treated with long‐term parenteral antibiotics.[4]

Other studies have looked at the treatment of culture‐negative osteoarticular infections in children and have similarly found favorable outcomes in transitioning to oral therapy after a short course of parenteral treatment.[18]

In short, enteral therapy has similar treatment outcomes for culture‐positive and culture‐negative osteomyelitis without the complications associated with parenteral treatment via a PICC line.

WHEN TO CONSIDER PROLONGED PARENTERAL ANTIBIOTICS

The studies indicating the safe transition to oral antibiotics discussed above all excluded children with certain comorbid conditions. Although this varied from study to study, exclusions were as general in some as not previously healthy, and others were as specific as hematologic malignancies, immunocompromised states, sickle cell disease, malabsorption, and penetrating injuries. Also, although we know blood cultures obtained in children with osteomyelitis are positive in only approximately half of the patients,[19] the studies cited do not contain information for their study populations regarding the duration of bacteremia or endovascular complications, such as septic thrombophlebitis, which are well described in the literature.[20, 21] There are limited data on optimal treatment of children with prolonged bacteremia and endovascular complications. Because studies generally involved previously healthy children and do not specifically address these potential complications, the safety of early oral transition in complicated cases is not clear. The current IDSA and Red Book Committee on Infectious Diseases recommend intravenous therapy for bacteremia and endovascular infections with methicillin‐resistant S aureus.[5, 22] Clinical judgement should be used when treating children with comorbid illnesses who experience persistent bacteremia >48 hours, or who have endovascular complications.

WHAT YOU SHOULD DO INSTEAD

For children with acute hematogenous osteomyelitis who are either culture negative and improve on empiric therapy, or who have culture results (blood or tissue) that are susceptible to a reasonable oral antibiotic agent and who have clinical improvement on initial IV antibiotic therapy, a growing body of evidence indicates that the benefit of early transition to oral antibiotics outweighs the risks of continuing with parenteral therapy. Discharging children on oral antibiotics does not increase their risk of treatment failure but seems to decrease the risk of therapy‐associated complications, including increased healthcare utilization with return visits to the emergency department or the hospital. The possible exceptions to early transition to enteral antibiotics are prolonged bacteremia or endovascular infection, though there are insufficient data in the literature indicating benefits or risks of one administration route over the other.

RECOMMENDATIONS

 

  1. Previously healthy children with acute hematogenous osteomyelitis, without endovascular complications, should be transitioned to enteral antibiotics when they are showing signs of clinical improvement, as defined by: resolution of fever, improving physical exam, ability to take oral medications, and decreasing C‐reactive protein.
  2. The choice of oral antibiotics should be based on the organism's antibiotic susceptibility. If cultures are negative and the child has improved on empiric IV therapy, transition to an oral regimen with similar spectrum is acceptable.
  3. Patients with acute osteomyelitis should have close follow‐up after discharge from the hospital, within 1 to 2 weeks, to ensure continued improvement on therapy.

 

CONCLUSION

Early transition to oral antibiotics should be used in children with acute, uncomplicated osteomyelitis. A growing body of evidence shows that early transition to oral antibiotics does not increase the risk of treatment failure and can obviate the need for an outpatient PICC line. Oral antibiotics do not carry the risk of potential complications and complexity that are inherent in outpatient parenteral therapy. The transition to oral therapy should occur prior to discharge from the hospital after clinical improvement. Close follow‐up is essential to ensure successful treatment in children with acute osteomyelitis.

Disclosure: Nothing to report.

Do you think this is a low‐value practice? Is this truly a Thing We Do for No Reason? Share what you do in your practice and join in the conversation online by retweeting it on Twitter (#TWDFNR) and liking it on Facebook. We invite you to propose ideas for other Things We Do for No Reason topics by emailing [email protected].

Files
References
  1. Krogstad P. Osteomyelitis. In: Feigin RD, Cherry JD, Kaplan, SL, Demmler‐Harrison, GJ, eds. Feigin and Cherry's Textbook of Pediatric Infectious Diseases. Philadelphia, PA: Saunders Elsevier; 2009.
  2. Vazquez M. Osteomyelitis in children. Curr Opin Pediatr. 2002;14:112115.
  3. Zaoutis T, Localio AR, Leckerman K, Saddlemire S, Bertoch D, Keren R. Prolonged intravenous therapy versus early transition to oral antimicrobial therapy for acute osteomyelitis in children. Pediatrics. 2009;123:636642.
  4. Keren R, Shah SS, Srivastava R, et al.; Pediatric Research in Inpatient Settings Network. Comparative effectiveness of intravenous vs oral antibiotics for postdischarge treatment of acute osteomyelitis in children. JAMA Pediatr. 2015;169(2):120128.
  5. Liu C, Bayer A, Cosgrove SE, et al. Clinical practice guidelines by the Infectious Diseases Society of America for the treatment of methicillin‐resistant staphylococcus aureus infections in adults and children: executive summary. Clin Infect Dis. 2011;52(3):285292.
  6. Chopra V, Flanders SA, Saint S, et al.; Michigan Appropriateness Guide for Intravenous Catheters (MAGIC) Panel. The Michigan appropriateness guide for intravenous catheters (MAGIC): results from a multispecialty panel using the RAND/UCLA appropriateness method. Ann Intern Med. 2015;163(6 suppl):S1S40.
  7. Schroeder AR, Ralston SL. Intravenous antibiotic durations for common bacterial infections in children: when is enough enough? J Hosp Med. 2014;9(9):604609.
  8. Ruebner R, Keren R, Coffin S, Chu J, Horn D, Zaoutis TE. Complications of central venous catheters used for the treatment of acute hematogenous osteomyelitis. Pediatrics. 2006;117:12101215.
  9. Tice AD, Rehm SJ, Dalovisio JR, et al; IDSA. Practice guidelines for outpatient parenteral antimicrobial therapy. Clin Infect Dis. 2004;38(12):16511672.
  10. Barrier A, Williams DJ, Connelly M, Creech CB. Frequency of Peripherally Inserted Central Catheter Complications in Children. Pediatr Infect Dis J. 2012;31(5):519521.
  11. J Jumani K, Advani S, Reich NG, Gosey L, Milstone AM. Risk factors for peripherally inserted central venous catheter complications in children. JAMA Pediatr. 2013;167(5):429435.
  12. Hussain S, Gomez MM, Wludyka P, Chiu T, Rathore MH. Survival times and complications of catheters used for outpatient parenteral antibiotic therapy in children. Clin Pediatr (Phila). 2007;46:247251.
  13. Winkle P, Whiffen T, Liu IL. Experience using peripherally inserted central venous catheters for outpatient parenteral antibiotic therapy in children at a community hospital. Pediatr Infect Dis J. 2008;27:10691072.
  14. Stephens JM, Gao X, Patel DA, Verheggen BG, Shelbaya A, Haider S. Economic burden of inpatient and outpatient antibiotic treatment for methicillin‐resistant Staphylococcus aureus complicated skin and soft‐tissue infections: a comparison of linezolid, vancomycin, and daptomycin. Clinicoecon Outcomes Res. 2013;5:447457.
  15. Adibe OO, Barnaby K, Dobies J, et al. Postoperative antibiotic therapy for children with perforated appendicitis: long course of intravenous antibiotics versus early conversion to an oral regimen. Am J Surg. 2008;195(2):141143.
  16. Peltola H, Unkila‐Kallio L, Kallio MJ. Simplified treatment of acute staphylococcal osteomyelitis of childhood. The Finnish Study Group. Pediatrics. 1997;99(6):846850.
  17. Peltola H, Pääkkönen M, Kallio P, Kallio MJ; Osteomyelitis‐Septic Arthritis Study Group. Short‐ versus long‐term antimicrobial treatment for acute hematogenous osteomyelitis of childhood: prospective, randomized trial on 131 culture‐positive cases. Pediatr Infect Dis J. 2010;29(12):11231128.
  18. Pääkkönen M, Kallio MJT, Kallio PE, Peltola H. Significance of negative cultures in the treatment of acute hematogenous bone and joint infections in children. J Ped Infect Dis. 2013;2(2):119125.
  19. Fink CW, Nelson JD. Septic arthritis and osteomyelitis in children. Clin Rheum Dis. 1986;12:423435.
  20. Crary SE, Buchanan GR, Drake CE, Journeycake JM. Venous thrombosis and thromboembolism in children with osteomyelitis. J Pediatr. 2006;149(4):537541.
  21. Gonzalez BE, Teruya J, Mahoney DH, et al. Venous thrombosis associated with staphylococcal osteomyelitis in children. Pediatrics. 2006;117(5):16731679.
  22. Pickering LK, Baker CJ, Kimberlin DW, Long SS. Red Book: 2009 Report of the Committee on Infectious Diseases. 28th ed. Elk Grove Village, IL: American Academy of Pediatrics; 2012.
Article PDF
Issue
Journal of Hospital Medicine - 11(7)
Page Number
505-508
Sections
Files
Files
Article PDF
Article PDF

The Things We Do for No Reason (TWDFNR) series reviews practices which have become common parts of hospital care but which may provide little value to our patients. Practices reviewed in the TWDFNR series do not represent black and white conclusions or clinical practice standards, but are meant as a starting place for research and active discussions among hospitalists and patients. We invite you to be part of that discussion. https://www.choosingwisely.org/

A previously healthy 6‐year‐old boy presented to the emergency room with 3 days of right lower leg pain and fevers up to 102F. The leg pain had progressed until he refused to walk. The patient and family did not recall any trauma to the leg. In the emergency department, he had a blood culture drawn. Because he had elevated inflammatory markers and a negative x‐ray of his right leg, a magnetic resonance imaging scan of the right leg was obtained that revealed right tibial osteomyelitis. He was taken to the operating room for debridement. After obtaining blood and bone cultures, he was started on intravenous (IV) vancomycin. His blood and surgical cultures grew methicillin‐resistant Staphylococcus aureus, sensitive to clindamycin. Subsequent blood cultures were negative, and his inflammatory markers trended down shortly after starting therapy. As he clinically improved, a peripherally inserted central catheter (PICC) was placed, and he was discharged home to complete a 6‐week course of IV vancomycin.

BACKGROUND

Osteoarticular infections (osteomyelitis and septic arthritis) are common problems in the pediatric population, affecting 1/2000 children annually and accounting for approximately 1% of all pediatric hospitalizations.[1, 2] Osteomyelitis can occur in children of all ages and usually requires hospitalization for diagnosis and initial management. The most common mechanism of infection in children is hematogenous inoculation of the bone during an episode of bacteremia (acute hematogenous osteomyelitis), particularly in young children, due to the highly vascular nature of the developing bone. Long bones, such as the femur, tibia, and humerus, are most commonly involved. Treatment of acute osteomyelitis requires prolonged administration of antimicrobial agents. Inadequately treated osteomyelitis can result in progression to chronic infection and loss of function of the affected bone.[3]

WHY YOU MIGHT THINK PARENTERAL ANTIBIOTICS AT DISCHARGE IS SUPERIOR TO ENTERAL THERAPY

In the United States, a large proportion of children with hematogenous osteomyelitis are discharged from the hospital with long‐term parenteral intravenous antibiotics through a PICC line.[3] The medical community historically favored parenteral therapy for young children with serious bacterial infections given concerns regarding impaired enteral absorption. As a result, children with osteomyelitis were initially stabilized in the hospital and discharged with parenteral therapy through a PICC line to continue or complete care, even when the organism was susceptible to a viable oral alternative such as clindamycin or cephalexin. Recommendations regarding the safety and timing to transition to oral antibiotics have been lacking. There is also extreme variation in practice in route of administration (oral vs prolonged IV therapy) in patients being discharged from the hospital with osteomyelitis.[3, 4] The most recent Infectious Diseases Society of America (IDSA) guidelines do not clearly state when transition to oral antibiotics may be safe. Specifically, they state that if patients are stable and without ongoing bacteremia, they can transition to oral therapy to complete a 4‐ to 6‐week course.[5]

WHY LONG‐TERM PARENTERAL ANTIBIOTICS MAY NOT BE SUPERIOR

The use of PICC lines has increased substantially in recent years. This has led to an increasing awareness of complications associated with PICC lines. As a result, guidelines for the appropriate use of PICC lines have been established in adults by collaborators at the University of Michigan.[6] Mounting evidence has called into question whether longer parenteral therapy is truly a more conservative or safer approach for the treatment of osteomyelitis.[3, 4, 7, 8, 9] Providing antibiotics via a PICC line in both the inpatient and outpatient settings may not be as benign as once accepted and may not improve outcomes in osteomyelitis as expected.

Costs and Potential Harms Associated With PICC Lines

PICC lines are known to have complications in the hospital including infection and thrombotic events,[10] but these events are not isolated to the hospital setting. Multiple studies have shown outpatient PICC line complication rates ranging from 29% to 41% depending on the type of catheter, the population, and the indication for use.[8, 10, 11, 12, 13] In a recently published study by Keren et al. looking specifically at children with osteomyelitis, emergency department visits and readmissions for PICC line complications occurred in 15% of patients discharged with a PICC line.[4] Given the potential complications and complexity that are inherent in outpatient parenteral therapy, the ISDA has even published guidelines regarding its use.[9] In addition, the cost of IV antibiotics, including administration costs, need for sedation in some children for line placement, and cost of the antibiotic itself, is significantly higher compared to oral therapy. In studies looking at early conversion to oral antibiotics versus prolonged intravenous antibiotics for complicated skin and soft tissue infections, as well as perforated appendicitis, oral antibiotics were more cost effective with an average savings of 30% to 50% and >$4000 respectively.[14, 15]

Patient Outcomes Are Similar When Comparing Parenteral and Enteral Therapy

In addition to increased costs and medication‐related complications, treatment of osteomyelitis with parenteral antibiotics through a PICC line does not improve clinical outcomes. As early as 1997, evidence emerged that an early transition to enteral therapy for osteomyelitis in children may be safe.[16] In 2010, the same group published a larger randomized study with the intent of determining overall treatment duration for osteomyelitis. This study involved 131 culture‐positive cases of osteomyelitis randomized to either a short‐term (20 days) or long‐term (30 days) oral antibiotics following 2 to 4 days of parenteral therapy. In this study, outcomes were favorable and similar despite such a short course of parenteral antibiotics and regardless of the overall treatment duration.[17] Although the aim of this study was not to compare oral and parenteral antibiotics, all patients in this large cohort were treated successfully with early transition to oral therapy.

In 2009, Zaoutis et al. published a large, multicenter, retrospective study of 1969 children with culture‐positive osteomyelitis treated with either prolonged IV therapy (defined as a central line placed before discharge) or oral therapy (no central line placed). They found a 4% incidence of treatment failure in the oral therapy group compared to a 5% incidence in the prolonged IV therapy group. They concluded that early transition to oral therapy was not associated with an increased risk of treatment failure.[3]

More recently, Keren et al. published a comparative effectiveness study using propensity scorebased matching to adjust for confounding variables. This retrospective study included 2060 children without comorbid conditions, ages 2 months to 18 years, with both culture‐positive and culture‐negative acute hematogenous osteomyelitis. Propensity‐based matching used logistic regression to compare patient‐level characteristics including age, race, insurance, length of stay, location of infection, surgical procedures, and isolation of causative pathogens. The rates of treatment failure were nearly identical in the oral therapy (5.0%) and PICC line (6.0%) groups. Similarly, in across‐hospital (risk difference, 0.3% [95% confidence interval {CI}: 0.1% to 2.5%]) and within‐hospital (risk difference, 0.6% [95% CI: 0.2% to 3.0%]) matched analyses, children in the oral therapy group did not have more treatment failures than those in the PICC line group. In the same comparisons, both adverse drug reactions and all treatment‐related events were significantly more likely to occur in children treated with long‐term parenteral antibiotics.[4]

Other studies have looked at the treatment of culture‐negative osteoarticular infections in children and have similarly found favorable outcomes in transitioning to oral therapy after a short course of parenteral treatment.[18]

In short, enteral therapy has similar treatment outcomes for culture‐positive and culture‐negative osteomyelitis without the complications associated with parenteral treatment via a PICC line.

WHEN TO CONSIDER PROLONGED PARENTERAL ANTIBIOTICS

The studies indicating the safe transition to oral antibiotics discussed above all excluded children with certain comorbid conditions. Although this varied from study to study, exclusions were as general in some as not previously healthy, and others were as specific as hematologic malignancies, immunocompromised states, sickle cell disease, malabsorption, and penetrating injuries. Also, although we know blood cultures obtained in children with osteomyelitis are positive in only approximately half of the patients,[19] the studies cited do not contain information for their study populations regarding the duration of bacteremia or endovascular complications, such as septic thrombophlebitis, which are well described in the literature.[20, 21] There are limited data on optimal treatment of children with prolonged bacteremia and endovascular complications. Because studies generally involved previously healthy children and do not specifically address these potential complications, the safety of early oral transition in complicated cases is not clear. The current IDSA and Red Book Committee on Infectious Diseases recommend intravenous therapy for bacteremia and endovascular infections with methicillin‐resistant S aureus.[5, 22] Clinical judgement should be used when treating children with comorbid illnesses who experience persistent bacteremia >48 hours, or who have endovascular complications.

WHAT YOU SHOULD DO INSTEAD

For children with acute hematogenous osteomyelitis who are either culture negative and improve on empiric therapy, or who have culture results (blood or tissue) that are susceptible to a reasonable oral antibiotic agent and who have clinical improvement on initial IV antibiotic therapy, a growing body of evidence indicates that the benefit of early transition to oral antibiotics outweighs the risks of continuing with parenteral therapy. Discharging children on oral antibiotics does not increase their risk of treatment failure but seems to decrease the risk of therapy‐associated complications, including increased healthcare utilization with return visits to the emergency department or the hospital. The possible exceptions to early transition to enteral antibiotics are prolonged bacteremia or endovascular infection, though there are insufficient data in the literature indicating benefits or risks of one administration route over the other.

RECOMMENDATIONS

 

  1. Previously healthy children with acute hematogenous osteomyelitis, without endovascular complications, should be transitioned to enteral antibiotics when they are showing signs of clinical improvement, as defined by: resolution of fever, improving physical exam, ability to take oral medications, and decreasing C‐reactive protein.
  2. The choice of oral antibiotics should be based on the organism's antibiotic susceptibility. If cultures are negative and the child has improved on empiric IV therapy, transition to an oral regimen with similar spectrum is acceptable.
  3. Patients with acute osteomyelitis should have close follow‐up after discharge from the hospital, within 1 to 2 weeks, to ensure continued improvement on therapy.

 

CONCLUSION

Early transition to oral antibiotics should be used in children with acute, uncomplicated osteomyelitis. A growing body of evidence shows that early transition to oral antibiotics does not increase the risk of treatment failure and can obviate the need for an outpatient PICC line. Oral antibiotics do not carry the risk of potential complications and complexity that are inherent in outpatient parenteral therapy. The transition to oral therapy should occur prior to discharge from the hospital after clinical improvement. Close follow‐up is essential to ensure successful treatment in children with acute osteomyelitis.

Disclosure: Nothing to report.

Do you think this is a low‐value practice? Is this truly a Thing We Do for No Reason? Share what you do in your practice and join in the conversation online by retweeting it on Twitter (#TWDFNR) and liking it on Facebook. We invite you to propose ideas for other Things We Do for No Reason topics by emailing [email protected].

The Things We Do for No Reason (TWDFNR) series reviews practices which have become common parts of hospital care but which may provide little value to our patients. Practices reviewed in the TWDFNR series do not represent black and white conclusions or clinical practice standards, but are meant as a starting place for research and active discussions among hospitalists and patients. We invite you to be part of that discussion. https://www.choosingwisely.org/

A previously healthy 6‐year‐old boy presented to the emergency room with 3 days of right lower leg pain and fevers up to 102F. The leg pain had progressed until he refused to walk. The patient and family did not recall any trauma to the leg. In the emergency department, he had a blood culture drawn. Because he had elevated inflammatory markers and a negative x‐ray of his right leg, a magnetic resonance imaging scan of the right leg was obtained that revealed right tibial osteomyelitis. He was taken to the operating room for debridement. After obtaining blood and bone cultures, he was started on intravenous (IV) vancomycin. His blood and surgical cultures grew methicillin‐resistant Staphylococcus aureus, sensitive to clindamycin. Subsequent blood cultures were negative, and his inflammatory markers trended down shortly after starting therapy. As he clinically improved, a peripherally inserted central catheter (PICC) was placed, and he was discharged home to complete a 6‐week course of IV vancomycin.

BACKGROUND

Osteoarticular infections (osteomyelitis and septic arthritis) are common problems in the pediatric population, affecting 1/2000 children annually and accounting for approximately 1% of all pediatric hospitalizations.[1, 2] Osteomyelitis can occur in children of all ages and usually requires hospitalization for diagnosis and initial management. The most common mechanism of infection in children is hematogenous inoculation of the bone during an episode of bacteremia (acute hematogenous osteomyelitis), particularly in young children, due to the highly vascular nature of the developing bone. Long bones, such as the femur, tibia, and humerus, are most commonly involved. Treatment of acute osteomyelitis requires prolonged administration of antimicrobial agents. Inadequately treated osteomyelitis can result in progression to chronic infection and loss of function of the affected bone.[3]

WHY YOU MIGHT THINK PARENTERAL ANTIBIOTICS AT DISCHARGE IS SUPERIOR TO ENTERAL THERAPY

In the United States, a large proportion of children with hematogenous osteomyelitis are discharged from the hospital with long‐term parenteral intravenous antibiotics through a PICC line.[3] The medical community historically favored parenteral therapy for young children with serious bacterial infections given concerns regarding impaired enteral absorption. As a result, children with osteomyelitis were initially stabilized in the hospital and discharged with parenteral therapy through a PICC line to continue or complete care, even when the organism was susceptible to a viable oral alternative such as clindamycin or cephalexin. Recommendations regarding the safety and timing to transition to oral antibiotics have been lacking. There is also extreme variation in practice in route of administration (oral vs prolonged IV therapy) in patients being discharged from the hospital with osteomyelitis.[3, 4] The most recent Infectious Diseases Society of America (IDSA) guidelines do not clearly state when transition to oral antibiotics may be safe. Specifically, they state that if patients are stable and without ongoing bacteremia, they can transition to oral therapy to complete a 4‐ to 6‐week course.[5]

WHY LONG‐TERM PARENTERAL ANTIBIOTICS MAY NOT BE SUPERIOR

The use of PICC lines has increased substantially in recent years. This has led to an increasing awareness of complications associated with PICC lines. As a result, guidelines for the appropriate use of PICC lines have been established in adults by collaborators at the University of Michigan.[6] Mounting evidence has called into question whether longer parenteral therapy is truly a more conservative or safer approach for the treatment of osteomyelitis.[3, 4, 7, 8, 9] Providing antibiotics via a PICC line in both the inpatient and outpatient settings may not be as benign as once accepted and may not improve outcomes in osteomyelitis as expected.

Costs and Potential Harms Associated With PICC Lines

PICC lines are known to have complications in the hospital including infection and thrombotic events,[10] but these events are not isolated to the hospital setting. Multiple studies have shown outpatient PICC line complication rates ranging from 29% to 41% depending on the type of catheter, the population, and the indication for use.[8, 10, 11, 12, 13] In a recently published study by Keren et al. looking specifically at children with osteomyelitis, emergency department visits and readmissions for PICC line complications occurred in 15% of patients discharged with a PICC line.[4] Given the potential complications and complexity that are inherent in outpatient parenteral therapy, the ISDA has even published guidelines regarding its use.[9] In addition, the cost of IV antibiotics, including administration costs, need for sedation in some children for line placement, and cost of the antibiotic itself, is significantly higher compared to oral therapy. In studies looking at early conversion to oral antibiotics versus prolonged intravenous antibiotics for complicated skin and soft tissue infections, as well as perforated appendicitis, oral antibiotics were more cost effective with an average savings of 30% to 50% and >$4000 respectively.[14, 15]

Patient Outcomes Are Similar When Comparing Parenteral and Enteral Therapy

In addition to increased costs and medication‐related complications, treatment of osteomyelitis with parenteral antibiotics through a PICC line does not improve clinical outcomes. As early as 1997, evidence emerged that an early transition to enteral therapy for osteomyelitis in children may be safe.[16] In 2010, the same group published a larger randomized study with the intent of determining overall treatment duration for osteomyelitis. This study involved 131 culture‐positive cases of osteomyelitis randomized to either a short‐term (20 days) or long‐term (30 days) oral antibiotics following 2 to 4 days of parenteral therapy. In this study, outcomes were favorable and similar despite such a short course of parenteral antibiotics and regardless of the overall treatment duration.[17] Although the aim of this study was not to compare oral and parenteral antibiotics, all patients in this large cohort were treated successfully with early transition to oral therapy.

In 2009, Zaoutis et al. published a large, multicenter, retrospective study of 1969 children with culture‐positive osteomyelitis treated with either prolonged IV therapy (defined as a central line placed before discharge) or oral therapy (no central line placed). They found a 4% incidence of treatment failure in the oral therapy group compared to a 5% incidence in the prolonged IV therapy group. They concluded that early transition to oral therapy was not associated with an increased risk of treatment failure.[3]

More recently, Keren et al. published a comparative effectiveness study using propensity scorebased matching to adjust for confounding variables. This retrospective study included 2060 children without comorbid conditions, ages 2 months to 18 years, with both culture‐positive and culture‐negative acute hematogenous osteomyelitis. Propensity‐based matching used logistic regression to compare patient‐level characteristics including age, race, insurance, length of stay, location of infection, surgical procedures, and isolation of causative pathogens. The rates of treatment failure were nearly identical in the oral therapy (5.0%) and PICC line (6.0%) groups. Similarly, in across‐hospital (risk difference, 0.3% [95% confidence interval {CI}: 0.1% to 2.5%]) and within‐hospital (risk difference, 0.6% [95% CI: 0.2% to 3.0%]) matched analyses, children in the oral therapy group did not have more treatment failures than those in the PICC line group. In the same comparisons, both adverse drug reactions and all treatment‐related events were significantly more likely to occur in children treated with long‐term parenteral antibiotics.[4]

Other studies have looked at the treatment of culture‐negative osteoarticular infections in children and have similarly found favorable outcomes in transitioning to oral therapy after a short course of parenteral treatment.[18]

In short, enteral therapy has similar treatment outcomes for culture‐positive and culture‐negative osteomyelitis without the complications associated with parenteral treatment via a PICC line.

WHEN TO CONSIDER PROLONGED PARENTERAL ANTIBIOTICS

The studies indicating the safe transition to oral antibiotics discussed above all excluded children with certain comorbid conditions. Although this varied from study to study, exclusions were as general in some as not previously healthy, and others were as specific as hematologic malignancies, immunocompromised states, sickle cell disease, malabsorption, and penetrating injuries. Also, although we know blood cultures obtained in children with osteomyelitis are positive in only approximately half of the patients,[19] the studies cited do not contain information for their study populations regarding the duration of bacteremia or endovascular complications, such as septic thrombophlebitis, which are well described in the literature.[20, 21] There are limited data on optimal treatment of children with prolonged bacteremia and endovascular complications. Because studies generally involved previously healthy children and do not specifically address these potential complications, the safety of early oral transition in complicated cases is not clear. The current IDSA and Red Book Committee on Infectious Diseases recommend intravenous therapy for bacteremia and endovascular infections with methicillin‐resistant S aureus.[5, 22] Clinical judgement should be used when treating children with comorbid illnesses who experience persistent bacteremia >48 hours, or who have endovascular complications.

WHAT YOU SHOULD DO INSTEAD

For children with acute hematogenous osteomyelitis who are either culture negative and improve on empiric therapy, or who have culture results (blood or tissue) that are susceptible to a reasonable oral antibiotic agent and who have clinical improvement on initial IV antibiotic therapy, a growing body of evidence indicates that the benefit of early transition to oral antibiotics outweighs the risks of continuing with parenteral therapy. Discharging children on oral antibiotics does not increase their risk of treatment failure but seems to decrease the risk of therapy‐associated complications, including increased healthcare utilization with return visits to the emergency department or the hospital. The possible exceptions to early transition to enteral antibiotics are prolonged bacteremia or endovascular infection, though there are insufficient data in the literature indicating benefits or risks of one administration route over the other.

RECOMMENDATIONS

 

  1. Previously healthy children with acute hematogenous osteomyelitis, without endovascular complications, should be transitioned to enteral antibiotics when they are showing signs of clinical improvement, as defined by: resolution of fever, improving physical exam, ability to take oral medications, and decreasing C‐reactive protein.
  2. The choice of oral antibiotics should be based on the organism's antibiotic susceptibility. If cultures are negative and the child has improved on empiric IV therapy, transition to an oral regimen with similar spectrum is acceptable.
  3. Patients with acute osteomyelitis should have close follow‐up after discharge from the hospital, within 1 to 2 weeks, to ensure continued improvement on therapy.

 

CONCLUSION

Early transition to oral antibiotics should be used in children with acute, uncomplicated osteomyelitis. A growing body of evidence shows that early transition to oral antibiotics does not increase the risk of treatment failure and can obviate the need for an outpatient PICC line. Oral antibiotics do not carry the risk of potential complications and complexity that are inherent in outpatient parenteral therapy. The transition to oral therapy should occur prior to discharge from the hospital after clinical improvement. Close follow‐up is essential to ensure successful treatment in children with acute osteomyelitis.

Disclosure: Nothing to report.

Do you think this is a low‐value practice? Is this truly a Thing We Do for No Reason? Share what you do in your practice and join in the conversation online by retweeting it on Twitter (#TWDFNR) and liking it on Facebook. We invite you to propose ideas for other Things We Do for No Reason topics by emailing [email protected].

References
  1. Krogstad P. Osteomyelitis. In: Feigin RD, Cherry JD, Kaplan, SL, Demmler‐Harrison, GJ, eds. Feigin and Cherry's Textbook of Pediatric Infectious Diseases. Philadelphia, PA: Saunders Elsevier; 2009.
  2. Vazquez M. Osteomyelitis in children. Curr Opin Pediatr. 2002;14:112115.
  3. Zaoutis T, Localio AR, Leckerman K, Saddlemire S, Bertoch D, Keren R. Prolonged intravenous therapy versus early transition to oral antimicrobial therapy for acute osteomyelitis in children. Pediatrics. 2009;123:636642.
  4. Keren R, Shah SS, Srivastava R, et al.; Pediatric Research in Inpatient Settings Network. Comparative effectiveness of intravenous vs oral antibiotics for postdischarge treatment of acute osteomyelitis in children. JAMA Pediatr. 2015;169(2):120128.
  5. Liu C, Bayer A, Cosgrove SE, et al. Clinical practice guidelines by the Infectious Diseases Society of America for the treatment of methicillin‐resistant staphylococcus aureus infections in adults and children: executive summary. Clin Infect Dis. 2011;52(3):285292.
  6. Chopra V, Flanders SA, Saint S, et al.; Michigan Appropriateness Guide for Intravenous Catheters (MAGIC) Panel. The Michigan appropriateness guide for intravenous catheters (MAGIC): results from a multispecialty panel using the RAND/UCLA appropriateness method. Ann Intern Med. 2015;163(6 suppl):S1S40.
  7. Schroeder AR, Ralston SL. Intravenous antibiotic durations for common bacterial infections in children: when is enough enough? J Hosp Med. 2014;9(9):604609.
  8. Ruebner R, Keren R, Coffin S, Chu J, Horn D, Zaoutis TE. Complications of central venous catheters used for the treatment of acute hematogenous osteomyelitis. Pediatrics. 2006;117:12101215.
  9. Tice AD, Rehm SJ, Dalovisio JR, et al; IDSA. Practice guidelines for outpatient parenteral antimicrobial therapy. Clin Infect Dis. 2004;38(12):16511672.
  10. Barrier A, Williams DJ, Connelly M, Creech CB. Frequency of Peripherally Inserted Central Catheter Complications in Children. Pediatr Infect Dis J. 2012;31(5):519521.
  11. J Jumani K, Advani S, Reich NG, Gosey L, Milstone AM. Risk factors for peripherally inserted central venous catheter complications in children. JAMA Pediatr. 2013;167(5):429435.
  12. Hussain S, Gomez MM, Wludyka P, Chiu T, Rathore MH. Survival times and complications of catheters used for outpatient parenteral antibiotic therapy in children. Clin Pediatr (Phila). 2007;46:247251.
  13. Winkle P, Whiffen T, Liu IL. Experience using peripherally inserted central venous catheters for outpatient parenteral antibiotic therapy in children at a community hospital. Pediatr Infect Dis J. 2008;27:10691072.
  14. Stephens JM, Gao X, Patel DA, Verheggen BG, Shelbaya A, Haider S. Economic burden of inpatient and outpatient antibiotic treatment for methicillin‐resistant Staphylococcus aureus complicated skin and soft‐tissue infections: a comparison of linezolid, vancomycin, and daptomycin. Clinicoecon Outcomes Res. 2013;5:447457.
  15. Adibe OO, Barnaby K, Dobies J, et al. Postoperative antibiotic therapy for children with perforated appendicitis: long course of intravenous antibiotics versus early conversion to an oral regimen. Am J Surg. 2008;195(2):141143.
  16. Peltola H, Unkila‐Kallio L, Kallio MJ. Simplified treatment of acute staphylococcal osteomyelitis of childhood. The Finnish Study Group. Pediatrics. 1997;99(6):846850.
  17. Peltola H, Pääkkönen M, Kallio P, Kallio MJ; Osteomyelitis‐Septic Arthritis Study Group. Short‐ versus long‐term antimicrobial treatment for acute hematogenous osteomyelitis of childhood: prospective, randomized trial on 131 culture‐positive cases. Pediatr Infect Dis J. 2010;29(12):11231128.
  18. Pääkkönen M, Kallio MJT, Kallio PE, Peltola H. Significance of negative cultures in the treatment of acute hematogenous bone and joint infections in children. J Ped Infect Dis. 2013;2(2):119125.
  19. Fink CW, Nelson JD. Septic arthritis and osteomyelitis in children. Clin Rheum Dis. 1986;12:423435.
  20. Crary SE, Buchanan GR, Drake CE, Journeycake JM. Venous thrombosis and thromboembolism in children with osteomyelitis. J Pediatr. 2006;149(4):537541.
  21. Gonzalez BE, Teruya J, Mahoney DH, et al. Venous thrombosis associated with staphylococcal osteomyelitis in children. Pediatrics. 2006;117(5):16731679.
  22. Pickering LK, Baker CJ, Kimberlin DW, Long SS. Red Book: 2009 Report of the Committee on Infectious Diseases. 28th ed. Elk Grove Village, IL: American Academy of Pediatrics; 2012.
References
  1. Krogstad P. Osteomyelitis. In: Feigin RD, Cherry JD, Kaplan, SL, Demmler‐Harrison, GJ, eds. Feigin and Cherry's Textbook of Pediatric Infectious Diseases. Philadelphia, PA: Saunders Elsevier; 2009.
  2. Vazquez M. Osteomyelitis in children. Curr Opin Pediatr. 2002;14:112115.
  3. Zaoutis T, Localio AR, Leckerman K, Saddlemire S, Bertoch D, Keren R. Prolonged intravenous therapy versus early transition to oral antimicrobial therapy for acute osteomyelitis in children. Pediatrics. 2009;123:636642.
  4. Keren R, Shah SS, Srivastava R, et al.; Pediatric Research in Inpatient Settings Network. Comparative effectiveness of intravenous vs oral antibiotics for postdischarge treatment of acute osteomyelitis in children. JAMA Pediatr. 2015;169(2):120128.
  5. Liu C, Bayer A, Cosgrove SE, et al. Clinical practice guidelines by the Infectious Diseases Society of America for the treatment of methicillin‐resistant staphylococcus aureus infections in adults and children: executive summary. Clin Infect Dis. 2011;52(3):285292.
  6. Chopra V, Flanders SA, Saint S, et al.; Michigan Appropriateness Guide for Intravenous Catheters (MAGIC) Panel. The Michigan appropriateness guide for intravenous catheters (MAGIC): results from a multispecialty panel using the RAND/UCLA appropriateness method. Ann Intern Med. 2015;163(6 suppl):S1S40.
  7. Schroeder AR, Ralston SL. Intravenous antibiotic durations for common bacterial infections in children: when is enough enough? J Hosp Med. 2014;9(9):604609.
  8. Ruebner R, Keren R, Coffin S, Chu J, Horn D, Zaoutis TE. Complications of central venous catheters used for the treatment of acute hematogenous osteomyelitis. Pediatrics. 2006;117:12101215.
  9. Tice AD, Rehm SJ, Dalovisio JR, et al; IDSA. Practice guidelines for outpatient parenteral antimicrobial therapy. Clin Infect Dis. 2004;38(12):16511672.
  10. Barrier A, Williams DJ, Connelly M, Creech CB. Frequency of Peripherally Inserted Central Catheter Complications in Children. Pediatr Infect Dis J. 2012;31(5):519521.
  11. J Jumani K, Advani S, Reich NG, Gosey L, Milstone AM. Risk factors for peripherally inserted central venous catheter complications in children. JAMA Pediatr. 2013;167(5):429435.
  12. Hussain S, Gomez MM, Wludyka P, Chiu T, Rathore MH. Survival times and complications of catheters used for outpatient parenteral antibiotic therapy in children. Clin Pediatr (Phila). 2007;46:247251.
  13. Winkle P, Whiffen T, Liu IL. Experience using peripherally inserted central venous catheters for outpatient parenteral antibiotic therapy in children at a community hospital. Pediatr Infect Dis J. 2008;27:10691072.
  14. Stephens JM, Gao X, Patel DA, Verheggen BG, Shelbaya A, Haider S. Economic burden of inpatient and outpatient antibiotic treatment for methicillin‐resistant Staphylococcus aureus complicated skin and soft‐tissue infections: a comparison of linezolid, vancomycin, and daptomycin. Clinicoecon Outcomes Res. 2013;5:447457.
  15. Adibe OO, Barnaby K, Dobies J, et al. Postoperative antibiotic therapy for children with perforated appendicitis: long course of intravenous antibiotics versus early conversion to an oral regimen. Am J Surg. 2008;195(2):141143.
  16. Peltola H, Unkila‐Kallio L, Kallio MJ. Simplified treatment of acute staphylococcal osteomyelitis of childhood. The Finnish Study Group. Pediatrics. 1997;99(6):846850.
  17. Peltola H, Pääkkönen M, Kallio P, Kallio MJ; Osteomyelitis‐Septic Arthritis Study Group. Short‐ versus long‐term antimicrobial treatment for acute hematogenous osteomyelitis of childhood: prospective, randomized trial on 131 culture‐positive cases. Pediatr Infect Dis J. 2010;29(12):11231128.
  18. Pääkkönen M, Kallio MJT, Kallio PE, Peltola H. Significance of negative cultures in the treatment of acute hematogenous bone and joint infections in children. J Ped Infect Dis. 2013;2(2):119125.
  19. Fink CW, Nelson JD. Septic arthritis and osteomyelitis in children. Clin Rheum Dis. 1986;12:423435.
  20. Crary SE, Buchanan GR, Drake CE, Journeycake JM. Venous thrombosis and thromboembolism in children with osteomyelitis. J Pediatr. 2006;149(4):537541.
  21. Gonzalez BE, Teruya J, Mahoney DH, et al. Venous thrombosis associated with staphylococcal osteomyelitis in children. Pediatrics. 2006;117(5):16731679.
  22. Pickering LK, Baker CJ, Kimberlin DW, Long SS. Red Book: 2009 Report of the Committee on Infectious Diseases. 28th ed. Elk Grove Village, IL: American Academy of Pediatrics; 2012.
Issue
Journal of Hospital Medicine - 11(7)
Issue
Journal of Hospital Medicine - 11(7)
Page Number
505-508
Page Number
505-508
Article Type
Display Headline
Prolonged intravenous instead of oral antibiotics for acute hematogenous osteomyelitis in children
Display Headline
Prolonged intravenous instead of oral antibiotics for acute hematogenous osteomyelitis in children
Sections
Article Source

© 2016 Society of Hospital Medicine

Disallow All Ads
Correspondence Location
Address for correspondence and reprint requests: James B. Wood, MD, Pediatric Infectious Diseases, Vanderbilt University Medical Center, D‐7221 MCN, 1161 21st Ave. South, Nashville, TN 37232; Telephone: 615‐343‐2401; Fax: 615‐343‐9723; E‐mail: [email protected]
Content Gating
Open Access (article Unlocked/Open Access)
Alternative CME
Use ProPublica
Hide sidebar & use full width
render the right sidebar.
Article PDF Media
Media Files

Next 20 Years of Hospital Medicine

Article Type
Changed
Mon, 01/02/2017 - 19:34
Display Headline
The next 20 years of hospital medicine: Continuing to foster the mind, heart, and soul of our field

In 1995 I took my first job as a hospitalist at a community teaching hospital where hospitalists, though then known as medical directors, had been in place for 20 years. Soon afterward, our field gained a name, and my old job no longer was mistaken for a utilization review functionary or lead of a medical unit.

I have been lucky enough to have seen the field of hospital medicine grow rapidly in scope and importance. The growth of our specialty in mere numbers alone is a testament to the value we in hospital medicine (MDs, DOs, PAs, NPs) bring to the care of acutely ill patients. We are the front line caring for the elderly and vulnerable, the glue holding transdisciplinary care teams together, and lead hospitals, health systems, and governmental organizations. Hospitalists touch the lives of our patients, and shape the health systems' practices and health policy on a national and international scale. These are remarkable achievements for a field which, just a few years ago, was concerned about becoming a job equivalent to perpetual residency training (or worse) and gained only grudging acceptance.[1] There is no doubt that the roles of hospitalists will continue to evolve, and whereas hospitalists will be able to shape the debates and development of new programs solving the problems of our health systems, we must take time to foster the mind, heart, and soul of our field.

When I speak of the mind of hospital medicine, I am thinking of our field's contribution to the evidence for how to care for patients' illnesses, a different body of knowledge than our field's focus to date on hospitals and health systems. Hospital medicine has been growing research capacity at a rate that is slower than the field overall, a problem in part due to limitations in National Institutes of Health funding for fellowships and early‐career awards, which in turn has restricted the pipeline of young and innovative researchers. Slow growth may also be a result of an emphasis on health systems rather than diseases.[2] I and others have written about the need to create mentoring support for junior research faculty as a way to promote success and avoid burnout,[3, 4, 5, 6, 7] and while at least 1 hospital medicine research network exists,[8] there is room for many more. However, at its core, our specialty needs to devote more time and focus to becoming a full scientific partner with our colleagues in cardiology, pulmonary medicine, and critical care, among others. To develop the mind of hospital medicine we will also need to think about our contributions to useful clinical guidelines for care of diseases and patients. Developing trustworthy clinical guidelines can be time consuming[9] but is a key part of ensuring patients and families understand the rationale for changes in clinical care. Hospital medicine as a field has been a leader in programs that develop approaches to implementing evidence and stands in an excellent position toperhaps in collaboration with other specialtiescreate the next‐generation guidelines that are practically minded, evidence based, and end up being used.

The heart I speak of is how we can make sure that the field of hospital medicine is one that is attractive and sustainable as a career. Electronic health records' impact on day‐to‐day work is substantial and a large part of the problem, though a more fundamental problem we face is in how to create sustainable jobs at a time where we are going to need to deliver higher‐value care to more patients with the same number (or fewer) providers. This is an issue that means we need to settle many important aspects of our workpay, relationships with our peers, control over our work on a day‐to‐day basis, hospitalists' work schedules (such as the 7 days on/7 days off model)while we also grapple with how to work within a population‐health framework. I am not prescient enough to see all the solutions to burnout, but there are at least 2 opportunities hospitalists are perhaps best suited to develop and lead. The first is how we arrange our teams in the hospital and afterward. Recent articles have talked about how medicine needs to be open to Uber‐like disruptive models,[10] where labor is deployed in fundamentally different ways. Tools such as e‐consults, the application of population health tools to inpatient care, telemedicine, or some forms of predictive analytics may be examples of these tools, which are routes to allowing more care to be delivered more effectively and more efficiently. Another opportunity lies in how we adapt our electronic health records to our work (and vice versa). The perils of sloppy and paste documentation are indicative of the burden of busywork, the pressures of needing to focus on revenue rather than clinical utility, and exhaustion; hospitalists are well positioned to think about howas payment reform continues to evolvedocumentation can be less busywork and more clinically useful, patient oriented, and shareable across sites and phases of care.

Now to the soul of our field. Hospital medicine has rightly been considered a key partner in developing the solutions hospitals and health systems need to address gaps in quality, safety, value, and clinical outcomes. However, this self‐image of hospital medicine has the downside of being viewed as doctors for hospitals, rather than doctors for patients and families who are in hospitals. As we think about burnout and jobs that are fulfilling and meaningful over the long term, I increasingly return to the factors that motivated me and many others to become physicians: meaningful relationships with patients, being an excellent clinician, and making a lasting contribution to my community through my patient care, support of my colleagues, and teaching younger physicians. It is easy for the pressures of the hospital and need to fix problems rapidly to obscure these larger motivators, but our field will need to ensure that these elements remain how we prioritize and shape our field going forward. Hospital medicine is comprised of physicians who do clinical care and who in most cases entered the field for that reason alone. Using the true north of improving and innovating care in ways that impact patient livesnot just the needs of our hospitalsin meaningful ways will need to be the soul of our field, and will allow the mind and heart of hospitalists and hospital medicine to thrive.

References
  1. McMahon LF. The hospitalist movement—time to move on. N Engl J Med. 2007;357(25):26272629.
  2. Goldman L. An intellectual agenda for hospitalists: lessons from bloodletting. J Hosp Med. 2013;8(7):418419.
  3. Reid MB, Misky GJ, Harrison RA, Sharpe B, Auerbach A, Glasheen JJ. Mentorship, productivity, and promotion among academic hospitalists. J Gen Intern Med. 2012;27(1):2327.
  4. Sehgal NL, Sharpe BA, Auerbach AA, Wachter RM. Investing in the future: building an academic hospitalist faculty development program. J Hosp Med. 2011;6(3):161166.
  5. Harrison R, Hunter AJ, Sharpe B, Auerbach AD. Survey of US academic hospitalist leaders about mentorship and academic activities in hospitalist groups. J Hosp Med. 2011;6(1):59.
  6. Glasheen JJ, Misky GJ, Reid MB, Harrison RA, Sharpe B, Auerbach A. Career satisfaction and burnout in academic hospital medicine. Arch Intern Med. 2011;171(8):782785.
  7. Flanders SA, Centor B, Weber V, McGinn T, Desalvo K, Auerbach A. Challenges and opportunities in academic hospital medicine: report from the academic hospital medicine summit. J Gen Intern Med. 2009;24(5):636641.
  8. Auerbach AD, Patel MS, Metlay JP, et al. The Hospital Medicine Reengineering Network (HOMERuN): a learning organization focused on improving hospital care. Acad Med. 2014;89(3):415420.
  9. Greenfield S, Steinberg E, Avorn J, et al. Clinical practice guidelines we can trust. National Academy of Sciences website. Available at: http://www.nationalacademies.org/hmd/Reports/2011/Clinical‐Practice‐Guidelines‐We‐Can‐Trust.aspx. Published March 23, 2011. Accessed May 20, 2016.
  10. Detsky AS, Garber AM. Uber's message for health care. N Engl J Med. 2016;374(9):806809.
Article PDF
Issue
Journal of Hospital Medicine - 11(12)
Page Number
892-893
Sections
Article PDF
Article PDF

In 1995 I took my first job as a hospitalist at a community teaching hospital where hospitalists, though then known as medical directors, had been in place for 20 years. Soon afterward, our field gained a name, and my old job no longer was mistaken for a utilization review functionary or lead of a medical unit.

I have been lucky enough to have seen the field of hospital medicine grow rapidly in scope and importance. The growth of our specialty in mere numbers alone is a testament to the value we in hospital medicine (MDs, DOs, PAs, NPs) bring to the care of acutely ill patients. We are the front line caring for the elderly and vulnerable, the glue holding transdisciplinary care teams together, and lead hospitals, health systems, and governmental organizations. Hospitalists touch the lives of our patients, and shape the health systems' practices and health policy on a national and international scale. These are remarkable achievements for a field which, just a few years ago, was concerned about becoming a job equivalent to perpetual residency training (or worse) and gained only grudging acceptance.[1] There is no doubt that the roles of hospitalists will continue to evolve, and whereas hospitalists will be able to shape the debates and development of new programs solving the problems of our health systems, we must take time to foster the mind, heart, and soul of our field.

When I speak of the mind of hospital medicine, I am thinking of our field's contribution to the evidence for how to care for patients' illnesses, a different body of knowledge than our field's focus to date on hospitals and health systems. Hospital medicine has been growing research capacity at a rate that is slower than the field overall, a problem in part due to limitations in National Institutes of Health funding for fellowships and early‐career awards, which in turn has restricted the pipeline of young and innovative researchers. Slow growth may also be a result of an emphasis on health systems rather than diseases.[2] I and others have written about the need to create mentoring support for junior research faculty as a way to promote success and avoid burnout,[3, 4, 5, 6, 7] and while at least 1 hospital medicine research network exists,[8] there is room for many more. However, at its core, our specialty needs to devote more time and focus to becoming a full scientific partner with our colleagues in cardiology, pulmonary medicine, and critical care, among others. To develop the mind of hospital medicine we will also need to think about our contributions to useful clinical guidelines for care of diseases and patients. Developing trustworthy clinical guidelines can be time consuming[9] but is a key part of ensuring patients and families understand the rationale for changes in clinical care. Hospital medicine as a field has been a leader in programs that develop approaches to implementing evidence and stands in an excellent position toperhaps in collaboration with other specialtiescreate the next‐generation guidelines that are practically minded, evidence based, and end up being used.

The heart I speak of is how we can make sure that the field of hospital medicine is one that is attractive and sustainable as a career. Electronic health records' impact on day‐to‐day work is substantial and a large part of the problem, though a more fundamental problem we face is in how to create sustainable jobs at a time where we are going to need to deliver higher‐value care to more patients with the same number (or fewer) providers. This is an issue that means we need to settle many important aspects of our workpay, relationships with our peers, control over our work on a day‐to‐day basis, hospitalists' work schedules (such as the 7 days on/7 days off model)while we also grapple with how to work within a population‐health framework. I am not prescient enough to see all the solutions to burnout, but there are at least 2 opportunities hospitalists are perhaps best suited to develop and lead. The first is how we arrange our teams in the hospital and afterward. Recent articles have talked about how medicine needs to be open to Uber‐like disruptive models,[10] where labor is deployed in fundamentally different ways. Tools such as e‐consults, the application of population health tools to inpatient care, telemedicine, or some forms of predictive analytics may be examples of these tools, which are routes to allowing more care to be delivered more effectively and more efficiently. Another opportunity lies in how we adapt our electronic health records to our work (and vice versa). The perils of sloppy and paste documentation are indicative of the burden of busywork, the pressures of needing to focus on revenue rather than clinical utility, and exhaustion; hospitalists are well positioned to think about howas payment reform continues to evolvedocumentation can be less busywork and more clinically useful, patient oriented, and shareable across sites and phases of care.

Now to the soul of our field. Hospital medicine has rightly been considered a key partner in developing the solutions hospitals and health systems need to address gaps in quality, safety, value, and clinical outcomes. However, this self‐image of hospital medicine has the downside of being viewed as doctors for hospitals, rather than doctors for patients and families who are in hospitals. As we think about burnout and jobs that are fulfilling and meaningful over the long term, I increasingly return to the factors that motivated me and many others to become physicians: meaningful relationships with patients, being an excellent clinician, and making a lasting contribution to my community through my patient care, support of my colleagues, and teaching younger physicians. It is easy for the pressures of the hospital and need to fix problems rapidly to obscure these larger motivators, but our field will need to ensure that these elements remain how we prioritize and shape our field going forward. Hospital medicine is comprised of physicians who do clinical care and who in most cases entered the field for that reason alone. Using the true north of improving and innovating care in ways that impact patient livesnot just the needs of our hospitalsin meaningful ways will need to be the soul of our field, and will allow the mind and heart of hospitalists and hospital medicine to thrive.

In 1995 I took my first job as a hospitalist at a community teaching hospital where hospitalists, though then known as medical directors, had been in place for 20 years. Soon afterward, our field gained a name, and my old job no longer was mistaken for a utilization review functionary or lead of a medical unit.

I have been lucky enough to have seen the field of hospital medicine grow rapidly in scope and importance. The growth of our specialty in mere numbers alone is a testament to the value we in hospital medicine (MDs, DOs, PAs, NPs) bring to the care of acutely ill patients. We are the front line caring for the elderly and vulnerable, the glue holding transdisciplinary care teams together, and lead hospitals, health systems, and governmental organizations. Hospitalists touch the lives of our patients, and shape the health systems' practices and health policy on a national and international scale. These are remarkable achievements for a field which, just a few years ago, was concerned about becoming a job equivalent to perpetual residency training (or worse) and gained only grudging acceptance.[1] There is no doubt that the roles of hospitalists will continue to evolve, and whereas hospitalists will be able to shape the debates and development of new programs solving the problems of our health systems, we must take time to foster the mind, heart, and soul of our field.

When I speak of the mind of hospital medicine, I am thinking of our field's contribution to the evidence for how to care for patients' illnesses, a different body of knowledge than our field's focus to date on hospitals and health systems. Hospital medicine has been growing research capacity at a rate that is slower than the field overall, a problem in part due to limitations in National Institutes of Health funding for fellowships and early‐career awards, which in turn has restricted the pipeline of young and innovative researchers. Slow growth may also be a result of an emphasis on health systems rather than diseases.[2] I and others have written about the need to create mentoring support for junior research faculty as a way to promote success and avoid burnout,[3, 4, 5, 6, 7] and while at least 1 hospital medicine research network exists,[8] there is room for many more. However, at its core, our specialty needs to devote more time and focus to becoming a full scientific partner with our colleagues in cardiology, pulmonary medicine, and critical care, among others. To develop the mind of hospital medicine we will also need to think about our contributions to useful clinical guidelines for care of diseases and patients. Developing trustworthy clinical guidelines can be time consuming[9] but is a key part of ensuring patients and families understand the rationale for changes in clinical care. Hospital medicine as a field has been a leader in programs that develop approaches to implementing evidence and stands in an excellent position toperhaps in collaboration with other specialtiescreate the next‐generation guidelines that are practically minded, evidence based, and end up being used.

The heart I speak of is how we can make sure that the field of hospital medicine is one that is attractive and sustainable as a career. Electronic health records' impact on day‐to‐day work is substantial and a large part of the problem, though a more fundamental problem we face is in how to create sustainable jobs at a time where we are going to need to deliver higher‐value care to more patients with the same number (or fewer) providers. This is an issue that means we need to settle many important aspects of our workpay, relationships with our peers, control over our work on a day‐to‐day basis, hospitalists' work schedules (such as the 7 days on/7 days off model)while we also grapple with how to work within a population‐health framework. I am not prescient enough to see all the solutions to burnout, but there are at least 2 opportunities hospitalists are perhaps best suited to develop and lead. The first is how we arrange our teams in the hospital and afterward. Recent articles have talked about how medicine needs to be open to Uber‐like disruptive models,[10] where labor is deployed in fundamentally different ways. Tools such as e‐consults, the application of population health tools to inpatient care, telemedicine, or some forms of predictive analytics may be examples of these tools, which are routes to allowing more care to be delivered more effectively and more efficiently. Another opportunity lies in how we adapt our electronic health records to our work (and vice versa). The perils of sloppy and paste documentation are indicative of the burden of busywork, the pressures of needing to focus on revenue rather than clinical utility, and exhaustion; hospitalists are well positioned to think about howas payment reform continues to evolvedocumentation can be less busywork and more clinically useful, patient oriented, and shareable across sites and phases of care.

Now to the soul of our field. Hospital medicine has rightly been considered a key partner in developing the solutions hospitals and health systems need to address gaps in quality, safety, value, and clinical outcomes. However, this self‐image of hospital medicine has the downside of being viewed as doctors for hospitals, rather than doctors for patients and families who are in hospitals. As we think about burnout and jobs that are fulfilling and meaningful over the long term, I increasingly return to the factors that motivated me and many others to become physicians: meaningful relationships with patients, being an excellent clinician, and making a lasting contribution to my community through my patient care, support of my colleagues, and teaching younger physicians. It is easy for the pressures of the hospital and need to fix problems rapidly to obscure these larger motivators, but our field will need to ensure that these elements remain how we prioritize and shape our field going forward. Hospital medicine is comprised of physicians who do clinical care and who in most cases entered the field for that reason alone. Using the true north of improving and innovating care in ways that impact patient livesnot just the needs of our hospitalsin meaningful ways will need to be the soul of our field, and will allow the mind and heart of hospitalists and hospital medicine to thrive.

References
  1. McMahon LF. The hospitalist movement—time to move on. N Engl J Med. 2007;357(25):26272629.
  2. Goldman L. An intellectual agenda for hospitalists: lessons from bloodletting. J Hosp Med. 2013;8(7):418419.
  3. Reid MB, Misky GJ, Harrison RA, Sharpe B, Auerbach A, Glasheen JJ. Mentorship, productivity, and promotion among academic hospitalists. J Gen Intern Med. 2012;27(1):2327.
  4. Sehgal NL, Sharpe BA, Auerbach AA, Wachter RM. Investing in the future: building an academic hospitalist faculty development program. J Hosp Med. 2011;6(3):161166.
  5. Harrison R, Hunter AJ, Sharpe B, Auerbach AD. Survey of US academic hospitalist leaders about mentorship and academic activities in hospitalist groups. J Hosp Med. 2011;6(1):59.
  6. Glasheen JJ, Misky GJ, Reid MB, Harrison RA, Sharpe B, Auerbach A. Career satisfaction and burnout in academic hospital medicine. Arch Intern Med. 2011;171(8):782785.
  7. Flanders SA, Centor B, Weber V, McGinn T, Desalvo K, Auerbach A. Challenges and opportunities in academic hospital medicine: report from the academic hospital medicine summit. J Gen Intern Med. 2009;24(5):636641.
  8. Auerbach AD, Patel MS, Metlay JP, et al. The Hospital Medicine Reengineering Network (HOMERuN): a learning organization focused on improving hospital care. Acad Med. 2014;89(3):415420.
  9. Greenfield S, Steinberg E, Avorn J, et al. Clinical practice guidelines we can trust. National Academy of Sciences website. Available at: http://www.nationalacademies.org/hmd/Reports/2011/Clinical‐Practice‐Guidelines‐We‐Can‐Trust.aspx. Published March 23, 2011. Accessed May 20, 2016.
  10. Detsky AS, Garber AM. Uber's message for health care. N Engl J Med. 2016;374(9):806809.
References
  1. McMahon LF. The hospitalist movement—time to move on. N Engl J Med. 2007;357(25):26272629.
  2. Goldman L. An intellectual agenda for hospitalists: lessons from bloodletting. J Hosp Med. 2013;8(7):418419.
  3. Reid MB, Misky GJ, Harrison RA, Sharpe B, Auerbach A, Glasheen JJ. Mentorship, productivity, and promotion among academic hospitalists. J Gen Intern Med. 2012;27(1):2327.
  4. Sehgal NL, Sharpe BA, Auerbach AA, Wachter RM. Investing in the future: building an academic hospitalist faculty development program. J Hosp Med. 2011;6(3):161166.
  5. Harrison R, Hunter AJ, Sharpe B, Auerbach AD. Survey of US academic hospitalist leaders about mentorship and academic activities in hospitalist groups. J Hosp Med. 2011;6(1):59.
  6. Glasheen JJ, Misky GJ, Reid MB, Harrison RA, Sharpe B, Auerbach A. Career satisfaction and burnout in academic hospital medicine. Arch Intern Med. 2011;171(8):782785.
  7. Flanders SA, Centor B, Weber V, McGinn T, Desalvo K, Auerbach A. Challenges and opportunities in academic hospital medicine: report from the academic hospital medicine summit. J Gen Intern Med. 2009;24(5):636641.
  8. Auerbach AD, Patel MS, Metlay JP, et al. The Hospital Medicine Reengineering Network (HOMERuN): a learning organization focused on improving hospital care. Acad Med. 2014;89(3):415420.
  9. Greenfield S, Steinberg E, Avorn J, et al. Clinical practice guidelines we can trust. National Academy of Sciences website. Available at: http://www.nationalacademies.org/hmd/Reports/2011/Clinical‐Practice‐Guidelines‐We‐Can‐Trust.aspx. Published March 23, 2011. Accessed May 20, 2016.
  10. Detsky AS, Garber AM. Uber's message for health care. N Engl J Med. 2016;374(9):806809.
Issue
Journal of Hospital Medicine - 11(12)
Issue
Journal of Hospital Medicine - 11(12)
Page Number
892-893
Page Number
892-893
Article Type
Display Headline
The next 20 years of hospital medicine: Continuing to foster the mind, heart, and soul of our field
Display Headline
The next 20 years of hospital medicine: Continuing to foster the mind, heart, and soul of our field
Sections
Article Source
© 2016 Society of Hospital Medicine
Disallow All Ads
Correspondence Location
Address for correspondence and reprint requests: Andrew D. Auerbach, MD, MPH, Department of Medicine, UCSF School of Medicine, 533 Parnassus Avenue, UC Hall, San Francisco, CA 94143‐0131; Telephone: 415‐502‐1412; Fax: 415‐514‐2094; E‐mail: [email protected]
Content Gating
Gated (full article locked unless allowed per User)
Gating Strategy
First Peek Free
Article PDF Media

Definition of a Children's Hospital

Article Type
Changed
Mon, 01/02/2017 - 19:34
Display Headline
What is a children's hospital and does it even matter?

When I was a resident, one common warning delivered to us by our putatively omniscient attendings was, Well you know, most children are not hospitalized at children's hospitals. This caution was likely meant to warn us future pediatricians that the supports and access to pediatric subspecialists we took for granted in a children's hospital would be different once we graduated and left for community settings. However, it is doubtful that any resident ever challenged the validity of that statement. Are most children hospitalized at general hospitals and is the availability of subspecialty services different between general and children's hospitals?

In this issue of the Journal of Hospital Medicine, Leyenaar et al.[1] set out to test that warning and to quantify where children in the United States are hospitalized. They investigated differences in the pediatric hospitalizations at general and freestanding children's hospitals. In doing so, their findings began to implicitly explore what is meant by the term children's hospital. The authors utilized the Agency for Healthcare Quality and Research's (AHQR) 2012 Kids Inpatient Database (KID), which after excluding in‐hospital births and pregnancy‐related admissions, captured nearly 4000 hospitals and 1.4 million acute care pediatric admissions across the United States.

Leyenaar et al. found that our attendings were correct, confirming a prior study on the subject[2]; close to three‐quarters of discharges were from general hospitals. However, although the most frequent reasons for hospitalization were similar between the 2 types of hospitals, that is where the similarities ended. They found that although the median annual number of discharges at the 50 freestanding children's hospitals was 12,000, it was only 56 at the nearly 4000 general hospitals. Approximately 80% of general hospitals (the equivalent of nearly 3000 hospitals) accounted for only 11% of all discharges and had less than 375 annual pediatric discharges, essentially 1 discharge per day or fewer. In addition, over one‐third of discharges at freestanding children's hospitals were for children with medical complexity, compared to 1 in 5 at general hospitals. Furthermore, one‐quarter of discharges at freestanding children's hospitals were of high or highest severity, compared with half that amount at general hospitals.

Although it is not possible to determine the quality of care from the KID, the authors insightfully discuss the implications these differences have on quality improvement and quality measurement. General hospitals with low volumes of pediatric inpatients may have difficulty providing condition‐specific quality metrics or implementing condition‐specific quality improvement processes. How can you compare quality across hospitals averaging only 56 pediatric admissions a year? If existing quality metrics are not meaningful for those hospitals, but the majority of children are admitted to them, the development of new, more useful, quality metrics is needed.

Perhaps the most interesting finding resulted from a new and unfortunate limitation in the KID database. Beginning in 2012, the AHQR began deidentifying all hospitals contributing data to the KID, leaving researchers reliant on KID's categorization of hospitals as either freestanding children's hospitals or general hospitals. The authors attempted to work around these limitations to identify those children's hospitals that were not freestanding but were located within general hospitals. They found that 36 general hospitals had patient volumes equivalent to freestanding children's hospitals, whereas 20 freestanding children's hospitals had very infrequent admissions for the most common discharge diagnoses. The authors are almost certainly correct in deeming the latter 20 hospitals to be subspecialty children's hospitals, such as those focused solely on orthopedic or oncologic conditions. Among the 36 high‐volume general hospitals, the authors found that patient complexity and severity was more similar to freestanding children's hospitals than to the low‐volume general hospitals. Length of stay (and therefore presumably costs as well) for high‐volume general hospitals was positioned between freestanding children's hospitals and low‐volume general hospitals.

Who are those high‐volume hospitals that appear to be general in name only? Because of KID's deidentification of hospitals, we do not know. It is possible that those hospitals self‐identify as being children's hospitals, but are not freestanding, meaning that they are located within a general hospital (hospitals within a hospital). If they are children's hospitals within general hospitals, it would provide a different perspective to the study's overall finding that 71% of hospitalizations, 64% of hospital days, and 50% of costs occur at general hospitals. As the authors allude to, some institutions may not call themselves freestanding children's hospitals but function that way; other institutions call themselves freestanding children's hospitals but offer very focused specialty services. Through this limitation in the KID database, the authors began the process of identifying hospitals that look like freestanding children's hospitals but are not called that. In other words, they began creating a more robust functional definition of which institutions are truly children's hospitals. Volume does not, of course, always equate into specialization, and much work needs to be done measuring the availability of subspecialty and critical care services before any functional definition of children's hospital can be made; the potential, however, is intriguing.

Does it matter which hospitals are deemed children's hospitals? Although a hospitalist may not place importance on the name over the hospital's entrance, the Centers for Medicare and Medicaid Services (CMS) and state insurance regulators may find the difference extremely important. CMS and state insurance regulators are increasingly focusing their attention on the adequacy of pediatric insurance networks.[3, 4, 5, 6] They are seeking to create rules that ensure health insurance plans have a broad range of pediatric subspecialists in close proximity to the great majority of children insured by the plan. For adult insurance, the adequacy of a plan's network is typically defined by the time and distance from a patient's home to a specialist. However, unlike in adult medicine, pediatric subspecialty care is becoming increasingly regionalized at academic medical centers, especially children's hospitals. Furthermore, unlike adult care, a wide range of pediatric subspecialists is unlikely to be found at the hospital closest to a patient's home. Therefore, time and distance rules for ensuring network adequacy may fail within pediatric care. Instead, inclusion of a hospital designatedby functional or other criteriaas a children's hospital may be the best way to ensure the adequate provision of pediatric specialty care within a network.

How policymakers define pediatric network adequacy will have important implications for ensuring that pediatric inpatient medicine achieves the goal of the right patient, the right place, the right time. Therefore, the attending from our residency may have been correct that most children are not hospitalized at children's hospitals. However, depending on how pediatric network adequacy rules are developed, that may not have to mean that these children (and their pediatricians) will be out there alone.

Disclosure

Nothing to report.

References
  1. Leyenaar J, Ralston S, Shieh M‐S, Pekow P, Mangione‐Smith R, Lindenauer P. Epidemiology of pediatric hospitalizations at general hospitals and freestanding children's hospitals in the United States. J Hosp Med. 2016;11(11):743749.
  2. Colvin JD, Hall M, Gottlieb L, et al. Hospitalizations of low‐income children and children with severe health conditions: implications of the Patient Protection and Affordable Care Act. JAMA Pediatr. 2016;170(2):176178.
  3. Iritani KM. Provider networks: comparison of child‐focused network adequacy standards between CHIP and private health plans. United States Government Accountability Office Report to the Ranking Member, Committee on Finance, United States Senate. Available at: http://www.gao.gov/assets/680/674999.pdf. Published February 2016. Accessed May 10, 2016.
  4. Medicaid and CHIP Payment and Access Commission. March 2015 Report to Congress on Medicaid and CHIP. Available at: https://www.macpac.gov/wp‐content/uploads/2015/03/March‐2015‐Report‐to‐Congress‐on‐Medicaid‐and‐CHIP.pdf. Published March 2015. Accessed May 10, 2016.
  5. Noble A. Insurance carriers and access to healthcare providers: network adequacy. National Conference of State Legislatures website. Available at: www.ncsl.org/research/health/insurance‐carriers‐and‐access‐to‐healthcare‐providers‐network‐adequacy.aspx. Published November 13, 2015. Accessed April 4, 2016.
  6. Barber C, Bridgeland B, Burns B, et al. Ensuring consumers' access to care: network adequacy state insurance survey findings and recommendations for regulatory reforms in a changing insurance market. Available at: http://www.naic.org/documents/committees_conliaison_network_adequacy_report.pdf. Published November 2014. Accessed May 10, 2016.
Article PDF
Issue
Journal of Hospital Medicine - 11(11)
Page Number
809-810
Sections
Article PDF
Article PDF

When I was a resident, one common warning delivered to us by our putatively omniscient attendings was, Well you know, most children are not hospitalized at children's hospitals. This caution was likely meant to warn us future pediatricians that the supports and access to pediatric subspecialists we took for granted in a children's hospital would be different once we graduated and left for community settings. However, it is doubtful that any resident ever challenged the validity of that statement. Are most children hospitalized at general hospitals and is the availability of subspecialty services different between general and children's hospitals?

In this issue of the Journal of Hospital Medicine, Leyenaar et al.[1] set out to test that warning and to quantify where children in the United States are hospitalized. They investigated differences in the pediatric hospitalizations at general and freestanding children's hospitals. In doing so, their findings began to implicitly explore what is meant by the term children's hospital. The authors utilized the Agency for Healthcare Quality and Research's (AHQR) 2012 Kids Inpatient Database (KID), which after excluding in‐hospital births and pregnancy‐related admissions, captured nearly 4000 hospitals and 1.4 million acute care pediatric admissions across the United States.

Leyenaar et al. found that our attendings were correct, confirming a prior study on the subject[2]; close to three‐quarters of discharges were from general hospitals. However, although the most frequent reasons for hospitalization were similar between the 2 types of hospitals, that is where the similarities ended. They found that although the median annual number of discharges at the 50 freestanding children's hospitals was 12,000, it was only 56 at the nearly 4000 general hospitals. Approximately 80% of general hospitals (the equivalent of nearly 3000 hospitals) accounted for only 11% of all discharges and had less than 375 annual pediatric discharges, essentially 1 discharge per day or fewer. In addition, over one‐third of discharges at freestanding children's hospitals were for children with medical complexity, compared to 1 in 5 at general hospitals. Furthermore, one‐quarter of discharges at freestanding children's hospitals were of high or highest severity, compared with half that amount at general hospitals.

Although it is not possible to determine the quality of care from the KID, the authors insightfully discuss the implications these differences have on quality improvement and quality measurement. General hospitals with low volumes of pediatric inpatients may have difficulty providing condition‐specific quality metrics or implementing condition‐specific quality improvement processes. How can you compare quality across hospitals averaging only 56 pediatric admissions a year? If existing quality metrics are not meaningful for those hospitals, but the majority of children are admitted to them, the development of new, more useful, quality metrics is needed.

Perhaps the most interesting finding resulted from a new and unfortunate limitation in the KID database. Beginning in 2012, the AHQR began deidentifying all hospitals contributing data to the KID, leaving researchers reliant on KID's categorization of hospitals as either freestanding children's hospitals or general hospitals. The authors attempted to work around these limitations to identify those children's hospitals that were not freestanding but were located within general hospitals. They found that 36 general hospitals had patient volumes equivalent to freestanding children's hospitals, whereas 20 freestanding children's hospitals had very infrequent admissions for the most common discharge diagnoses. The authors are almost certainly correct in deeming the latter 20 hospitals to be subspecialty children's hospitals, such as those focused solely on orthopedic or oncologic conditions. Among the 36 high‐volume general hospitals, the authors found that patient complexity and severity was more similar to freestanding children's hospitals than to the low‐volume general hospitals. Length of stay (and therefore presumably costs as well) for high‐volume general hospitals was positioned between freestanding children's hospitals and low‐volume general hospitals.

Who are those high‐volume hospitals that appear to be general in name only? Because of KID's deidentification of hospitals, we do not know. It is possible that those hospitals self‐identify as being children's hospitals, but are not freestanding, meaning that they are located within a general hospital (hospitals within a hospital). If they are children's hospitals within general hospitals, it would provide a different perspective to the study's overall finding that 71% of hospitalizations, 64% of hospital days, and 50% of costs occur at general hospitals. As the authors allude to, some institutions may not call themselves freestanding children's hospitals but function that way; other institutions call themselves freestanding children's hospitals but offer very focused specialty services. Through this limitation in the KID database, the authors began the process of identifying hospitals that look like freestanding children's hospitals but are not called that. In other words, they began creating a more robust functional definition of which institutions are truly children's hospitals. Volume does not, of course, always equate into specialization, and much work needs to be done measuring the availability of subspecialty and critical care services before any functional definition of children's hospital can be made; the potential, however, is intriguing.

Does it matter which hospitals are deemed children's hospitals? Although a hospitalist may not place importance on the name over the hospital's entrance, the Centers for Medicare and Medicaid Services (CMS) and state insurance regulators may find the difference extremely important. CMS and state insurance regulators are increasingly focusing their attention on the adequacy of pediatric insurance networks.[3, 4, 5, 6] They are seeking to create rules that ensure health insurance plans have a broad range of pediatric subspecialists in close proximity to the great majority of children insured by the plan. For adult insurance, the adequacy of a plan's network is typically defined by the time and distance from a patient's home to a specialist. However, unlike in adult medicine, pediatric subspecialty care is becoming increasingly regionalized at academic medical centers, especially children's hospitals. Furthermore, unlike adult care, a wide range of pediatric subspecialists is unlikely to be found at the hospital closest to a patient's home. Therefore, time and distance rules for ensuring network adequacy may fail within pediatric care. Instead, inclusion of a hospital designatedby functional or other criteriaas a children's hospital may be the best way to ensure the adequate provision of pediatric specialty care within a network.

How policymakers define pediatric network adequacy will have important implications for ensuring that pediatric inpatient medicine achieves the goal of the right patient, the right place, the right time. Therefore, the attending from our residency may have been correct that most children are not hospitalized at children's hospitals. However, depending on how pediatric network adequacy rules are developed, that may not have to mean that these children (and their pediatricians) will be out there alone.

Disclosure

Nothing to report.

When I was a resident, one common warning delivered to us by our putatively omniscient attendings was, Well you know, most children are not hospitalized at children's hospitals. This caution was likely meant to warn us future pediatricians that the supports and access to pediatric subspecialists we took for granted in a children's hospital would be different once we graduated and left for community settings. However, it is doubtful that any resident ever challenged the validity of that statement. Are most children hospitalized at general hospitals and is the availability of subspecialty services different between general and children's hospitals?

In this issue of the Journal of Hospital Medicine, Leyenaar et al.[1] set out to test that warning and to quantify where children in the United States are hospitalized. They investigated differences in the pediatric hospitalizations at general and freestanding children's hospitals. In doing so, their findings began to implicitly explore what is meant by the term children's hospital. The authors utilized the Agency for Healthcare Quality and Research's (AHQR) 2012 Kids Inpatient Database (KID), which after excluding in‐hospital births and pregnancy‐related admissions, captured nearly 4000 hospitals and 1.4 million acute care pediatric admissions across the United States.

Leyenaar et al. found that our attendings were correct, confirming a prior study on the subject[2]; close to three‐quarters of discharges were from general hospitals. However, although the most frequent reasons for hospitalization were similar between the 2 types of hospitals, that is where the similarities ended. They found that although the median annual number of discharges at the 50 freestanding children's hospitals was 12,000, it was only 56 at the nearly 4000 general hospitals. Approximately 80% of general hospitals (the equivalent of nearly 3000 hospitals) accounted for only 11% of all discharges and had less than 375 annual pediatric discharges, essentially 1 discharge per day or fewer. In addition, over one‐third of discharges at freestanding children's hospitals were for children with medical complexity, compared to 1 in 5 at general hospitals. Furthermore, one‐quarter of discharges at freestanding children's hospitals were of high or highest severity, compared with half that amount at general hospitals.

Although it is not possible to determine the quality of care from the KID, the authors insightfully discuss the implications these differences have on quality improvement and quality measurement. General hospitals with low volumes of pediatric inpatients may have difficulty providing condition‐specific quality metrics or implementing condition‐specific quality improvement processes. How can you compare quality across hospitals averaging only 56 pediatric admissions a year? If existing quality metrics are not meaningful for those hospitals, but the majority of children are admitted to them, the development of new, more useful, quality metrics is needed.

Perhaps the most interesting finding resulted from a new and unfortunate limitation in the KID database. Beginning in 2012, the AHQR began deidentifying all hospitals contributing data to the KID, leaving researchers reliant on KID's categorization of hospitals as either freestanding children's hospitals or general hospitals. The authors attempted to work around these limitations to identify those children's hospitals that were not freestanding but were located within general hospitals. They found that 36 general hospitals had patient volumes equivalent to freestanding children's hospitals, whereas 20 freestanding children's hospitals had very infrequent admissions for the most common discharge diagnoses. The authors are almost certainly correct in deeming the latter 20 hospitals to be subspecialty children's hospitals, such as those focused solely on orthopedic or oncologic conditions. Among the 36 high‐volume general hospitals, the authors found that patient complexity and severity was more similar to freestanding children's hospitals than to the low‐volume general hospitals. Length of stay (and therefore presumably costs as well) for high‐volume general hospitals was positioned between freestanding children's hospitals and low‐volume general hospitals.

Who are those high‐volume hospitals that appear to be general in name only? Because of KID's deidentification of hospitals, we do not know. It is possible that those hospitals self‐identify as being children's hospitals, but are not freestanding, meaning that they are located within a general hospital (hospitals within a hospital). If they are children's hospitals within general hospitals, it would provide a different perspective to the study's overall finding that 71% of hospitalizations, 64% of hospital days, and 50% of costs occur at general hospitals. As the authors allude to, some institutions may not call themselves freestanding children's hospitals but function that way; other institutions call themselves freestanding children's hospitals but offer very focused specialty services. Through this limitation in the KID database, the authors began the process of identifying hospitals that look like freestanding children's hospitals but are not called that. In other words, they began creating a more robust functional definition of which institutions are truly children's hospitals. Volume does not, of course, always equate into specialization, and much work needs to be done measuring the availability of subspecialty and critical care services before any functional definition of children's hospital can be made; the potential, however, is intriguing.

Does it matter which hospitals are deemed children's hospitals? Although a hospitalist may not place importance on the name over the hospital's entrance, the Centers for Medicare and Medicaid Services (CMS) and state insurance regulators may find the difference extremely important. CMS and state insurance regulators are increasingly focusing their attention on the adequacy of pediatric insurance networks.[3, 4, 5, 6] They are seeking to create rules that ensure health insurance plans have a broad range of pediatric subspecialists in close proximity to the great majority of children insured by the plan. For adult insurance, the adequacy of a plan's network is typically defined by the time and distance from a patient's home to a specialist. However, unlike in adult medicine, pediatric subspecialty care is becoming increasingly regionalized at academic medical centers, especially children's hospitals. Furthermore, unlike adult care, a wide range of pediatric subspecialists is unlikely to be found at the hospital closest to a patient's home. Therefore, time and distance rules for ensuring network adequacy may fail within pediatric care. Instead, inclusion of a hospital designatedby functional or other criteriaas a children's hospital may be the best way to ensure the adequate provision of pediatric specialty care within a network.

How policymakers define pediatric network adequacy will have important implications for ensuring that pediatric inpatient medicine achieves the goal of the right patient, the right place, the right time. Therefore, the attending from our residency may have been correct that most children are not hospitalized at children's hospitals. However, depending on how pediatric network adequacy rules are developed, that may not have to mean that these children (and their pediatricians) will be out there alone.

Disclosure

Nothing to report.

References
  1. Leyenaar J, Ralston S, Shieh M‐S, Pekow P, Mangione‐Smith R, Lindenauer P. Epidemiology of pediatric hospitalizations at general hospitals and freestanding children's hospitals in the United States. J Hosp Med. 2016;11(11):743749.
  2. Colvin JD, Hall M, Gottlieb L, et al. Hospitalizations of low‐income children and children with severe health conditions: implications of the Patient Protection and Affordable Care Act. JAMA Pediatr. 2016;170(2):176178.
  3. Iritani KM. Provider networks: comparison of child‐focused network adequacy standards between CHIP and private health plans. United States Government Accountability Office Report to the Ranking Member, Committee on Finance, United States Senate. Available at: http://www.gao.gov/assets/680/674999.pdf. Published February 2016. Accessed May 10, 2016.
  4. Medicaid and CHIP Payment and Access Commission. March 2015 Report to Congress on Medicaid and CHIP. Available at: https://www.macpac.gov/wp‐content/uploads/2015/03/March‐2015‐Report‐to‐Congress‐on‐Medicaid‐and‐CHIP.pdf. Published March 2015. Accessed May 10, 2016.
  5. Noble A. Insurance carriers and access to healthcare providers: network adequacy. National Conference of State Legislatures website. Available at: www.ncsl.org/research/health/insurance‐carriers‐and‐access‐to‐healthcare‐providers‐network‐adequacy.aspx. Published November 13, 2015. Accessed April 4, 2016.
  6. Barber C, Bridgeland B, Burns B, et al. Ensuring consumers' access to care: network adequacy state insurance survey findings and recommendations for regulatory reforms in a changing insurance market. Available at: http://www.naic.org/documents/committees_conliaison_network_adequacy_report.pdf. Published November 2014. Accessed May 10, 2016.
References
  1. Leyenaar J, Ralston S, Shieh M‐S, Pekow P, Mangione‐Smith R, Lindenauer P. Epidemiology of pediatric hospitalizations at general hospitals and freestanding children's hospitals in the United States. J Hosp Med. 2016;11(11):743749.
  2. Colvin JD, Hall M, Gottlieb L, et al. Hospitalizations of low‐income children and children with severe health conditions: implications of the Patient Protection and Affordable Care Act. JAMA Pediatr. 2016;170(2):176178.
  3. Iritani KM. Provider networks: comparison of child‐focused network adequacy standards between CHIP and private health plans. United States Government Accountability Office Report to the Ranking Member, Committee on Finance, United States Senate. Available at: http://www.gao.gov/assets/680/674999.pdf. Published February 2016. Accessed May 10, 2016.
  4. Medicaid and CHIP Payment and Access Commission. March 2015 Report to Congress on Medicaid and CHIP. Available at: https://www.macpac.gov/wp‐content/uploads/2015/03/March‐2015‐Report‐to‐Congress‐on‐Medicaid‐and‐CHIP.pdf. Published March 2015. Accessed May 10, 2016.
  5. Noble A. Insurance carriers and access to healthcare providers: network adequacy. National Conference of State Legislatures website. Available at: www.ncsl.org/research/health/insurance‐carriers‐and‐access‐to‐healthcare‐providers‐network‐adequacy.aspx. Published November 13, 2015. Accessed April 4, 2016.
  6. Barber C, Bridgeland B, Burns B, et al. Ensuring consumers' access to care: network adequacy state insurance survey findings and recommendations for regulatory reforms in a changing insurance market. Available at: http://www.naic.org/documents/committees_conliaison_network_adequacy_report.pdf. Published November 2014. Accessed May 10, 2016.
Issue
Journal of Hospital Medicine - 11(11)
Issue
Journal of Hospital Medicine - 11(11)
Page Number
809-810
Page Number
809-810
Article Type
Display Headline
What is a children's hospital and does it even matter?
Display Headline
What is a children's hospital and does it even matter?
Sections
Article Source
© 2016 Society of Hospital Medicine
Disallow All Ads
Correspondence Location
Address for correspondence and reprint requests: Jeffrey D. Colvin, MD, JD, Children's Mercy Hospital, University of Missouri‐Kansas City School of Medicine, 3101 Broadway Blvd., Kansas City, MO 64111; Telephone: 816‐960‐2805; Fax: 816‐960‐3084; E‐mail: [email protected]
Content Gating
Gated (full article locked unless allowed per User)
Gating Strategy
First Peek Free
Article PDF Media

Pediatric Hospitalization Epidemiology

Article Type
Changed
Mon, 01/02/2017 - 19:34
Display Headline
Epidemiology of pediatric hospitalizations at general hospitals and freestanding children's hospitals in the United States

Improvement in the quality of hospital care in the United States is a national priority, both to advance patient safety and because our expenditures exceed any other nation's, but our health outcomes lag behind.[1, 2] Healthcare spending for children is growing at a faster rate than any other age group, with hospital care accounting for more than 40% of pediatric healthcare expenditures.[3] Inpatient healthcare comprises a greater proportion of healthcare costs for children than for adults, yet we have limited knowledge about where this care is provided.[4]

There is substantial variability in the settings in which children are hospitalized. Children may be hospitalized in freestanding children's hospitals, where all services are designed for children and which operate independently of adult‐focused institutions. They may also be hospitalized in general hospitals where care may be provided in a general inpatient bed, on a dedicated pediatric ward, or in a children's hospital nested within a hospital, which may have specialized nursing and physician care but often shares other resources such as laboratory and radiology with the primarily adult‐focused institution. Medical students and residents may be trained in all of these settings. We know little about how these hospital types differ with respect to patient populations, disease volumes, and resource utilization, and this knowledge is important to inform clinical programs, implementation research, and quality improvement (QI) priorities. To this end, we aimed to describe the volume and characteristics of pediatric hospitalizations at acute care general hospitals and freestanding children's hospitals in the United States.

METHODS

Study Design and Eligibility

The data source for this analysis was the Healthcare Cost and Utilization Project's (HCUP) 2012 Kids' Inpatient Database (KID). We conducted a cross‐sectional study of hospitalizations in children and adolescents less than 18 years of age, excluding in‐hospital births and hospitalizations for pregnancy and delivery (identified using All Patient Refined‐Diagnostic Related Groups [APR‐DRGs]).[5] Neonatal hospitalizations not representing in‐hospital births but resulting from transfers or new admissions were retained. Because the dataset does not contain identifiable information, the institutional review board at Baystate Medical Center determined that our study did not constitute human subjects research.

The KID is released every 3 years and is the only publicly available, nationally representative database developed to study pediatric hospitalizations, including an 80% sample of noninborn pediatric discharges from all community, nonrehabilitation hospitals from 44 participating states.[6] Short‐term rehabilitation hospitals, long‐term nonacute care hospitals, psychiatric hospitals, and alcoholism/chemical dependency treatment facilities are excluded. The KID contains information on all patients, regardless of payer, and provides discharge weights to calculate national estimates.[6] It contains both hospital‐level and patient‐level variables, including demographic characteristics, charges, and other clinical and resource use data available from discharge abstracts. Beginning in 2012, freestanding children's hospitals (FCHs) are assigned to a separate stratum in the KID, with data from the Children's Hospital Association used by HCUP to verify the American Hospital Association's (AHA) list of FCHs.[6] Hospitals that are not FCHs were categorized as general hospitals (GHs). We were interested in examining patterns of care at acute care hospitals and not specialty hospitals; unlike previous years, the KID 2012 does not include a specialty hospital identifier.[6] Therefore, as a proxy for specialty hospital status, we excluded hospitals that had 2% hospitalizations for 12 common medical conditions (pneumonia, asthma, bronchiolitis, cellulitis, dehydration, urinary tract infection, neonatal hyperbilirubinemia, fever, upper respiratory infection, infectious gastroenteritis, unspecified viral infection, and croup). These medical conditions were the 12 most common reasons for medical hospitalizations identified using Keren's pediatric diagnosis code grouper,[7] excluding chronic diseases, and represented 26.2% of all pediatric hospitalizations. This 2% threshold was developed empirically, based on visual analysis of the distribution of cases across hospitals and was limited to hospitals with total pediatric volumes >25/year, allowing for stable case‐mix estimates.

Descriptor Variables

Hospital level characteristics included US Census region; teaching status classified in the KID based on results of the AHA Annual Survey; urban/rural location; hospital ownership, classified as public, private nonprofit and private investor‐owned; and total volume of pediatric hospitalizations, in deciles.[6] At the patient level, we examined age, gender, race/ethnicity, expected primary payer, and median household income (in quartiles) for patient's zip code. Medical complexity was categorized as (1) nonchronic disease, (2) complex chronic disease, or (3) noncomplex chronic disease, using the previously validated Pediatric Medical Complexity Algorithm (PMCA) based on International Classification of Diseases, 9th Revision, Clinical Modification (ICD‐9‐CM) codes.[8] Disease severity was classified based on APR‐DRG severity of illness coding, which classifies illnesses severity as minor, moderate, major, or extreme.[9]

We examined the following characteristics of the hospitalizations: (1) length of hospital stay (LOS) measured in calendar days; (2) high‐turnover hospitalization defined as LOS less than 2 days[10, 11, 12]; (3) long LOS, defined as greater than 4 days, equivalent to LOS greater than the 75th percentile; (4) neonatal versus non‐neonatal hospitalization, identified using APR‐DRGs; (5) admission type categorized as elective and nonelective; (6) admission source, categorized as transfer from another acute care hospital, admission from the emergency department, or direct admission; (7) discharge status, categorized as routine discharge, transfer to another hospital or healthcare facility, and discharge against medical advice; and (8) total hospital costs, calculated by applying the cost‐to‐charge ratios available in the KID to total hospital charges.

Reasons for hospitalization were categorized using the pediatric diagnosis code grouper by Keren, which uses ICD‐9‐CM codes to group common and costly principal diagnoses into distinct conditions (eg, pneumonia, idiopathic scoliosis), excluding children who have ICD‐9‐CM principal procedure codes unlikely related to their principal diagnosis (for example, appendectomy for a child with a principal diagnosis of pneumonia).[7] This pediatric grouper classifies diagnoses as medical, surgical, or medical‐surgical based on whether <20% (medical), >80% (surgical) or between 20% and 80% (medical‐surgical) of encounters for the condition had an ICD‐9‐CM principal procedure code for a surgery related to that condition. We further characterized medical hospitalizations as either medical or mental health hospitalizations.

Statistical Analysis

We categorized each discharge record as a hospitalization at a GH or an FCH. We then calculated patient‐level summary statistics, applying weights to calculate national estimates with an associated standard deviation (SD). We assessed differences in characteristics of hospitalizations at GHs and FCHs using Rao‐Scott 2 tests for categorical variables and Wald F tests for continuous variables.[6] We identified the most common reasons for hospitalization, including those responsible for at least 2% of all medical or surgical hospitalizations and at least 0.5% of medical hospitalizations for mental health diagnoses, given the lower prevalence of these conditions and our desire to include mental health diagnoses in our analysis. For these common conditions, we calculated the proportion of condition‐specific hospitalizations and aggregate hospital costs at GHs and FCHs. We also determined the number of hospitalizations at each hospital and calculated the median and interquartile range for the number of hospitalizations for each of these conditions according to hospital type, assessing for differences using Kruskal‐Wallis tests. Finally, we identified the most common and costly conditions at GHs and FCHs by ranking frequency and aggregate costs for each condition according to hospital type, limited to the 20 most costly and/or prevalent pediatric diagnoses. Because we used a novel method to identify specialty hospitals in this dataset, we repeated these analyses using all hospitals classified as a GH and FCH as a sensitivity analysis.

RESULTS

Overall, 3866 hospitals were categorized as a GH, whereas 70 hospitals were categorized as FCHs. Following exclusion of specialty hospitals, 3758 GHs and 50 FCHs were retained in this study. The geographic distribution of hospitals was similar, but although GHs included those in both urban and rural regions, all FCHs were located in urban regions (Table 1).

Characteristics of General Hospitals and Freestanding Children's Hospitals
General Hospitals, n = 3,758 Children's Hospitals, n = 50
Hospital characteristics n % n % P Value
  • NOTE: Abbreviations: IQR, interquartile range.

Geographic region
Northeast 458 12.2 4 8.0 0.50
Midwest 1,209 32.2 15 30.0
South 1,335 35.6 17 34.0
West 753 20.1 14 28.0
Location and teaching status
Rural 1,524 40.6 0 0 <0.0001
Urban nonteaching 1,506 40.1 7 14.0
Urban teaching 725 19.3 43 86.0
Hospital ownership
Government, nonfederal 741 19.7 0 0 <0.0001
Private, nonprofit 2,364 63.0 48 96.0
Private, investor‐owned 650 17.3 2 4.0
Volume of pediatric hospitalizations (deciles)
<185 hospitalizations/year (<8th decile) 2,664 71.0 0 0 <0.0001
186375 hospitalizations/year (8th decile) 378 10.1 2 4.0
376996 hospitalizations/year (9th decile) 380 10.1 1 2.0
>986 hospitalizations/year (10th decile) 333 8.9 47 94.0
Volume of pediatric hospitalizations, median [IQR] 56 [14240] 12,001 [5,83815,448] <0.0001

A total of 1,407,822 (SD 50,456) hospitalizations occurred at GHs, representing 71.7% of pediatric hospitalizations, whereas 554,458 (SD 45,046) hospitalizations occurred at FCHs. Hospitalizations at GHs accounted for 63.6% of days in hospital and 50.0% of pediatric inpatient healthcare costs. Eighty percent of the GHs had total pediatric patient volumes of less than 375 hospitalizations yearly; 11.1% of pediatric hospitalizations occurred at these lower‐volume centers. At FCHs, the median volume of pediatric hospitalizations was 12,001 (interquartile range [IQR]: 583815,448). A total of 36 GHs had pediatric hospitalization volumes in this IQR.

The median age for pediatric patients was slightly higher at GHs, whereas gender, race/ethnicity, primary payer, and median household income for zip code did not differ significantly between hospital types (Table 2). Medical complexity differed between hospital types: children with complex chronic diseases represented 20.2% of hospitalizations at GHs and 35.6% of hospitalizations at FCHs. Severity of illness differed between hospital types, with fewer hospitalizations categorized at the highest level of severity at GHs than FCHs. There were no significant differences between hospital types with respect to the proportion of hospitalizations categorized as neonatal hospitalizations or as elective hospitalizations. The median LOS was shorter at GHs than FCHs. Approximately 1 in 5 children hospitalized at GHs had LOS greater than 4 days, whereas almost 30% of children hospitalized at FCHs had LOS of this duration.

Patient Characteristics and Characteristics of Hospitalizations at General Hospitals and Freestanding Children's Hospitals
Patient Characteristics

General Hospitals,1,407,822 (50,456), 71.7%

Children's Hospitals,554,458 (45,046), 28.3%

P Value
n (SD Weighted Frequency) (%) n (SD Weighted Frequency) %
  • NOTE: Abbreviations: APR‐DRG, All Patient Refined Diagnosis‐Related Group; ED, emergency department; IQR, interquartile range; SD, standard deviation. *Race/ethnicity data missing for approximately 8% of discharge records.[8] Includes in‐hospital death, discharge destination unknown.

Age, y, median [IQR] 3.6 [011.7] 3.4 [010.8] 0.001
Gender (% female) 644,250 (23,089) 45.8 254,505 (20,688) 45.9 0.50
Race*
White 668,876 (27,741) 47.5 233,930 (26,349) 42.2 0.05
Black 231,586 (12,890) 16.5 80,568 (11,739) 14.5
Hispanic 279,021 (16,843) 19.8 12,1425 (21,183) 21.9
Other 133,062 (8,572) 9.5 41,190 (6,394) 7.4
Insurance status
Public 740,033 (28,675) 52.6 284,795 (25,324) 51.4 0.90
Private 563,562 (21,930) 40.0 224,042 (21,613) 40.4
Uninsured 37,265 (1,445) 2.7 16,355 (3,804) 3.0
No charge/other/unknown 66,962 (5,807) 4.8 29,266 (6,789) 5.3
Median household income for zip code, quartiles
<$38,999 457,139 (19,725) 33.3 164,831 (17,016) 30.1 0.07
$39,000$47,999 347,229 (14,104) 25.3 125,105 (10,712) 22.9
$48,000$62,999 304,795 (13,427) 22.2 134,915 (13,999) 24.7
>$63,000 263,171 (15,418) 19.2 122,164 (16,279) 22.3
Medical complexity
Nonchronic disease 717,009 (21,807) 50.9 211,089 (17,023) 38.1 <0.001
Noncomplex chronic disease 406,070 (14,951) 28.8 146,077 (12,442) 26.4
Complex chronic disease 284,742 (17,111) 20.2 197,292 (18,236) 35.6
APR‐DRG severity of illness
1 (lowest severity) 730,134 (23,162) 51.9 217,202 (18,433) 39.2 <0.001
2 486,748 (18,395) 34.6 202,931 (16,864) 36.6
3 146,921 (8,432) 10.4 100,566 (9,041) 18.1
4 (highest severity) 41,749 (3,002) 3.0 33,340 (3,199) 6.0
Hospitalization characteristics
Neonatal hospitalization 98,512 (3,336) 7.0 39,584 (4,274) 7.1 0.84
Admission type
Elective 255,774 (12,285) 18.3 109,854 (13,061) 19.8 0.05
Length of stay, d, (median [IQR]) 1.8 (0.01) [0.8‐3.6] 2.2 (0.06) [1.1‐4.7] <0.001
High turnover hospitalizations 416,790 (14,995) 29.6 130,441 (12,405) 23.5 <0.001
Length of stay >4 days 298,315 (14,421) 21.2 161,804 (14,354) 29.2 <0.001
Admission source
Transfer from another acute care hospital 154,058 (10,067) 10.9 82,118 (8,952) 14.8 0.05
Direct admission 550,123 (21,954) 39.1 211,117 (20,203) 38.1
Admission from ED 703,641 (26,155) 50.0 261,223 (28,708) 47.1
Discharge status
Routine 1,296,638 (46,012) 92.1 519,785 (42,613) 93.8 <0.01
Transfer to another hospital or healthcare facility 56,115 (1,922) 4.0 13,035 (1,437) 2.4
Discharge against medical advice 2,792 (181) 0.2 382 (70) 0.1
Other 52,276 (4,223) 3.7 21,256 (4,501) 3.8

The most common pediatric medical, mental health, and surgical conditions are shown in Figure 1, together representing 32% of pediatric hospitalizations during the study period. For these medical conditions, 77.9% of hospitalizations occurred at GHs, ranging from 52.6% of chemotherapy hospitalizations to 89.0% of hospitalizations for neonatal hyperbilirubinemia. Sixty‐two percent of total hospital costs for these conditions were incurred at GHs. For the common mental health hospitalizations, 86% of hospitalizations occurred at GHs. The majority of hospitalizations and aggregate hospital costs for common surgical conditions also occurred at GHs.

Figure 1
Share of national pediatric hospitalizations and aggregate costs in general and freestanding children's hospitals, by condition, for common medical, mental health and surgical diagnoses. (n = national estimates of number of hospitalizations and associated total hospital costs at general hospitals and children's hospitals).

Whereas pneumonia, asthma, and bronchiolitis were the most common reasons for hospitalization at both GHs and FCHs, the most costly conditions differed (see Supporting Table 1 in the online version of this article). At GHs, these respiratory diseases were responsible for the highest condition‐specific total hospital costs. At FCHs, the highest aggregate costs were due to respiratory distress syndrome and chemotherapy. Congenital heart diseases, including hypoplastic left heart syndrome, transposition of the great vessels, tetralogy of Fallot, endocardial cushion defects, coarctation of the aorta and ventricular septal defects accounted for 6 of the 20 most costly conditions at FCHs.

Figure 2 illustrates the volume of hospitalizations, per hospital, at GHs and FCHs for the most common medical hospitalizations. The median number of hospitalizations, per hospital, was consistently significantly lower at GHs than at FCHs (all P values <0.001). Similar results for surgical and mental health hospitalizations are shown as Supporting Figures 1 and 2 in the online version of this article. In our sensitivity analyses that included all hospitals classified as GH and FCH, all results were essentially unchanged.

Figure 2
Box and whisker plots illustrating median volume of hospitalizations per hospital and associated interquartile range for common medical condition at general hospitals and freestanding children's hospitals (n = number of hospitals represented).

Recognizing the wide range of pediatric volumes at GHs (Table 1) and our inability to differentiate children's hospitals nested within GHs from GHs with pediatric beds, we examined differences in patient and hospitalization characteristics at GHs with volumes 5838 hospitalizations (the 25th percentile for FCH volume) and GHs with pediatric volumes <5838/year (see Supporting Table 2 in the online version of this article). We also compared patient and hospitalization characteristics at FCHs and the higher‐volume GHs. A total of 36 GHs had pediatric volumes 5838, with hospitalizations at these sites together accounting for 15.4% of all pediatric hospitalizations. Characteristics of patients hospitalized at these higher‐volume GHs were similar to patients hospitalized at FCHs, but they had significantly lower disease severity, fewer neonatal hospitalizations, shorter LOS, and more high‐turnover hospitalizations than patients hospitalized at FCHs. We also observed several differences between children hospitalized at higher‐ and lower‐volume GHs (see Supporting Table 2 in the online version of this article). Children hospitalized at the lower‐volume GHs were more likely to have public health insurance and less likely to have complex chronic diseases, although overall, 39.0% of all hospitalizations for children with complex chronic diseases occurred at these lower‐volume GHs. Compared to children hospitalized at higher‐volume GHs, children hospitalized at the lower‐volume hospitals had significantly lower disease severity, shorter LOS, more direct admissions, and a greater proportion of routine discharges.

DISCUSSION

Of the 2 million pediatric hospitalizations in the United States in 2012, more than 70% occurred at GHs. We observed considerable heterogeneity in pediatric volumes across GHs, with 11% of pediatric hospitalizations occurring at hospitals with pediatric volumes of <375 hospitalizations annually, whereas 15% of pediatric hospitalizations occurred at GHs with volumes similar to those observed at FCHs. The remaining pediatric hospitalizations at GHs occurred at centers with intermediate volumes. The most common reasons for hospitalization were similar at GHs and FCHs, but the most costly conditions differed substantially. These findings have important implications for pediatric clinical care programs, research, and QI efforts.

Our finding that more than 70% of pediatric hospitalizations occurred at GHs speaks to the importance of quality measurement at these hospitals, whereas low per‐hospital pediatric volumes at the majority of GHs makes such measurement particularly challenging. Several previous studies have illustrated that volumes of pediatric hospitalizations are too small to detect meaningful differences in quality between hospitals using established condition‐specific metrics.[13, 14, 15] Our finding that more than 10% of pediatric hospitalizations occurred at GHs with pediatric volumes <375 year supports previous research suggesting that cross‐cutting, all‐condition quality metrics, composite measures, and/or multihospital reporting networks may be needed to enable quality measurement at these sites. In addition, the heterogeneity in patient volumes and characteristics across GHs raise questions about the applicability of quality metrics developed and validated at FCHs to the many GH settings. Field‐testing quality measures to ensure their validity at diverse GHs, particularly those with patient volumes and infrastructure different from FCHs, will be important to meaningful pediatric quality measurement.

Our results illustrating differences in the most common and costly conditions at GHs and FCHs have further implications for prioritization and implementation of research and QI efforts. Implementation research and QI efforts focused on cardiac and neurosurgical procedures, as well as neonatal intensive care, may have considerable impact on cost and quality at FCHs. At GHs, research and QI efforts focused on common conditions are needed to increase our knowledge of contextually relevant barriers to and facilitators of high‐quality pediatric care. This, however, can be made more difficult by small sample sizes, limited resources, and infrastructure, and competing priorities in adult‐focused GH settings.[16, 17, 18] Multihospital learning collaboratives and partnerships between FCHs and GHs can begin to address these challenges, but their success is contingent upon national advocacy and funding to support pediatric research and quality measures at GHs.

One of the most notable differences in the characteristics of pediatric hospitalizations at GHs and FCHs was the proportion of hospitalizations attributable to children with medical complexity (CMC); more than one‐third of hospitalizations at FCHs were for CMC compared to 1 in 5 at GHs. These findings align with the results of several previous studies describing the substantial resource utilization attributed to CMC, and with growing research, innovation, and quality metrics focused on improving both inpatient and outpatient care for these vulnerable children.[19, 20, 21, 22] Structured complex care programs, developed to improve care coordination and healthcare quality for CMC, are common at FCHs, and have been associated with decreased resource utilization and improved outcomes.[23, 24, 25] Notably, however, more than half of all hospitalizations for CMC, exceeding 250,000 annually, occurred at GHs, and almost 40% of hospitalizations for CMC occurred at the lower‐volume GHs. These findings speak to the importance of translating effective and innovative programs of care for CMC to GHs as resources allow, accompanied by robust evaluations of their effectiveness. Lower patient volume at most GHs, however, may be a barrier to dedicated CMC programs. As a result, decentralized community‐based programs of care for CMC, linking primary care programs with regional and tertiary care hospitals, warrant further consideration.[26, 27, 28]

This analysis should be interpreted in light of several limitations. First, we were unable to distinguish between GHs with scant pediatric‐specific resources from those with a large volume of dedicated pediatric resources, such as children's hospitals nested within GHs. We did identify 36 GHs with pediatric volumes similar to those observed at FCHs (see Supporting Table 2 in the online version of this article); patient and hospitalization characteristics at these higher‐volume GHs were similar in many ways to children hospitalized at FCHs. Several of these higher‐volume GHs may have considerable resources dedicated to the care of children, including subspecialty care, and may represent children's hospitals nested within GHs. Because nested children's hospitals are included in the GH categorization, our results may have underestimated the proportion of children cared for at children's hospitals. Further work is needed to identify the health systems challenges and opportunities that may be unique to these institutions. Second, because the 2012 KID does not include a specialty hospital indicator, we developed a proxy method for identifying these hospitals, which may have resulted in some misclassification. We are reassured that the results of our analyses did not change substantively when we included all hospitals. Similarly, although we are reassured that the number of hospitals classified in our analysis as acute care FCHs aligns, approximately, with the number of hospitals classified as such by the Children's Hospital Association, we were unable to assess the validity of this variable within the KID. Third, the KID does not link records at the patient level, so we are unable to report the number of unique children included in this analysis. In addition, the KID includes only inpatient stays with exclusion of observation status stays; potential differences between GH and FCH in the use of observation status could have biased our findings. Fifth, we used the PMCA to identify CMC; although this algorithm has been shown to have excellent sensitivity in identifying children with chronic diseases, using up to 3 years of Medicaid claims data, the sensitivity using the KID, where only 1 inpatient stay is available for assessment, is unknown.[8, 29] Similarly, use of Keren's pediatric diagnosis grouper to classify reasons for hospitalization may have resulted in misclassification, though there are few other nonproprietary pediatric‐specific diagnostic groupers available.

In 2012, more than 70% of pediatric hospitalizations occurred at GHs in the United States. The considerably higher pediatric volumes at FCHs makes these institutions well suited for research, innovation, and the development and application of disease‐specific QI initiatives. Recognizing that the majority of pediatric hospitalizations occurred at GHs, there is a clear need for implementation research, program development, and quality metrics that align with the characteristics of hospitalizations at these centers. National support for research and quality improvement that reflects the diverse hospital settings where children receive their hospital care is critical to further our nation's goal of improving hospital quality for children.

Disclosures

Dr. Leyenaar was supported by grant number K08HS024133 from the Agency for Healthcare Research and Quality. The content is solely the responsibility of the authors and does not necessarily represent the official views of the Agency for Healthcare Research and Quality. The authors have no conflicts of interest relevant to this article to disclose.

Files
References
  1. Davis K, Stremikis K, Squires D, Schoen C. Mirror, Mirror on the wall: how the performance of the US health care system compares internationally. The Commonwealth Fund. Available at: http://www.commonwealthfund.org/publications/fund‐reports/2014/jun/mirror‐mirror. Published June 16, 2014. Accessed August 26, 2015.
  2. Fairbrother G, Guttmann A, Klein JD, Simpson LA, Thomas P, Kempe A. Higher cost, but poorer outcomes: the US health disadvantage and implications for pediatrics. Pediatrics. 2015;135(6):961964.
  3. Lassman D, Hartman M, Washington B, Andrews K, Catlin A. US health spending trends by age and gender: selected years 2002–10. Health Aff (Millwood). 2014;33(5):815822.
  4. Moore B, Levit K, Elixhauser A. Costs for hospital stays in the United States, 2012. Healthcare Cost and Utilization Project 181. Available at: http://www.hcup‐us.ahrq.gov/reports/statbriefs/sb181‐Hospital‐Costs‐United‐States‐2012.pdf. Published October 2014. Accessed September 2015.
  5. Averill RF, Goldfield N, Hughes JS, et al. All Patient Refined Diagnosis Related Groups: Methodology Overview. 3M Health Information Systems. Available at: https://www.hcup‐us.ahrq.gov/db/nation/nis/APR‐DRGsV20MethodologyOverviewandBibliography.pdf. Accessed February 8, 2016.
  6. Agency for Healthcare Research and Quality. Healthcare Cost and Utilization Project. Introduction to the HCUP Kids' Inpatient Database (KID) 2012. Available at: https://www.hcup‐us.ahrq.gov/db/nation/kid/kid_2012_introduction.jsp. Published Issued July 2014. Accessed February 8, 2016.
  7. Keren R. Prioritization of comparative effectiveness research topics in hospital pediatrics. Arch Pediatr Adolesc Med. 2012;166(12):1155.
  8. Simon TD, Cawthon ML, Stanford S, et al. Pediatric medical complexity algorithm: a new method to stratify children by medical complexity. Pediatrics. 2014;133(6):e1647e1654.
  9. Averill RF, Goldfield N, Hughes JS, et al. 3M APR DRG Classification System. 3M Health Information Systems. Available at: http://www.hcup‐us.ahrq.gov/db/nation/nis/v261_aprdrg_meth_ovrview.pdf. Accessed August 7, 2015.
  10. Macy ML, Stanley RM, Lozon MM, Sasson C, Gebremariam A, Davis MM. Trends in high‐turnover stays among children hospitalized in the United States, 1993–2003. Pediatrics. 2009;123(3):9961002.
  11. Macy ML, Stanley RM, Sasson C, Gebremariam A DM. High turnover stays for pediatric asthma in the United States. Med Care. 2010;48(9):827833.
  12. Leyenaar JK, Shieh M, Lagu T, Pekow PS, Lindenauer PK. Variation and outcomes associated with direct admission among children with pneumonia in the United States. JAMA Pediatr. 2014;168(9):829836.
  13. Berry JG, Zaslavsky AM, Toomey SL, et al. Recognizing differences in hospital quality performance for pediatric inpatient care. Pediatrics. 2015;136(2):251262.
  14. Bardach NS, Chien AT, Dudley RA. Small numbers limit the use of the inpatient pediatric quality indicators for hospital comparison. Acad Pediatr. 2010;10(4):266273.
  15. Feudtner C, Berry JG, Parry G, et al. Statistical uncertainty of mortality rates and rankings for children's hospitals. Pediatrics. 2011;128(4):e966e972.
  16. Leyenaar JK, Capra LA, O'Brien ER, Leslie LK, Mackie TI. Determinants of career satisfaction among pediatric hospitalists: a qualitative exploration. Acad Pediatr. 2014;14(4):361368.
  17. Simon TD, Starmer AJ, Conway PH, et al. Quality improvement research in pediatric hospital medicine and the role of the Pediatric Research in Inpatient Settings (PRIS) network. Acad Pediatr. 2013;13(6 suppl):S54S60.
  18. Miller M. Roles for children's hospitals in pediatric collaborative improvement networks. Pediatrics. 2013;131(suppl 4):S215S218.
  19. Cohen E, Kuo DZ, Agrawal R, et al. Children with medical complexity: an emerging population for clinical and research initiatives. Pediatrics. 2011;127(3):529538.
  20. Simon TD, Berry J, Feudtner C, et al. Children with complex chronic conditions in inpatient hospital settings in the United States. Pediatrics. 2010;126(4):647655.
  21. Cohen E, Berry JG, Camacho X, Anderson G, Wodchis W, Guttmann A. Patterns and costs of health care use of children with medical complexity. Pediatrics. 2012;130(6):e1463e1470.
  22. Berry JG, Hall DE, Kuo DZ, Hall M, Kueser J, Kaplan W. Hospital utilization and characteristics of patients experiencing recurrent readmissions within children's hospitals. JAMA. 2011;305(7):682690.
  23. Berry JG, Agrawal R, Kuo DZ, et al. Characteristics of hospitalizations for patients who use a structured clinical care program for children with medical complexity. J Pediatr. 2011;159(2):284290.
  24. Cohen E, Jovcevska V, Kuo D, Mahant S. Hospital‐based comprehensive care programs for children with special health care needs: a systematic review. Arch Pediatr Adolesc Med. 2011;165(6):554561.
  25. Gordon J, Colby H, Bartelt T, Jablonski D, Krauthoefer ML, Havens P. A tertiary care–primary care partnership model for medically complex and fragile children and youth with special health care needs. Arch Pediatr Adolesc Med. 2007;161(10):937944.
  26. Cohen E, Lacombe‐Duncan A, Spalding K, et al. Integrated complex care coordination for children with medical complexity: a mixed‐methods evaluation of tertiary care‐community collaboration. BMC Health Serv Res. 2012;12:366.
  27. Lerner CF, Kelly RB, Hamilton LJ, Klitzner TS. Medical transport of children with complex chronic conditions. Emerg Med Int. 2012;2012:837020.
  28. Stiles AD, Tayloe DT, Wegner SE. Comanagement of medically complex children by subspecialists, generalists, and care coordinators. Pediatrics. 2014;134(2):203205.
  29. Berry JG, Hall M, Cohen E, O'Neill M, Feudtner C. Ways to identify children with medical complexity and the importance of why. J Pediatr. 2015;167(2):229237.
Article PDF
Issue
Journal of Hospital Medicine - 11(11)
Page Number
743-749
Sections
Files
Files
Article PDF
Article PDF

Improvement in the quality of hospital care in the United States is a national priority, both to advance patient safety and because our expenditures exceed any other nation's, but our health outcomes lag behind.[1, 2] Healthcare spending for children is growing at a faster rate than any other age group, with hospital care accounting for more than 40% of pediatric healthcare expenditures.[3] Inpatient healthcare comprises a greater proportion of healthcare costs for children than for adults, yet we have limited knowledge about where this care is provided.[4]

There is substantial variability in the settings in which children are hospitalized. Children may be hospitalized in freestanding children's hospitals, where all services are designed for children and which operate independently of adult‐focused institutions. They may also be hospitalized in general hospitals where care may be provided in a general inpatient bed, on a dedicated pediatric ward, or in a children's hospital nested within a hospital, which may have specialized nursing and physician care but often shares other resources such as laboratory and radiology with the primarily adult‐focused institution. Medical students and residents may be trained in all of these settings. We know little about how these hospital types differ with respect to patient populations, disease volumes, and resource utilization, and this knowledge is important to inform clinical programs, implementation research, and quality improvement (QI) priorities. To this end, we aimed to describe the volume and characteristics of pediatric hospitalizations at acute care general hospitals and freestanding children's hospitals in the United States.

METHODS

Study Design and Eligibility

The data source for this analysis was the Healthcare Cost and Utilization Project's (HCUP) 2012 Kids' Inpatient Database (KID). We conducted a cross‐sectional study of hospitalizations in children and adolescents less than 18 years of age, excluding in‐hospital births and hospitalizations for pregnancy and delivery (identified using All Patient Refined‐Diagnostic Related Groups [APR‐DRGs]).[5] Neonatal hospitalizations not representing in‐hospital births but resulting from transfers or new admissions were retained. Because the dataset does not contain identifiable information, the institutional review board at Baystate Medical Center determined that our study did not constitute human subjects research.

The KID is released every 3 years and is the only publicly available, nationally representative database developed to study pediatric hospitalizations, including an 80% sample of noninborn pediatric discharges from all community, nonrehabilitation hospitals from 44 participating states.[6] Short‐term rehabilitation hospitals, long‐term nonacute care hospitals, psychiatric hospitals, and alcoholism/chemical dependency treatment facilities are excluded. The KID contains information on all patients, regardless of payer, and provides discharge weights to calculate national estimates.[6] It contains both hospital‐level and patient‐level variables, including demographic characteristics, charges, and other clinical and resource use data available from discharge abstracts. Beginning in 2012, freestanding children's hospitals (FCHs) are assigned to a separate stratum in the KID, with data from the Children's Hospital Association used by HCUP to verify the American Hospital Association's (AHA) list of FCHs.[6] Hospitals that are not FCHs were categorized as general hospitals (GHs). We were interested in examining patterns of care at acute care hospitals and not specialty hospitals; unlike previous years, the KID 2012 does not include a specialty hospital identifier.[6] Therefore, as a proxy for specialty hospital status, we excluded hospitals that had 2% hospitalizations for 12 common medical conditions (pneumonia, asthma, bronchiolitis, cellulitis, dehydration, urinary tract infection, neonatal hyperbilirubinemia, fever, upper respiratory infection, infectious gastroenteritis, unspecified viral infection, and croup). These medical conditions were the 12 most common reasons for medical hospitalizations identified using Keren's pediatric diagnosis code grouper,[7] excluding chronic diseases, and represented 26.2% of all pediatric hospitalizations. This 2% threshold was developed empirically, based on visual analysis of the distribution of cases across hospitals and was limited to hospitals with total pediatric volumes >25/year, allowing for stable case‐mix estimates.

Descriptor Variables

Hospital level characteristics included US Census region; teaching status classified in the KID based on results of the AHA Annual Survey; urban/rural location; hospital ownership, classified as public, private nonprofit and private investor‐owned; and total volume of pediatric hospitalizations, in deciles.[6] At the patient level, we examined age, gender, race/ethnicity, expected primary payer, and median household income (in quartiles) for patient's zip code. Medical complexity was categorized as (1) nonchronic disease, (2) complex chronic disease, or (3) noncomplex chronic disease, using the previously validated Pediatric Medical Complexity Algorithm (PMCA) based on International Classification of Diseases, 9th Revision, Clinical Modification (ICD‐9‐CM) codes.[8] Disease severity was classified based on APR‐DRG severity of illness coding, which classifies illnesses severity as minor, moderate, major, or extreme.[9]

We examined the following characteristics of the hospitalizations: (1) length of hospital stay (LOS) measured in calendar days; (2) high‐turnover hospitalization defined as LOS less than 2 days[10, 11, 12]; (3) long LOS, defined as greater than 4 days, equivalent to LOS greater than the 75th percentile; (4) neonatal versus non‐neonatal hospitalization, identified using APR‐DRGs; (5) admission type categorized as elective and nonelective; (6) admission source, categorized as transfer from another acute care hospital, admission from the emergency department, or direct admission; (7) discharge status, categorized as routine discharge, transfer to another hospital or healthcare facility, and discharge against medical advice; and (8) total hospital costs, calculated by applying the cost‐to‐charge ratios available in the KID to total hospital charges.

Reasons for hospitalization were categorized using the pediatric diagnosis code grouper by Keren, which uses ICD‐9‐CM codes to group common and costly principal diagnoses into distinct conditions (eg, pneumonia, idiopathic scoliosis), excluding children who have ICD‐9‐CM principal procedure codes unlikely related to their principal diagnosis (for example, appendectomy for a child with a principal diagnosis of pneumonia).[7] This pediatric grouper classifies diagnoses as medical, surgical, or medical‐surgical based on whether <20% (medical), >80% (surgical) or between 20% and 80% (medical‐surgical) of encounters for the condition had an ICD‐9‐CM principal procedure code for a surgery related to that condition. We further characterized medical hospitalizations as either medical or mental health hospitalizations.

Statistical Analysis

We categorized each discharge record as a hospitalization at a GH or an FCH. We then calculated patient‐level summary statistics, applying weights to calculate national estimates with an associated standard deviation (SD). We assessed differences in characteristics of hospitalizations at GHs and FCHs using Rao‐Scott 2 tests for categorical variables and Wald F tests for continuous variables.[6] We identified the most common reasons for hospitalization, including those responsible for at least 2% of all medical or surgical hospitalizations and at least 0.5% of medical hospitalizations for mental health diagnoses, given the lower prevalence of these conditions and our desire to include mental health diagnoses in our analysis. For these common conditions, we calculated the proportion of condition‐specific hospitalizations and aggregate hospital costs at GHs and FCHs. We also determined the number of hospitalizations at each hospital and calculated the median and interquartile range for the number of hospitalizations for each of these conditions according to hospital type, assessing for differences using Kruskal‐Wallis tests. Finally, we identified the most common and costly conditions at GHs and FCHs by ranking frequency and aggregate costs for each condition according to hospital type, limited to the 20 most costly and/or prevalent pediatric diagnoses. Because we used a novel method to identify specialty hospitals in this dataset, we repeated these analyses using all hospitals classified as a GH and FCH as a sensitivity analysis.

RESULTS

Overall, 3866 hospitals were categorized as a GH, whereas 70 hospitals were categorized as FCHs. Following exclusion of specialty hospitals, 3758 GHs and 50 FCHs were retained in this study. The geographic distribution of hospitals was similar, but although GHs included those in both urban and rural regions, all FCHs were located in urban regions (Table 1).

Characteristics of General Hospitals and Freestanding Children's Hospitals
General Hospitals, n = 3,758 Children's Hospitals, n = 50
Hospital characteristics n % n % P Value
  • NOTE: Abbreviations: IQR, interquartile range.

Geographic region
Northeast 458 12.2 4 8.0 0.50
Midwest 1,209 32.2 15 30.0
South 1,335 35.6 17 34.0
West 753 20.1 14 28.0
Location and teaching status
Rural 1,524 40.6 0 0 <0.0001
Urban nonteaching 1,506 40.1 7 14.0
Urban teaching 725 19.3 43 86.0
Hospital ownership
Government, nonfederal 741 19.7 0 0 <0.0001
Private, nonprofit 2,364 63.0 48 96.0
Private, investor‐owned 650 17.3 2 4.0
Volume of pediatric hospitalizations (deciles)
<185 hospitalizations/year (<8th decile) 2,664 71.0 0 0 <0.0001
186375 hospitalizations/year (8th decile) 378 10.1 2 4.0
376996 hospitalizations/year (9th decile) 380 10.1 1 2.0
>986 hospitalizations/year (10th decile) 333 8.9 47 94.0
Volume of pediatric hospitalizations, median [IQR] 56 [14240] 12,001 [5,83815,448] <0.0001

A total of 1,407,822 (SD 50,456) hospitalizations occurred at GHs, representing 71.7% of pediatric hospitalizations, whereas 554,458 (SD 45,046) hospitalizations occurred at FCHs. Hospitalizations at GHs accounted for 63.6% of days in hospital and 50.0% of pediatric inpatient healthcare costs. Eighty percent of the GHs had total pediatric patient volumes of less than 375 hospitalizations yearly; 11.1% of pediatric hospitalizations occurred at these lower‐volume centers. At FCHs, the median volume of pediatric hospitalizations was 12,001 (interquartile range [IQR]: 583815,448). A total of 36 GHs had pediatric hospitalization volumes in this IQR.

The median age for pediatric patients was slightly higher at GHs, whereas gender, race/ethnicity, primary payer, and median household income for zip code did not differ significantly between hospital types (Table 2). Medical complexity differed between hospital types: children with complex chronic diseases represented 20.2% of hospitalizations at GHs and 35.6% of hospitalizations at FCHs. Severity of illness differed between hospital types, with fewer hospitalizations categorized at the highest level of severity at GHs than FCHs. There were no significant differences between hospital types with respect to the proportion of hospitalizations categorized as neonatal hospitalizations or as elective hospitalizations. The median LOS was shorter at GHs than FCHs. Approximately 1 in 5 children hospitalized at GHs had LOS greater than 4 days, whereas almost 30% of children hospitalized at FCHs had LOS of this duration.

Patient Characteristics and Characteristics of Hospitalizations at General Hospitals and Freestanding Children's Hospitals
Patient Characteristics

General Hospitals,1,407,822 (50,456), 71.7%

Children's Hospitals,554,458 (45,046), 28.3%

P Value
n (SD Weighted Frequency) (%) n (SD Weighted Frequency) %
  • NOTE: Abbreviations: APR‐DRG, All Patient Refined Diagnosis‐Related Group; ED, emergency department; IQR, interquartile range; SD, standard deviation. *Race/ethnicity data missing for approximately 8% of discharge records.[8] Includes in‐hospital death, discharge destination unknown.

Age, y, median [IQR] 3.6 [011.7] 3.4 [010.8] 0.001
Gender (% female) 644,250 (23,089) 45.8 254,505 (20,688) 45.9 0.50
Race*
White 668,876 (27,741) 47.5 233,930 (26,349) 42.2 0.05
Black 231,586 (12,890) 16.5 80,568 (11,739) 14.5
Hispanic 279,021 (16,843) 19.8 12,1425 (21,183) 21.9
Other 133,062 (8,572) 9.5 41,190 (6,394) 7.4
Insurance status
Public 740,033 (28,675) 52.6 284,795 (25,324) 51.4 0.90
Private 563,562 (21,930) 40.0 224,042 (21,613) 40.4
Uninsured 37,265 (1,445) 2.7 16,355 (3,804) 3.0
No charge/other/unknown 66,962 (5,807) 4.8 29,266 (6,789) 5.3
Median household income for zip code, quartiles
<$38,999 457,139 (19,725) 33.3 164,831 (17,016) 30.1 0.07
$39,000$47,999 347,229 (14,104) 25.3 125,105 (10,712) 22.9
$48,000$62,999 304,795 (13,427) 22.2 134,915 (13,999) 24.7
>$63,000 263,171 (15,418) 19.2 122,164 (16,279) 22.3
Medical complexity
Nonchronic disease 717,009 (21,807) 50.9 211,089 (17,023) 38.1 <0.001
Noncomplex chronic disease 406,070 (14,951) 28.8 146,077 (12,442) 26.4
Complex chronic disease 284,742 (17,111) 20.2 197,292 (18,236) 35.6
APR‐DRG severity of illness
1 (lowest severity) 730,134 (23,162) 51.9 217,202 (18,433) 39.2 <0.001
2 486,748 (18,395) 34.6 202,931 (16,864) 36.6
3 146,921 (8,432) 10.4 100,566 (9,041) 18.1
4 (highest severity) 41,749 (3,002) 3.0 33,340 (3,199) 6.0
Hospitalization characteristics
Neonatal hospitalization 98,512 (3,336) 7.0 39,584 (4,274) 7.1 0.84
Admission type
Elective 255,774 (12,285) 18.3 109,854 (13,061) 19.8 0.05
Length of stay, d, (median [IQR]) 1.8 (0.01) [0.8‐3.6] 2.2 (0.06) [1.1‐4.7] <0.001
High turnover hospitalizations 416,790 (14,995) 29.6 130,441 (12,405) 23.5 <0.001
Length of stay >4 days 298,315 (14,421) 21.2 161,804 (14,354) 29.2 <0.001
Admission source
Transfer from another acute care hospital 154,058 (10,067) 10.9 82,118 (8,952) 14.8 0.05
Direct admission 550,123 (21,954) 39.1 211,117 (20,203) 38.1
Admission from ED 703,641 (26,155) 50.0 261,223 (28,708) 47.1
Discharge status
Routine 1,296,638 (46,012) 92.1 519,785 (42,613) 93.8 <0.01
Transfer to another hospital or healthcare facility 56,115 (1,922) 4.0 13,035 (1,437) 2.4
Discharge against medical advice 2,792 (181) 0.2 382 (70) 0.1
Other 52,276 (4,223) 3.7 21,256 (4,501) 3.8

The most common pediatric medical, mental health, and surgical conditions are shown in Figure 1, together representing 32% of pediatric hospitalizations during the study period. For these medical conditions, 77.9% of hospitalizations occurred at GHs, ranging from 52.6% of chemotherapy hospitalizations to 89.0% of hospitalizations for neonatal hyperbilirubinemia. Sixty‐two percent of total hospital costs for these conditions were incurred at GHs. For the common mental health hospitalizations, 86% of hospitalizations occurred at GHs. The majority of hospitalizations and aggregate hospital costs for common surgical conditions also occurred at GHs.

Figure 1
Share of national pediatric hospitalizations and aggregate costs in general and freestanding children's hospitals, by condition, for common medical, mental health and surgical diagnoses. (n = national estimates of number of hospitalizations and associated total hospital costs at general hospitals and children's hospitals).

Whereas pneumonia, asthma, and bronchiolitis were the most common reasons for hospitalization at both GHs and FCHs, the most costly conditions differed (see Supporting Table 1 in the online version of this article). At GHs, these respiratory diseases were responsible for the highest condition‐specific total hospital costs. At FCHs, the highest aggregate costs were due to respiratory distress syndrome and chemotherapy. Congenital heart diseases, including hypoplastic left heart syndrome, transposition of the great vessels, tetralogy of Fallot, endocardial cushion defects, coarctation of the aorta and ventricular septal defects accounted for 6 of the 20 most costly conditions at FCHs.

Figure 2 illustrates the volume of hospitalizations, per hospital, at GHs and FCHs for the most common medical hospitalizations. The median number of hospitalizations, per hospital, was consistently significantly lower at GHs than at FCHs (all P values <0.001). Similar results for surgical and mental health hospitalizations are shown as Supporting Figures 1 and 2 in the online version of this article. In our sensitivity analyses that included all hospitals classified as GH and FCH, all results were essentially unchanged.

Figure 2
Box and whisker plots illustrating median volume of hospitalizations per hospital and associated interquartile range for common medical condition at general hospitals and freestanding children's hospitals (n = number of hospitals represented).

Recognizing the wide range of pediatric volumes at GHs (Table 1) and our inability to differentiate children's hospitals nested within GHs from GHs with pediatric beds, we examined differences in patient and hospitalization characteristics at GHs with volumes 5838 hospitalizations (the 25th percentile for FCH volume) and GHs with pediatric volumes <5838/year (see Supporting Table 2 in the online version of this article). We also compared patient and hospitalization characteristics at FCHs and the higher‐volume GHs. A total of 36 GHs had pediatric volumes 5838, with hospitalizations at these sites together accounting for 15.4% of all pediatric hospitalizations. Characteristics of patients hospitalized at these higher‐volume GHs were similar to patients hospitalized at FCHs, but they had significantly lower disease severity, fewer neonatal hospitalizations, shorter LOS, and more high‐turnover hospitalizations than patients hospitalized at FCHs. We also observed several differences between children hospitalized at higher‐ and lower‐volume GHs (see Supporting Table 2 in the online version of this article). Children hospitalized at the lower‐volume GHs were more likely to have public health insurance and less likely to have complex chronic diseases, although overall, 39.0% of all hospitalizations for children with complex chronic diseases occurred at these lower‐volume GHs. Compared to children hospitalized at higher‐volume GHs, children hospitalized at the lower‐volume hospitals had significantly lower disease severity, shorter LOS, more direct admissions, and a greater proportion of routine discharges.

DISCUSSION

Of the 2 million pediatric hospitalizations in the United States in 2012, more than 70% occurred at GHs. We observed considerable heterogeneity in pediatric volumes across GHs, with 11% of pediatric hospitalizations occurring at hospitals with pediatric volumes of <375 hospitalizations annually, whereas 15% of pediatric hospitalizations occurred at GHs with volumes similar to those observed at FCHs. The remaining pediatric hospitalizations at GHs occurred at centers with intermediate volumes. The most common reasons for hospitalization were similar at GHs and FCHs, but the most costly conditions differed substantially. These findings have important implications for pediatric clinical care programs, research, and QI efforts.

Our finding that more than 70% of pediatric hospitalizations occurred at GHs speaks to the importance of quality measurement at these hospitals, whereas low per‐hospital pediatric volumes at the majority of GHs makes such measurement particularly challenging. Several previous studies have illustrated that volumes of pediatric hospitalizations are too small to detect meaningful differences in quality between hospitals using established condition‐specific metrics.[13, 14, 15] Our finding that more than 10% of pediatric hospitalizations occurred at GHs with pediatric volumes <375 year supports previous research suggesting that cross‐cutting, all‐condition quality metrics, composite measures, and/or multihospital reporting networks may be needed to enable quality measurement at these sites. In addition, the heterogeneity in patient volumes and characteristics across GHs raise questions about the applicability of quality metrics developed and validated at FCHs to the many GH settings. Field‐testing quality measures to ensure their validity at diverse GHs, particularly those with patient volumes and infrastructure different from FCHs, will be important to meaningful pediatric quality measurement.

Our results illustrating differences in the most common and costly conditions at GHs and FCHs have further implications for prioritization and implementation of research and QI efforts. Implementation research and QI efforts focused on cardiac and neurosurgical procedures, as well as neonatal intensive care, may have considerable impact on cost and quality at FCHs. At GHs, research and QI efforts focused on common conditions are needed to increase our knowledge of contextually relevant barriers to and facilitators of high‐quality pediatric care. This, however, can be made more difficult by small sample sizes, limited resources, and infrastructure, and competing priorities in adult‐focused GH settings.[16, 17, 18] Multihospital learning collaboratives and partnerships between FCHs and GHs can begin to address these challenges, but their success is contingent upon national advocacy and funding to support pediatric research and quality measures at GHs.

One of the most notable differences in the characteristics of pediatric hospitalizations at GHs and FCHs was the proportion of hospitalizations attributable to children with medical complexity (CMC); more than one‐third of hospitalizations at FCHs were for CMC compared to 1 in 5 at GHs. These findings align with the results of several previous studies describing the substantial resource utilization attributed to CMC, and with growing research, innovation, and quality metrics focused on improving both inpatient and outpatient care for these vulnerable children.[19, 20, 21, 22] Structured complex care programs, developed to improve care coordination and healthcare quality for CMC, are common at FCHs, and have been associated with decreased resource utilization and improved outcomes.[23, 24, 25] Notably, however, more than half of all hospitalizations for CMC, exceeding 250,000 annually, occurred at GHs, and almost 40% of hospitalizations for CMC occurred at the lower‐volume GHs. These findings speak to the importance of translating effective and innovative programs of care for CMC to GHs as resources allow, accompanied by robust evaluations of their effectiveness. Lower patient volume at most GHs, however, may be a barrier to dedicated CMC programs. As a result, decentralized community‐based programs of care for CMC, linking primary care programs with regional and tertiary care hospitals, warrant further consideration.[26, 27, 28]

This analysis should be interpreted in light of several limitations. First, we were unable to distinguish between GHs with scant pediatric‐specific resources from those with a large volume of dedicated pediatric resources, such as children's hospitals nested within GHs. We did identify 36 GHs with pediatric volumes similar to those observed at FCHs (see Supporting Table 2 in the online version of this article); patient and hospitalization characteristics at these higher‐volume GHs were similar in many ways to children hospitalized at FCHs. Several of these higher‐volume GHs may have considerable resources dedicated to the care of children, including subspecialty care, and may represent children's hospitals nested within GHs. Because nested children's hospitals are included in the GH categorization, our results may have underestimated the proportion of children cared for at children's hospitals. Further work is needed to identify the health systems challenges and opportunities that may be unique to these institutions. Second, because the 2012 KID does not include a specialty hospital indicator, we developed a proxy method for identifying these hospitals, which may have resulted in some misclassification. We are reassured that the results of our analyses did not change substantively when we included all hospitals. Similarly, although we are reassured that the number of hospitals classified in our analysis as acute care FCHs aligns, approximately, with the number of hospitals classified as such by the Children's Hospital Association, we were unable to assess the validity of this variable within the KID. Third, the KID does not link records at the patient level, so we are unable to report the number of unique children included in this analysis. In addition, the KID includes only inpatient stays with exclusion of observation status stays; potential differences between GH and FCH in the use of observation status could have biased our findings. Fifth, we used the PMCA to identify CMC; although this algorithm has been shown to have excellent sensitivity in identifying children with chronic diseases, using up to 3 years of Medicaid claims data, the sensitivity using the KID, where only 1 inpatient stay is available for assessment, is unknown.[8, 29] Similarly, use of Keren's pediatric diagnosis grouper to classify reasons for hospitalization may have resulted in misclassification, though there are few other nonproprietary pediatric‐specific diagnostic groupers available.

In 2012, more than 70% of pediatric hospitalizations occurred at GHs in the United States. The considerably higher pediatric volumes at FCHs makes these institutions well suited for research, innovation, and the development and application of disease‐specific QI initiatives. Recognizing that the majority of pediatric hospitalizations occurred at GHs, there is a clear need for implementation research, program development, and quality metrics that align with the characteristics of hospitalizations at these centers. National support for research and quality improvement that reflects the diverse hospital settings where children receive their hospital care is critical to further our nation's goal of improving hospital quality for children.

Disclosures

Dr. Leyenaar was supported by grant number K08HS024133 from the Agency for Healthcare Research and Quality. The content is solely the responsibility of the authors and does not necessarily represent the official views of the Agency for Healthcare Research and Quality. The authors have no conflicts of interest relevant to this article to disclose.

Improvement in the quality of hospital care in the United States is a national priority, both to advance patient safety and because our expenditures exceed any other nation's, but our health outcomes lag behind.[1, 2] Healthcare spending for children is growing at a faster rate than any other age group, with hospital care accounting for more than 40% of pediatric healthcare expenditures.[3] Inpatient healthcare comprises a greater proportion of healthcare costs for children than for adults, yet we have limited knowledge about where this care is provided.[4]

There is substantial variability in the settings in which children are hospitalized. Children may be hospitalized in freestanding children's hospitals, where all services are designed for children and which operate independently of adult‐focused institutions. They may also be hospitalized in general hospitals where care may be provided in a general inpatient bed, on a dedicated pediatric ward, or in a children's hospital nested within a hospital, which may have specialized nursing and physician care but often shares other resources such as laboratory and radiology with the primarily adult‐focused institution. Medical students and residents may be trained in all of these settings. We know little about how these hospital types differ with respect to patient populations, disease volumes, and resource utilization, and this knowledge is important to inform clinical programs, implementation research, and quality improvement (QI) priorities. To this end, we aimed to describe the volume and characteristics of pediatric hospitalizations at acute care general hospitals and freestanding children's hospitals in the United States.

METHODS

Study Design and Eligibility

The data source for this analysis was the Healthcare Cost and Utilization Project's (HCUP) 2012 Kids' Inpatient Database (KID). We conducted a cross‐sectional study of hospitalizations in children and adolescents less than 18 years of age, excluding in‐hospital births and hospitalizations for pregnancy and delivery (identified using All Patient Refined‐Diagnostic Related Groups [APR‐DRGs]).[5] Neonatal hospitalizations not representing in‐hospital births but resulting from transfers or new admissions were retained. Because the dataset does not contain identifiable information, the institutional review board at Baystate Medical Center determined that our study did not constitute human subjects research.

The KID is released every 3 years and is the only publicly available, nationally representative database developed to study pediatric hospitalizations, including an 80% sample of noninborn pediatric discharges from all community, nonrehabilitation hospitals from 44 participating states.[6] Short‐term rehabilitation hospitals, long‐term nonacute care hospitals, psychiatric hospitals, and alcoholism/chemical dependency treatment facilities are excluded. The KID contains information on all patients, regardless of payer, and provides discharge weights to calculate national estimates.[6] It contains both hospital‐level and patient‐level variables, including demographic characteristics, charges, and other clinical and resource use data available from discharge abstracts. Beginning in 2012, freestanding children's hospitals (FCHs) are assigned to a separate stratum in the KID, with data from the Children's Hospital Association used by HCUP to verify the American Hospital Association's (AHA) list of FCHs.[6] Hospitals that are not FCHs were categorized as general hospitals (GHs). We were interested in examining patterns of care at acute care hospitals and not specialty hospitals; unlike previous years, the KID 2012 does not include a specialty hospital identifier.[6] Therefore, as a proxy for specialty hospital status, we excluded hospitals that had 2% hospitalizations for 12 common medical conditions (pneumonia, asthma, bronchiolitis, cellulitis, dehydration, urinary tract infection, neonatal hyperbilirubinemia, fever, upper respiratory infection, infectious gastroenteritis, unspecified viral infection, and croup). These medical conditions were the 12 most common reasons for medical hospitalizations identified using Keren's pediatric diagnosis code grouper,[7] excluding chronic diseases, and represented 26.2% of all pediatric hospitalizations. This 2% threshold was developed empirically, based on visual analysis of the distribution of cases across hospitals and was limited to hospitals with total pediatric volumes >25/year, allowing for stable case‐mix estimates.

Descriptor Variables

Hospital level characteristics included US Census region; teaching status classified in the KID based on results of the AHA Annual Survey; urban/rural location; hospital ownership, classified as public, private nonprofit and private investor‐owned; and total volume of pediatric hospitalizations, in deciles.[6] At the patient level, we examined age, gender, race/ethnicity, expected primary payer, and median household income (in quartiles) for patient's zip code. Medical complexity was categorized as (1) nonchronic disease, (2) complex chronic disease, or (3) noncomplex chronic disease, using the previously validated Pediatric Medical Complexity Algorithm (PMCA) based on International Classification of Diseases, 9th Revision, Clinical Modification (ICD‐9‐CM) codes.[8] Disease severity was classified based on APR‐DRG severity of illness coding, which classifies illnesses severity as minor, moderate, major, or extreme.[9]

We examined the following characteristics of the hospitalizations: (1) length of hospital stay (LOS) measured in calendar days; (2) high‐turnover hospitalization defined as LOS less than 2 days[10, 11, 12]; (3) long LOS, defined as greater than 4 days, equivalent to LOS greater than the 75th percentile; (4) neonatal versus non‐neonatal hospitalization, identified using APR‐DRGs; (5) admission type categorized as elective and nonelective; (6) admission source, categorized as transfer from another acute care hospital, admission from the emergency department, or direct admission; (7) discharge status, categorized as routine discharge, transfer to another hospital or healthcare facility, and discharge against medical advice; and (8) total hospital costs, calculated by applying the cost‐to‐charge ratios available in the KID to total hospital charges.

Reasons for hospitalization were categorized using the pediatric diagnosis code grouper by Keren, which uses ICD‐9‐CM codes to group common and costly principal diagnoses into distinct conditions (eg, pneumonia, idiopathic scoliosis), excluding children who have ICD‐9‐CM principal procedure codes unlikely related to their principal diagnosis (for example, appendectomy for a child with a principal diagnosis of pneumonia).[7] This pediatric grouper classifies diagnoses as medical, surgical, or medical‐surgical based on whether <20% (medical), >80% (surgical) or between 20% and 80% (medical‐surgical) of encounters for the condition had an ICD‐9‐CM principal procedure code for a surgery related to that condition. We further characterized medical hospitalizations as either medical or mental health hospitalizations.

Statistical Analysis

We categorized each discharge record as a hospitalization at a GH or an FCH. We then calculated patient‐level summary statistics, applying weights to calculate national estimates with an associated standard deviation (SD). We assessed differences in characteristics of hospitalizations at GHs and FCHs using Rao‐Scott 2 tests for categorical variables and Wald F tests for continuous variables.[6] We identified the most common reasons for hospitalization, including those responsible for at least 2% of all medical or surgical hospitalizations and at least 0.5% of medical hospitalizations for mental health diagnoses, given the lower prevalence of these conditions and our desire to include mental health diagnoses in our analysis. For these common conditions, we calculated the proportion of condition‐specific hospitalizations and aggregate hospital costs at GHs and FCHs. We also determined the number of hospitalizations at each hospital and calculated the median and interquartile range for the number of hospitalizations for each of these conditions according to hospital type, assessing for differences using Kruskal‐Wallis tests. Finally, we identified the most common and costly conditions at GHs and FCHs by ranking frequency and aggregate costs for each condition according to hospital type, limited to the 20 most costly and/or prevalent pediatric diagnoses. Because we used a novel method to identify specialty hospitals in this dataset, we repeated these analyses using all hospitals classified as a GH and FCH as a sensitivity analysis.

RESULTS

Overall, 3866 hospitals were categorized as a GH, whereas 70 hospitals were categorized as FCHs. Following exclusion of specialty hospitals, 3758 GHs and 50 FCHs were retained in this study. The geographic distribution of hospitals was similar, but although GHs included those in both urban and rural regions, all FCHs were located in urban regions (Table 1).

Characteristics of General Hospitals and Freestanding Children's Hospitals
General Hospitals, n = 3,758 Children's Hospitals, n = 50
Hospital characteristics n % n % P Value
  • NOTE: Abbreviations: IQR, interquartile range.

Geographic region
Northeast 458 12.2 4 8.0 0.50
Midwest 1,209 32.2 15 30.0
South 1,335 35.6 17 34.0
West 753 20.1 14 28.0
Location and teaching status
Rural 1,524 40.6 0 0 <0.0001
Urban nonteaching 1,506 40.1 7 14.0
Urban teaching 725 19.3 43 86.0
Hospital ownership
Government, nonfederal 741 19.7 0 0 <0.0001
Private, nonprofit 2,364 63.0 48 96.0
Private, investor‐owned 650 17.3 2 4.0
Volume of pediatric hospitalizations (deciles)
<185 hospitalizations/year (<8th decile) 2,664 71.0 0 0 <0.0001
186375 hospitalizations/year (8th decile) 378 10.1 2 4.0
376996 hospitalizations/year (9th decile) 380 10.1 1 2.0
>986 hospitalizations/year (10th decile) 333 8.9 47 94.0
Volume of pediatric hospitalizations, median [IQR] 56 [14240] 12,001 [5,83815,448] <0.0001

A total of 1,407,822 (SD 50,456) hospitalizations occurred at GHs, representing 71.7% of pediatric hospitalizations, whereas 554,458 (SD 45,046) hospitalizations occurred at FCHs. Hospitalizations at GHs accounted for 63.6% of days in hospital and 50.0% of pediatric inpatient healthcare costs. Eighty percent of the GHs had total pediatric patient volumes of less than 375 hospitalizations yearly; 11.1% of pediatric hospitalizations occurred at these lower‐volume centers. At FCHs, the median volume of pediatric hospitalizations was 12,001 (interquartile range [IQR]: 583815,448). A total of 36 GHs had pediatric hospitalization volumes in this IQR.

The median age for pediatric patients was slightly higher at GHs, whereas gender, race/ethnicity, primary payer, and median household income for zip code did not differ significantly between hospital types (Table 2). Medical complexity differed between hospital types: children with complex chronic diseases represented 20.2% of hospitalizations at GHs and 35.6% of hospitalizations at FCHs. Severity of illness differed between hospital types, with fewer hospitalizations categorized at the highest level of severity at GHs than FCHs. There were no significant differences between hospital types with respect to the proportion of hospitalizations categorized as neonatal hospitalizations or as elective hospitalizations. The median LOS was shorter at GHs than FCHs. Approximately 1 in 5 children hospitalized at GHs had LOS greater than 4 days, whereas almost 30% of children hospitalized at FCHs had LOS of this duration.

Patient Characteristics and Characteristics of Hospitalizations at General Hospitals and Freestanding Children's Hospitals
Patient Characteristics

General Hospitals,1,407,822 (50,456), 71.7%

Children's Hospitals,554,458 (45,046), 28.3%

P Value
n (SD Weighted Frequency) (%) n (SD Weighted Frequency) %
  • NOTE: Abbreviations: APR‐DRG, All Patient Refined Diagnosis‐Related Group; ED, emergency department; IQR, interquartile range; SD, standard deviation. *Race/ethnicity data missing for approximately 8% of discharge records.[8] Includes in‐hospital death, discharge destination unknown.

Age, y, median [IQR] 3.6 [011.7] 3.4 [010.8] 0.001
Gender (% female) 644,250 (23,089) 45.8 254,505 (20,688) 45.9 0.50
Race*
White 668,876 (27,741) 47.5 233,930 (26,349) 42.2 0.05
Black 231,586 (12,890) 16.5 80,568 (11,739) 14.5
Hispanic 279,021 (16,843) 19.8 12,1425 (21,183) 21.9
Other 133,062 (8,572) 9.5 41,190 (6,394) 7.4
Insurance status
Public 740,033 (28,675) 52.6 284,795 (25,324) 51.4 0.90
Private 563,562 (21,930) 40.0 224,042 (21,613) 40.4
Uninsured 37,265 (1,445) 2.7 16,355 (3,804) 3.0
No charge/other/unknown 66,962 (5,807) 4.8 29,266 (6,789) 5.3
Median household income for zip code, quartiles
<$38,999 457,139 (19,725) 33.3 164,831 (17,016) 30.1 0.07
$39,000$47,999 347,229 (14,104) 25.3 125,105 (10,712) 22.9
$48,000$62,999 304,795 (13,427) 22.2 134,915 (13,999) 24.7
>$63,000 263,171 (15,418) 19.2 122,164 (16,279) 22.3
Medical complexity
Nonchronic disease 717,009 (21,807) 50.9 211,089 (17,023) 38.1 <0.001
Noncomplex chronic disease 406,070 (14,951) 28.8 146,077 (12,442) 26.4
Complex chronic disease 284,742 (17,111) 20.2 197,292 (18,236) 35.6
APR‐DRG severity of illness
1 (lowest severity) 730,134 (23,162) 51.9 217,202 (18,433) 39.2 <0.001
2 486,748 (18,395) 34.6 202,931 (16,864) 36.6
3 146,921 (8,432) 10.4 100,566 (9,041) 18.1
4 (highest severity) 41,749 (3,002) 3.0 33,340 (3,199) 6.0
Hospitalization characteristics
Neonatal hospitalization 98,512 (3,336) 7.0 39,584 (4,274) 7.1 0.84
Admission type
Elective 255,774 (12,285) 18.3 109,854 (13,061) 19.8 0.05
Length of stay, d, (median [IQR]) 1.8 (0.01) [0.8‐3.6] 2.2 (0.06) [1.1‐4.7] <0.001
High turnover hospitalizations 416,790 (14,995) 29.6 130,441 (12,405) 23.5 <0.001
Length of stay >4 days 298,315 (14,421) 21.2 161,804 (14,354) 29.2 <0.001
Admission source
Transfer from another acute care hospital 154,058 (10,067) 10.9 82,118 (8,952) 14.8 0.05
Direct admission 550,123 (21,954) 39.1 211,117 (20,203) 38.1
Admission from ED 703,641 (26,155) 50.0 261,223 (28,708) 47.1
Discharge status
Routine 1,296,638 (46,012) 92.1 519,785 (42,613) 93.8 <0.01
Transfer to another hospital or healthcare facility 56,115 (1,922) 4.0 13,035 (1,437) 2.4
Discharge against medical advice 2,792 (181) 0.2 382 (70) 0.1
Other 52,276 (4,223) 3.7 21,256 (4,501) 3.8

The most common pediatric medical, mental health, and surgical conditions are shown in Figure 1, together representing 32% of pediatric hospitalizations during the study period. For these medical conditions, 77.9% of hospitalizations occurred at GHs, ranging from 52.6% of chemotherapy hospitalizations to 89.0% of hospitalizations for neonatal hyperbilirubinemia. Sixty‐two percent of total hospital costs for these conditions were incurred at GHs. For the common mental health hospitalizations, 86% of hospitalizations occurred at GHs. The majority of hospitalizations and aggregate hospital costs for common surgical conditions also occurred at GHs.

Figure 1
Share of national pediatric hospitalizations and aggregate costs in general and freestanding children's hospitals, by condition, for common medical, mental health and surgical diagnoses. (n = national estimates of number of hospitalizations and associated total hospital costs at general hospitals and children's hospitals).

Whereas pneumonia, asthma, and bronchiolitis were the most common reasons for hospitalization at both GHs and FCHs, the most costly conditions differed (see Supporting Table 1 in the online version of this article). At GHs, these respiratory diseases were responsible for the highest condition‐specific total hospital costs. At FCHs, the highest aggregate costs were due to respiratory distress syndrome and chemotherapy. Congenital heart diseases, including hypoplastic left heart syndrome, transposition of the great vessels, tetralogy of Fallot, endocardial cushion defects, coarctation of the aorta and ventricular septal defects accounted for 6 of the 20 most costly conditions at FCHs.

Figure 2 illustrates the volume of hospitalizations, per hospital, at GHs and FCHs for the most common medical hospitalizations. The median number of hospitalizations, per hospital, was consistently significantly lower at GHs than at FCHs (all P values <0.001). Similar results for surgical and mental health hospitalizations are shown as Supporting Figures 1 and 2 in the online version of this article. In our sensitivity analyses that included all hospitals classified as GH and FCH, all results were essentially unchanged.

Figure 2
Box and whisker plots illustrating median volume of hospitalizations per hospital and associated interquartile range for common medical condition at general hospitals and freestanding children's hospitals (n = number of hospitals represented).

Recognizing the wide range of pediatric volumes at GHs (Table 1) and our inability to differentiate children's hospitals nested within GHs from GHs with pediatric beds, we examined differences in patient and hospitalization characteristics at GHs with volumes 5838 hospitalizations (the 25th percentile for FCH volume) and GHs with pediatric volumes <5838/year (see Supporting Table 2 in the online version of this article). We also compared patient and hospitalization characteristics at FCHs and the higher‐volume GHs. A total of 36 GHs had pediatric volumes 5838, with hospitalizations at these sites together accounting for 15.4% of all pediatric hospitalizations. Characteristics of patients hospitalized at these higher‐volume GHs were similar to patients hospitalized at FCHs, but they had significantly lower disease severity, fewer neonatal hospitalizations, shorter LOS, and more high‐turnover hospitalizations than patients hospitalized at FCHs. We also observed several differences between children hospitalized at higher‐ and lower‐volume GHs (see Supporting Table 2 in the online version of this article). Children hospitalized at the lower‐volume GHs were more likely to have public health insurance and less likely to have complex chronic diseases, although overall, 39.0% of all hospitalizations for children with complex chronic diseases occurred at these lower‐volume GHs. Compared to children hospitalized at higher‐volume GHs, children hospitalized at the lower‐volume hospitals had significantly lower disease severity, shorter LOS, more direct admissions, and a greater proportion of routine discharges.

DISCUSSION

Of the 2 million pediatric hospitalizations in the United States in 2012, more than 70% occurred at GHs. We observed considerable heterogeneity in pediatric volumes across GHs, with 11% of pediatric hospitalizations occurring at hospitals with pediatric volumes of <375 hospitalizations annually, whereas 15% of pediatric hospitalizations occurred at GHs with volumes similar to those observed at FCHs. The remaining pediatric hospitalizations at GHs occurred at centers with intermediate volumes. The most common reasons for hospitalization were similar at GHs and FCHs, but the most costly conditions differed substantially. These findings have important implications for pediatric clinical care programs, research, and QI efforts.

Our finding that more than 70% of pediatric hospitalizations occurred at GHs speaks to the importance of quality measurement at these hospitals, whereas low per‐hospital pediatric volumes at the majority of GHs makes such measurement particularly challenging. Several previous studies have illustrated that volumes of pediatric hospitalizations are too small to detect meaningful differences in quality between hospitals using established condition‐specific metrics.[13, 14, 15] Our finding that more than 10% of pediatric hospitalizations occurred at GHs with pediatric volumes <375 year supports previous research suggesting that cross‐cutting, all‐condition quality metrics, composite measures, and/or multihospital reporting networks may be needed to enable quality measurement at these sites. In addition, the heterogeneity in patient volumes and characteristics across GHs raise questions about the applicability of quality metrics developed and validated at FCHs to the many GH settings. Field‐testing quality measures to ensure their validity at diverse GHs, particularly those with patient volumes and infrastructure different from FCHs, will be important to meaningful pediatric quality measurement.

Our results illustrating differences in the most common and costly conditions at GHs and FCHs have further implications for prioritization and implementation of research and QI efforts. Implementation research and QI efforts focused on cardiac and neurosurgical procedures, as well as neonatal intensive care, may have considerable impact on cost and quality at FCHs. At GHs, research and QI efforts focused on common conditions are needed to increase our knowledge of contextually relevant barriers to and facilitators of high‐quality pediatric care. This, however, can be made more difficult by small sample sizes, limited resources, and infrastructure, and competing priorities in adult‐focused GH settings.[16, 17, 18] Multihospital learning collaboratives and partnerships between FCHs and GHs can begin to address these challenges, but their success is contingent upon national advocacy and funding to support pediatric research and quality measures at GHs.

One of the most notable differences in the characteristics of pediatric hospitalizations at GHs and FCHs was the proportion of hospitalizations attributable to children with medical complexity (CMC); more than one‐third of hospitalizations at FCHs were for CMC compared to 1 in 5 at GHs. These findings align with the results of several previous studies describing the substantial resource utilization attributed to CMC, and with growing research, innovation, and quality metrics focused on improving both inpatient and outpatient care for these vulnerable children.[19, 20, 21, 22] Structured complex care programs, developed to improve care coordination and healthcare quality for CMC, are common at FCHs, and have been associated with decreased resource utilization and improved outcomes.[23, 24, 25] Notably, however, more than half of all hospitalizations for CMC, exceeding 250,000 annually, occurred at GHs, and almost 40% of hospitalizations for CMC occurred at the lower‐volume GHs. These findings speak to the importance of translating effective and innovative programs of care for CMC to GHs as resources allow, accompanied by robust evaluations of their effectiveness. Lower patient volume at most GHs, however, may be a barrier to dedicated CMC programs. As a result, decentralized community‐based programs of care for CMC, linking primary care programs with regional and tertiary care hospitals, warrant further consideration.[26, 27, 28]

This analysis should be interpreted in light of several limitations. First, we were unable to distinguish between GHs with scant pediatric‐specific resources from those with a large volume of dedicated pediatric resources, such as children's hospitals nested within GHs. We did identify 36 GHs with pediatric volumes similar to those observed at FCHs (see Supporting Table 2 in the online version of this article); patient and hospitalization characteristics at these higher‐volume GHs were similar in many ways to children hospitalized at FCHs. Several of these higher‐volume GHs may have considerable resources dedicated to the care of children, including subspecialty care, and may represent children's hospitals nested within GHs. Because nested children's hospitals are included in the GH categorization, our results may have underestimated the proportion of children cared for at children's hospitals. Further work is needed to identify the health systems challenges and opportunities that may be unique to these institutions. Second, because the 2012 KID does not include a specialty hospital indicator, we developed a proxy method for identifying these hospitals, which may have resulted in some misclassification. We are reassured that the results of our analyses did not change substantively when we included all hospitals. Similarly, although we are reassured that the number of hospitals classified in our analysis as acute care FCHs aligns, approximately, with the number of hospitals classified as such by the Children's Hospital Association, we were unable to assess the validity of this variable within the KID. Third, the KID does not link records at the patient level, so we are unable to report the number of unique children included in this analysis. In addition, the KID includes only inpatient stays with exclusion of observation status stays; potential differences between GH and FCH in the use of observation status could have biased our findings. Fifth, we used the PMCA to identify CMC; although this algorithm has been shown to have excellent sensitivity in identifying children with chronic diseases, using up to 3 years of Medicaid claims data, the sensitivity using the KID, where only 1 inpatient stay is available for assessment, is unknown.[8, 29] Similarly, use of Keren's pediatric diagnosis grouper to classify reasons for hospitalization may have resulted in misclassification, though there are few other nonproprietary pediatric‐specific diagnostic groupers available.

In 2012, more than 70% of pediatric hospitalizations occurred at GHs in the United States. The considerably higher pediatric volumes at FCHs makes these institutions well suited for research, innovation, and the development and application of disease‐specific QI initiatives. Recognizing that the majority of pediatric hospitalizations occurred at GHs, there is a clear need for implementation research, program development, and quality metrics that align with the characteristics of hospitalizations at these centers. National support for research and quality improvement that reflects the diverse hospital settings where children receive their hospital care is critical to further our nation's goal of improving hospital quality for children.

Disclosures

Dr. Leyenaar was supported by grant number K08HS024133 from the Agency for Healthcare Research and Quality. The content is solely the responsibility of the authors and does not necessarily represent the official views of the Agency for Healthcare Research and Quality. The authors have no conflicts of interest relevant to this article to disclose.

References
  1. Davis K, Stremikis K, Squires D, Schoen C. Mirror, Mirror on the wall: how the performance of the US health care system compares internationally. The Commonwealth Fund. Available at: http://www.commonwealthfund.org/publications/fund‐reports/2014/jun/mirror‐mirror. Published June 16, 2014. Accessed August 26, 2015.
  2. Fairbrother G, Guttmann A, Klein JD, Simpson LA, Thomas P, Kempe A. Higher cost, but poorer outcomes: the US health disadvantage and implications for pediatrics. Pediatrics. 2015;135(6):961964.
  3. Lassman D, Hartman M, Washington B, Andrews K, Catlin A. US health spending trends by age and gender: selected years 2002–10. Health Aff (Millwood). 2014;33(5):815822.
  4. Moore B, Levit K, Elixhauser A. Costs for hospital stays in the United States, 2012. Healthcare Cost and Utilization Project 181. Available at: http://www.hcup‐us.ahrq.gov/reports/statbriefs/sb181‐Hospital‐Costs‐United‐States‐2012.pdf. Published October 2014. Accessed September 2015.
  5. Averill RF, Goldfield N, Hughes JS, et al. All Patient Refined Diagnosis Related Groups: Methodology Overview. 3M Health Information Systems. Available at: https://www.hcup‐us.ahrq.gov/db/nation/nis/APR‐DRGsV20MethodologyOverviewandBibliography.pdf. Accessed February 8, 2016.
  6. Agency for Healthcare Research and Quality. Healthcare Cost and Utilization Project. Introduction to the HCUP Kids' Inpatient Database (KID) 2012. Available at: https://www.hcup‐us.ahrq.gov/db/nation/kid/kid_2012_introduction.jsp. Published Issued July 2014. Accessed February 8, 2016.
  7. Keren R. Prioritization of comparative effectiveness research topics in hospital pediatrics. Arch Pediatr Adolesc Med. 2012;166(12):1155.
  8. Simon TD, Cawthon ML, Stanford S, et al. Pediatric medical complexity algorithm: a new method to stratify children by medical complexity. Pediatrics. 2014;133(6):e1647e1654.
  9. Averill RF, Goldfield N, Hughes JS, et al. 3M APR DRG Classification System. 3M Health Information Systems. Available at: http://www.hcup‐us.ahrq.gov/db/nation/nis/v261_aprdrg_meth_ovrview.pdf. Accessed August 7, 2015.
  10. Macy ML, Stanley RM, Lozon MM, Sasson C, Gebremariam A, Davis MM. Trends in high‐turnover stays among children hospitalized in the United States, 1993–2003. Pediatrics. 2009;123(3):9961002.
  11. Macy ML, Stanley RM, Sasson C, Gebremariam A DM. High turnover stays for pediatric asthma in the United States. Med Care. 2010;48(9):827833.
  12. Leyenaar JK, Shieh M, Lagu T, Pekow PS, Lindenauer PK. Variation and outcomes associated with direct admission among children with pneumonia in the United States. JAMA Pediatr. 2014;168(9):829836.
  13. Berry JG, Zaslavsky AM, Toomey SL, et al. Recognizing differences in hospital quality performance for pediatric inpatient care. Pediatrics. 2015;136(2):251262.
  14. Bardach NS, Chien AT, Dudley RA. Small numbers limit the use of the inpatient pediatric quality indicators for hospital comparison. Acad Pediatr. 2010;10(4):266273.
  15. Feudtner C, Berry JG, Parry G, et al. Statistical uncertainty of mortality rates and rankings for children's hospitals. Pediatrics. 2011;128(4):e966e972.
  16. Leyenaar JK, Capra LA, O'Brien ER, Leslie LK, Mackie TI. Determinants of career satisfaction among pediatric hospitalists: a qualitative exploration. Acad Pediatr. 2014;14(4):361368.
  17. Simon TD, Starmer AJ, Conway PH, et al. Quality improvement research in pediatric hospital medicine and the role of the Pediatric Research in Inpatient Settings (PRIS) network. Acad Pediatr. 2013;13(6 suppl):S54S60.
  18. Miller M. Roles for children's hospitals in pediatric collaborative improvement networks. Pediatrics. 2013;131(suppl 4):S215S218.
  19. Cohen E, Kuo DZ, Agrawal R, et al. Children with medical complexity: an emerging population for clinical and research initiatives. Pediatrics. 2011;127(3):529538.
  20. Simon TD, Berry J, Feudtner C, et al. Children with complex chronic conditions in inpatient hospital settings in the United States. Pediatrics. 2010;126(4):647655.
  21. Cohen E, Berry JG, Camacho X, Anderson G, Wodchis W, Guttmann A. Patterns and costs of health care use of children with medical complexity. Pediatrics. 2012;130(6):e1463e1470.
  22. Berry JG, Hall DE, Kuo DZ, Hall M, Kueser J, Kaplan W. Hospital utilization and characteristics of patients experiencing recurrent readmissions within children's hospitals. JAMA. 2011;305(7):682690.
  23. Berry JG, Agrawal R, Kuo DZ, et al. Characteristics of hospitalizations for patients who use a structured clinical care program for children with medical complexity. J Pediatr. 2011;159(2):284290.
  24. Cohen E, Jovcevska V, Kuo D, Mahant S. Hospital‐based comprehensive care programs for children with special health care needs: a systematic review. Arch Pediatr Adolesc Med. 2011;165(6):554561.
  25. Gordon J, Colby H, Bartelt T, Jablonski D, Krauthoefer ML, Havens P. A tertiary care–primary care partnership model for medically complex and fragile children and youth with special health care needs. Arch Pediatr Adolesc Med. 2007;161(10):937944.
  26. Cohen E, Lacombe‐Duncan A, Spalding K, et al. Integrated complex care coordination for children with medical complexity: a mixed‐methods evaluation of tertiary care‐community collaboration. BMC Health Serv Res. 2012;12:366.
  27. Lerner CF, Kelly RB, Hamilton LJ, Klitzner TS. Medical transport of children with complex chronic conditions. Emerg Med Int. 2012;2012:837020.
  28. Stiles AD, Tayloe DT, Wegner SE. Comanagement of medically complex children by subspecialists, generalists, and care coordinators. Pediatrics. 2014;134(2):203205.
  29. Berry JG, Hall M, Cohen E, O'Neill M, Feudtner C. Ways to identify children with medical complexity and the importance of why. J Pediatr. 2015;167(2):229237.
References
  1. Davis K, Stremikis K, Squires D, Schoen C. Mirror, Mirror on the wall: how the performance of the US health care system compares internationally. The Commonwealth Fund. Available at: http://www.commonwealthfund.org/publications/fund‐reports/2014/jun/mirror‐mirror. Published June 16, 2014. Accessed August 26, 2015.
  2. Fairbrother G, Guttmann A, Klein JD, Simpson LA, Thomas P, Kempe A. Higher cost, but poorer outcomes: the US health disadvantage and implications for pediatrics. Pediatrics. 2015;135(6):961964.
  3. Lassman D, Hartman M, Washington B, Andrews K, Catlin A. US health spending trends by age and gender: selected years 2002–10. Health Aff (Millwood). 2014;33(5):815822.
  4. Moore B, Levit K, Elixhauser A. Costs for hospital stays in the United States, 2012. Healthcare Cost and Utilization Project 181. Available at: http://www.hcup‐us.ahrq.gov/reports/statbriefs/sb181‐Hospital‐Costs‐United‐States‐2012.pdf. Published October 2014. Accessed September 2015.
  5. Averill RF, Goldfield N, Hughes JS, et al. All Patient Refined Diagnosis Related Groups: Methodology Overview. 3M Health Information Systems. Available at: https://www.hcup‐us.ahrq.gov/db/nation/nis/APR‐DRGsV20MethodologyOverviewandBibliography.pdf. Accessed February 8, 2016.
  6. Agency for Healthcare Research and Quality. Healthcare Cost and Utilization Project. Introduction to the HCUP Kids' Inpatient Database (KID) 2012. Available at: https://www.hcup‐us.ahrq.gov/db/nation/kid/kid_2012_introduction.jsp. Published Issued July 2014. Accessed February 8, 2016.
  7. Keren R. Prioritization of comparative effectiveness research topics in hospital pediatrics. Arch Pediatr Adolesc Med. 2012;166(12):1155.
  8. Simon TD, Cawthon ML, Stanford S, et al. Pediatric medical complexity algorithm: a new method to stratify children by medical complexity. Pediatrics. 2014;133(6):e1647e1654.
  9. Averill RF, Goldfield N, Hughes JS, et al. 3M APR DRG Classification System. 3M Health Information Systems. Available at: http://www.hcup‐us.ahrq.gov/db/nation/nis/v261_aprdrg_meth_ovrview.pdf. Accessed August 7, 2015.
  10. Macy ML, Stanley RM, Lozon MM, Sasson C, Gebremariam A, Davis MM. Trends in high‐turnover stays among children hospitalized in the United States, 1993–2003. Pediatrics. 2009;123(3):9961002.
  11. Macy ML, Stanley RM, Sasson C, Gebremariam A DM. High turnover stays for pediatric asthma in the United States. Med Care. 2010;48(9):827833.
  12. Leyenaar JK, Shieh M, Lagu T, Pekow PS, Lindenauer PK. Variation and outcomes associated with direct admission among children with pneumonia in the United States. JAMA Pediatr. 2014;168(9):829836.
  13. Berry JG, Zaslavsky AM, Toomey SL, et al. Recognizing differences in hospital quality performance for pediatric inpatient care. Pediatrics. 2015;136(2):251262.
  14. Bardach NS, Chien AT, Dudley RA. Small numbers limit the use of the inpatient pediatric quality indicators for hospital comparison. Acad Pediatr. 2010;10(4):266273.
  15. Feudtner C, Berry JG, Parry G, et al. Statistical uncertainty of mortality rates and rankings for children's hospitals. Pediatrics. 2011;128(4):e966e972.
  16. Leyenaar JK, Capra LA, O'Brien ER, Leslie LK, Mackie TI. Determinants of career satisfaction among pediatric hospitalists: a qualitative exploration. Acad Pediatr. 2014;14(4):361368.
  17. Simon TD, Starmer AJ, Conway PH, et al. Quality improvement research in pediatric hospital medicine and the role of the Pediatric Research in Inpatient Settings (PRIS) network. Acad Pediatr. 2013;13(6 suppl):S54S60.
  18. Miller M. Roles for children's hospitals in pediatric collaborative improvement networks. Pediatrics. 2013;131(suppl 4):S215S218.
  19. Cohen E, Kuo DZ, Agrawal R, et al. Children with medical complexity: an emerging population for clinical and research initiatives. Pediatrics. 2011;127(3):529538.
  20. Simon TD, Berry J, Feudtner C, et al. Children with complex chronic conditions in inpatient hospital settings in the United States. Pediatrics. 2010;126(4):647655.
  21. Cohen E, Berry JG, Camacho X, Anderson G, Wodchis W, Guttmann A. Patterns and costs of health care use of children with medical complexity. Pediatrics. 2012;130(6):e1463e1470.
  22. Berry JG, Hall DE, Kuo DZ, Hall M, Kueser J, Kaplan W. Hospital utilization and characteristics of patients experiencing recurrent readmissions within children's hospitals. JAMA. 2011;305(7):682690.
  23. Berry JG, Agrawal R, Kuo DZ, et al. Characteristics of hospitalizations for patients who use a structured clinical care program for children with medical complexity. J Pediatr. 2011;159(2):284290.
  24. Cohen E, Jovcevska V, Kuo D, Mahant S. Hospital‐based comprehensive care programs for children with special health care needs: a systematic review. Arch Pediatr Adolesc Med. 2011;165(6):554561.
  25. Gordon J, Colby H, Bartelt T, Jablonski D, Krauthoefer ML, Havens P. A tertiary care–primary care partnership model for medically complex and fragile children and youth with special health care needs. Arch Pediatr Adolesc Med. 2007;161(10):937944.
  26. Cohen E, Lacombe‐Duncan A, Spalding K, et al. Integrated complex care coordination for children with medical complexity: a mixed‐methods evaluation of tertiary care‐community collaboration. BMC Health Serv Res. 2012;12:366.
  27. Lerner CF, Kelly RB, Hamilton LJ, Klitzner TS. Medical transport of children with complex chronic conditions. Emerg Med Int. 2012;2012:837020.
  28. Stiles AD, Tayloe DT, Wegner SE. Comanagement of medically complex children by subspecialists, generalists, and care coordinators. Pediatrics. 2014;134(2):203205.
  29. Berry JG, Hall M, Cohen E, O'Neill M, Feudtner C. Ways to identify children with medical complexity and the importance of why. J Pediatr. 2015;167(2):229237.
Issue
Journal of Hospital Medicine - 11(11)
Issue
Journal of Hospital Medicine - 11(11)
Page Number
743-749
Page Number
743-749
Article Type
Display Headline
Epidemiology of pediatric hospitalizations at general hospitals and freestanding children's hospitals in the United States
Display Headline
Epidemiology of pediatric hospitalizations at general hospitals and freestanding children's hospitals in the United States
Sections
Article Source
© 2016 Society of Hospital Medicine
Disallow All Ads
Correspondence Location
Address for correspondence and reprint requests: JoAnna Leyenaar, MD, Division of Pediatric Hospital Medicine, Department of Pediatrics, Tufts University School of Medicine, 800 Washington Street, Boston, MA 02111; Telephone: 617‐636‐8821; Fax: 617‐636‐8391; E‐mail: [email protected]
Content Gating
Gated (full article locked unless allowed per User)
Gating Strategy
First Peek Free
Article PDF Media
Media Files

LETTER: Point-of-Care Ultrasound: The (Sound) Wave of the Future for Hospitalists

Article Type
Changed
Fri, 09/14/2018 - 12:03
Display Headline
LETTER: Point-of-Care Ultrasound: The (Sound) Wave of the Future for Hospitalists

Small devices carried in pockets during rounds can enable hospitalists to make quick decisions at the bedside, enhance and teach physical exam skills, streamline patient flow through the hospital, and potentially avoid the cost and risk of exposure to radiation. Point-of-care (POC) ultrasound enhances both patient satisfaction and the clinician’s professional satisfaction. Hospital medicine will be the next field to rapidly assimilate its use.

POC, or “bedside,” ultrasound has been used by ob-gyns, vascular access, and procedural teams for quite some time. Of late, emergency medicine and critical care physicians have adopted its use. It offers the advantage of gaining immediate information regarding the patient through dynamic imaging and the ability to integrate that information into the clinical picture. This enables providers to make decisions about patient care in real time.

With the advent of affordable handheld devices with quality images, rounding with these devices has become practical for hospitalists. Hospitalists should rapidly embrace this skill set. POC ultrasound can be very useful to quickly improve patient diagnosis, patient satisfaction, patient safety, length of stay, and provider satisfaction.

For example, in patients complaining of dyspnea, for which there is not a clear diagnosis of COPD, congestive heart failure, pulmonary embolism, or pneumonia, a focused cardiac ultrasound can rapidly differentiate between right ventricular dysfunction, left ventricular dysfunction, pericardial effusion, or a hyperdynamic heart. Lung ultrasound with diffuse or focal “B lines,” focal consolidation, and/or pleural effusion can assist in differentiating the cause as well.

POC ultrasound also is a teaching tool that can enhance exam skills. Hospitalists can confirm exam findings and teach as they palpate the liver or percuss the chest. Performing a procedure such as paracentesis or a central line with ultrasound guidance is now considered standard of care in some centers. The literature shows ultrasound guidance is safer even when compared to clinicians skilled in landmark techniques. In addition, many hospitalists and/or trainees will work in areas where 24-7 echo, interventional radiologists, and ultrasound techs are not available. Hospitalists need to know how to use POC ultrasound to serve patients well.

POC ultrasound can also be used in daily care. For heart failure patients, watching the B lines (pulmonary edema), pleural effusions, and inferior vena cava size can avoid over- or under-diuresis and reduce length of stay and cost. The same can be said for patients with percutaneous catheters to ensure proper drainage of the pockets of fluid in the chest or abdomen.

It is important to know the limitations of POC ultrasound. It is best used to answer binary questions (e.g., pericardial effusion present or not). It is a skill to be acquired and honed, and it requires specialized training. There are many one- to two-day courses as well simulators and other means. The basics of image acquisition and interpretation can be found online, and much of it is free. Manufacturers often are willing to provide machines to practice with.

Many patients enjoy seeing the images and having a better understanding of their disease process, which leads to improved patient satisfaction. Overall, there are many benefits for hospitalists.


Gordon Johnson, MD, hospitalist and president, Oregon/Southwest Washington SHM Chapter

Issue
The Hospitalist - 2016(07)
Publications
Sections

Small devices carried in pockets during rounds can enable hospitalists to make quick decisions at the bedside, enhance and teach physical exam skills, streamline patient flow through the hospital, and potentially avoid the cost and risk of exposure to radiation. Point-of-care (POC) ultrasound enhances both patient satisfaction and the clinician’s professional satisfaction. Hospital medicine will be the next field to rapidly assimilate its use.

POC, or “bedside,” ultrasound has been used by ob-gyns, vascular access, and procedural teams for quite some time. Of late, emergency medicine and critical care physicians have adopted its use. It offers the advantage of gaining immediate information regarding the patient through dynamic imaging and the ability to integrate that information into the clinical picture. This enables providers to make decisions about patient care in real time.

With the advent of affordable handheld devices with quality images, rounding with these devices has become practical for hospitalists. Hospitalists should rapidly embrace this skill set. POC ultrasound can be very useful to quickly improve patient diagnosis, patient satisfaction, patient safety, length of stay, and provider satisfaction.

For example, in patients complaining of dyspnea, for which there is not a clear diagnosis of COPD, congestive heart failure, pulmonary embolism, or pneumonia, a focused cardiac ultrasound can rapidly differentiate between right ventricular dysfunction, left ventricular dysfunction, pericardial effusion, or a hyperdynamic heart. Lung ultrasound with diffuse or focal “B lines,” focal consolidation, and/or pleural effusion can assist in differentiating the cause as well.

POC ultrasound also is a teaching tool that can enhance exam skills. Hospitalists can confirm exam findings and teach as they palpate the liver or percuss the chest. Performing a procedure such as paracentesis or a central line with ultrasound guidance is now considered standard of care in some centers. The literature shows ultrasound guidance is safer even when compared to clinicians skilled in landmark techniques. In addition, many hospitalists and/or trainees will work in areas where 24-7 echo, interventional radiologists, and ultrasound techs are not available. Hospitalists need to know how to use POC ultrasound to serve patients well.

POC ultrasound can also be used in daily care. For heart failure patients, watching the B lines (pulmonary edema), pleural effusions, and inferior vena cava size can avoid over- or under-diuresis and reduce length of stay and cost. The same can be said for patients with percutaneous catheters to ensure proper drainage of the pockets of fluid in the chest or abdomen.

It is important to know the limitations of POC ultrasound. It is best used to answer binary questions (e.g., pericardial effusion present or not). It is a skill to be acquired and honed, and it requires specialized training. There are many one- to two-day courses as well simulators and other means. The basics of image acquisition and interpretation can be found online, and much of it is free. Manufacturers often are willing to provide machines to practice with.

Many patients enjoy seeing the images and having a better understanding of their disease process, which leads to improved patient satisfaction. Overall, there are many benefits for hospitalists.


Gordon Johnson, MD, hospitalist and president, Oregon/Southwest Washington SHM Chapter

Small devices carried in pockets during rounds can enable hospitalists to make quick decisions at the bedside, enhance and teach physical exam skills, streamline patient flow through the hospital, and potentially avoid the cost and risk of exposure to radiation. Point-of-care (POC) ultrasound enhances both patient satisfaction and the clinician’s professional satisfaction. Hospital medicine will be the next field to rapidly assimilate its use.

POC, or “bedside,” ultrasound has been used by ob-gyns, vascular access, and procedural teams for quite some time. Of late, emergency medicine and critical care physicians have adopted its use. It offers the advantage of gaining immediate information regarding the patient through dynamic imaging and the ability to integrate that information into the clinical picture. This enables providers to make decisions about patient care in real time.

With the advent of affordable handheld devices with quality images, rounding with these devices has become practical for hospitalists. Hospitalists should rapidly embrace this skill set. POC ultrasound can be very useful to quickly improve patient diagnosis, patient satisfaction, patient safety, length of stay, and provider satisfaction.

For example, in patients complaining of dyspnea, for which there is not a clear diagnosis of COPD, congestive heart failure, pulmonary embolism, or pneumonia, a focused cardiac ultrasound can rapidly differentiate between right ventricular dysfunction, left ventricular dysfunction, pericardial effusion, or a hyperdynamic heart. Lung ultrasound with diffuse or focal “B lines,” focal consolidation, and/or pleural effusion can assist in differentiating the cause as well.

POC ultrasound also is a teaching tool that can enhance exam skills. Hospitalists can confirm exam findings and teach as they palpate the liver or percuss the chest. Performing a procedure such as paracentesis or a central line with ultrasound guidance is now considered standard of care in some centers. The literature shows ultrasound guidance is safer even when compared to clinicians skilled in landmark techniques. In addition, many hospitalists and/or trainees will work in areas where 24-7 echo, interventional radiologists, and ultrasound techs are not available. Hospitalists need to know how to use POC ultrasound to serve patients well.

POC ultrasound can also be used in daily care. For heart failure patients, watching the B lines (pulmonary edema), pleural effusions, and inferior vena cava size can avoid over- or under-diuresis and reduce length of stay and cost. The same can be said for patients with percutaneous catheters to ensure proper drainage of the pockets of fluid in the chest or abdomen.

It is important to know the limitations of POC ultrasound. It is best used to answer binary questions (e.g., pericardial effusion present or not). It is a skill to be acquired and honed, and it requires specialized training. There are many one- to two-day courses as well simulators and other means. The basics of image acquisition and interpretation can be found online, and much of it is free. Manufacturers often are willing to provide machines to practice with.

Many patients enjoy seeing the images and having a better understanding of their disease process, which leads to improved patient satisfaction. Overall, there are many benefits for hospitalists.


Gordon Johnson, MD, hospitalist and president, Oregon/Southwest Washington SHM Chapter

Issue
The Hospitalist - 2016(07)
Issue
The Hospitalist - 2016(07)
Publications
Publications
Article Type
Display Headline
LETTER: Point-of-Care Ultrasound: The (Sound) Wave of the Future for Hospitalists
Display Headline
LETTER: Point-of-Care Ultrasound: The (Sound) Wave of the Future for Hospitalists
Sections
Disallow All Ads
Content Gating
No Gating (article Unlocked/Free)

Efficacy of malaria vaccine declines over time

Article Type
Changed
Sun, 07/03/2016 - 05:00
Display Headline
Efficacy of malaria vaccine declines over time

Child receiving RTS,S

Photo by Caitlin Kleiboer

Results from a phase 2 study of the malaria vaccine RTS,S (also known as RTS,S/AS01 or Mosquirix) suggest its efficacy decreases over time, and this decline is fastest in children living in areas with higher-than-average rates of malaria.

Researchers say the results suggest the benefits of the vaccine are likely to vary across different populations and highlight the need for more research to

determine the most effective way of using RTS,S, which last year became the first malaria vaccine to receive a green light from the European Medicines Agency.

“We found that 3-dose vaccination with RTS,S was initially protective, but this was offset by a rebound in later years among children exposed to higher-than-average levels of malaria-carrying mosquitoes,” said Philip Bejon, PhD, of the Kenya Medical Research Institute–Wellcome Trust Programme in Kilifi, Kenya.

Dr Bejon and his colleagues reported these results in NEJM.

The researchers followed 447 children who had received 3 doses of either RTS,S or a rabies (control) vaccine when they were 5 months to 17 months old.

After 7 years, there were 312 children still involved in the study. During the first year, the risk of getting malaria in the vaccinated children was 35.9% less than in the control group. After 7 years, this protection fell to 3.6%.

And in children exposed to higher-than-average rates of malaria, there were slightly more cases of malaria in the vaccinated group than the control group—1002 and 992 cases, respectively—5 years after vaccination.

This “rebound” effect, which has been seen in previous studies, is thought to occur because children initially protected by the vaccine develop their natural immunity against malaria more slowly than unvaccinated children.

Results from a phase 3 study showed that 3 doses of RTS,S reduced the risk of malaria in young children by 28% over 4 years, but this improved to 36% when children were given a fourth dose 18 months after the first dose. Longer-term follow up of these children is ongoing.

“Overall, our study shows that RTS,S can benefit children but suggests that a fourth dose may be important for sustaining this protection over the long term and to protect against a potential rebound,” said Ally Olotu, PhD, of the Kenya Medical Research Institute–Wellcome Trust Programme.

“Results from 3 sites involved in the original phase 3 study that are continuing follow up, and the WHO’s planned pilot program, will tell us more about the vaccine’s efficacy in different settings and help determine which populations would benefit most from receiving it as part of a wider vaccination strategy.”

Publications
Topics

Child receiving RTS,S

Photo by Caitlin Kleiboer

Results from a phase 2 study of the malaria vaccine RTS,S (also known as RTS,S/AS01 or Mosquirix) suggest its efficacy decreases over time, and this decline is fastest in children living in areas with higher-than-average rates of malaria.

Researchers say the results suggest the benefits of the vaccine are likely to vary across different populations and highlight the need for more research to

determine the most effective way of using RTS,S, which last year became the first malaria vaccine to receive a green light from the European Medicines Agency.

“We found that 3-dose vaccination with RTS,S was initially protective, but this was offset by a rebound in later years among children exposed to higher-than-average levels of malaria-carrying mosquitoes,” said Philip Bejon, PhD, of the Kenya Medical Research Institute–Wellcome Trust Programme in Kilifi, Kenya.

Dr Bejon and his colleagues reported these results in NEJM.

The researchers followed 447 children who had received 3 doses of either RTS,S or a rabies (control) vaccine when they were 5 months to 17 months old.

After 7 years, there were 312 children still involved in the study. During the first year, the risk of getting malaria in the vaccinated children was 35.9% less than in the control group. After 7 years, this protection fell to 3.6%.

And in children exposed to higher-than-average rates of malaria, there were slightly more cases of malaria in the vaccinated group than the control group—1002 and 992 cases, respectively—5 years after vaccination.

This “rebound” effect, which has been seen in previous studies, is thought to occur because children initially protected by the vaccine develop their natural immunity against malaria more slowly than unvaccinated children.

Results from a phase 3 study showed that 3 doses of RTS,S reduced the risk of malaria in young children by 28% over 4 years, but this improved to 36% when children were given a fourth dose 18 months after the first dose. Longer-term follow up of these children is ongoing.

“Overall, our study shows that RTS,S can benefit children but suggests that a fourth dose may be important for sustaining this protection over the long term and to protect against a potential rebound,” said Ally Olotu, PhD, of the Kenya Medical Research Institute–Wellcome Trust Programme.

“Results from 3 sites involved in the original phase 3 study that are continuing follow up, and the WHO’s planned pilot program, will tell us more about the vaccine’s efficacy in different settings and help determine which populations would benefit most from receiving it as part of a wider vaccination strategy.”

Child receiving RTS,S

Photo by Caitlin Kleiboer

Results from a phase 2 study of the malaria vaccine RTS,S (also known as RTS,S/AS01 or Mosquirix) suggest its efficacy decreases over time, and this decline is fastest in children living in areas with higher-than-average rates of malaria.

Researchers say the results suggest the benefits of the vaccine are likely to vary across different populations and highlight the need for more research to

determine the most effective way of using RTS,S, which last year became the first malaria vaccine to receive a green light from the European Medicines Agency.

“We found that 3-dose vaccination with RTS,S was initially protective, but this was offset by a rebound in later years among children exposed to higher-than-average levels of malaria-carrying mosquitoes,” said Philip Bejon, PhD, of the Kenya Medical Research Institute–Wellcome Trust Programme in Kilifi, Kenya.

Dr Bejon and his colleagues reported these results in NEJM.

The researchers followed 447 children who had received 3 doses of either RTS,S or a rabies (control) vaccine when they were 5 months to 17 months old.

After 7 years, there were 312 children still involved in the study. During the first year, the risk of getting malaria in the vaccinated children was 35.9% less than in the control group. After 7 years, this protection fell to 3.6%.

And in children exposed to higher-than-average rates of malaria, there were slightly more cases of malaria in the vaccinated group than the control group—1002 and 992 cases, respectively—5 years after vaccination.

This “rebound” effect, which has been seen in previous studies, is thought to occur because children initially protected by the vaccine develop their natural immunity against malaria more slowly than unvaccinated children.

Results from a phase 3 study showed that 3 doses of RTS,S reduced the risk of malaria in young children by 28% over 4 years, but this improved to 36% when children were given a fourth dose 18 months after the first dose. Longer-term follow up of these children is ongoing.

“Overall, our study shows that RTS,S can benefit children but suggests that a fourth dose may be important for sustaining this protection over the long term and to protect against a potential rebound,” said Ally Olotu, PhD, of the Kenya Medical Research Institute–Wellcome Trust Programme.

“Results from 3 sites involved in the original phase 3 study that are continuing follow up, and the WHO’s planned pilot program, will tell us more about the vaccine’s efficacy in different settings and help determine which populations would benefit most from receiving it as part of a wider vaccination strategy.”

Publications
Publications
Topics
Article Type
Display Headline
Efficacy of malaria vaccine declines over time
Display Headline
Efficacy of malaria vaccine declines over time
Disallow All Ads
Content Gating
No Gating (article Unlocked/Free)
Alternative CME
Disqus Comments
Default
Use ProPublica